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SUMMARY
Lymphatic filarial worms are mosquito borne parasites which cause chronic disease in 
humans. Infection is characterized by proliferative suppression of T cells in the host and 
a skewing of the immune response, away from an IFN-y producing Thl response, 
towards a Tli2 or regulatory phenotype, with production of IL-4 and IL-10. In this 
study, a mouse model was used to investigate the role of the infective form of the 
parasite (the third stage larvae, L3) in regulating immune responses. BALB/c mice were 
infected by the subcutaneous route to mimic the natural transmission of the parasite, and 
immune responses generated by the L3 were analysed.
Experiments carried out in the intact BALB/c mouse showed that infection with L3 
results in increased IL-4, IL-10 and IL-5 with no IL-2 or IFN-y, a similar situation to 
that observed in infected humans. In order to investigate the key components in this 
skewing of the immune response, experiments were carried out using IL-4-/- mice. IL-4 
was shown to have a role in down-regulating Thl responses in wild type mice, as 
Imock-out animals produced elevated levels of IL-2 and IFN-y. Flowever these mice still 
had the capacity to produce IL-5, IL-13 and IL-10, suggesting that although IL-4 is an 
important Th2 cytokine, it may be dispensable in the initiation of such a response. In 
addition, reduced levels of proliferation of CD4^ and B220^ cells were observed in 
infected IL-4-/- mice. Despite elevated levels of IFN-y, this reduction in proliferation 
was not associated with increased production of NO, and neutralizing IFN-y itself did 
not restore proliferative responses. Addition of iiL-4 to cultures of splenocytes from 
these mice had a mild effect but did not result in a significant increase in proliferation.
Treatment of splenocytes from intact mice with anti-IL-10 MAb in vitro resulted in 
increased levels of IL-2 and IFN-y, but no significant effect on Ag-specific proliferation 
was observed. However, when mice were treated with an anti-IL-lOR MAb the opposite 
effect was seen, with a significant increase in levels of proliferation and no alteration in 
cytokines. When examined by FACS it was shown that CD4"  ^ cells were the major 
population which expanded during IL-IOR blockade. In addition, CD4^ cells were 
found to be the major source of IL-10 post-infection with L3, suggesting these cells may
X lll
modulate their own proliferation, or perhaps these cells were of a regulatory nature. 
Experiments were also carried out to determine the effect of natural transmission on 
host immune responses. L3 were administered via syringe inoculation or via mosquito 
transmission. Splenocytes from mice infected via syringe inoculation had an increased 
capacity to produce cytokines and displayed higher levels of proliferation. Further 
experiments demonstrated that cytokine and proliferative responses were not dose- 
dependant therefore there may be factors within mosquito saliva which down-regulate 
immune responses in the mouse model.
To further characterize the cellular source of IL-10 produced in response to infection 
with L3, RT-PCR was carried out. These experiments demonstrated that CD4^ cells 
produce not only IL-10 but another regulatory cytokine TGF-(3. Further phenotypic 
analysis of the CD4’^ population in L3 infected mice identified a small percentage of 
CD4^CD25^CTLA-4^ cells which were not present in MF infected or control mice. 
These cells were IL-4 independent, as was expression of IL-10 and TGF- 
(3 mRNA. Limiting the expansion of these cells in vivo with the administration of an 
anti-CD25 MAb, resulted in elevated levels of Ag-specific and spontaneous cytokine 
and proliferative responses, indicating that these cells are essential for regulating 
immune responses to infection with L3.
The aim of the final part of this study considered the role of B cells in L3 infection. It 
was shown by CFSE staining that B cells were the major population which proliferate in 
response to restimulation with parasite Ag, and B cells were also shown to be a source 
of IL-10, suggesting an important function for these cells. Experiments carried out in 
pMT mice confirmed results from depletion experiments as levels of Ag-specific 
proliferation were decreased in these mice. However, B cell depletion experiments 
showed that levels of IFN-y were significantly increased post-depletion, with decreased 
levels of Th2 cytokines and IL-10, suggesting that B cells are important in maintaining 
Th2 responses at least in the BALB/c mouse. This profile of cytokine responses differed 
from that in pMT mice. Further experiments demonstrated that B cells act as APC in 
this system, as most B7-l^ and B7-2‘^ cells in splenocyte cultures from L3 infected mice 
were also B220^. B7-1 and B7-2 expression was shown to be regulated by IL-10 as 
neutralizing IL-10 in vitro or analyzing splenocytes from IL-10-/- mice resulted in
XIV
significantly increased expression of these costimulatory molecules. As B cells have 
been shov^n to be a source of IL-10, this suggests another mechanism of negative 
feedback, where production of IL-10 leads to down-regulation of costimulatory 
molecules on the surface, thus attenuating the efficiency of these cells to present Ag to 
CD4^ cells.
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Chapter 1. Introduction
Lymphatic filariasis (LF) is a debilitating disease of humans which is responsible for 
considerable pathology and morbidity in tropical regions of the world. There are 
approximately 751 million individuals living in endemic areas where transmission is 
Imown to oceur and of these individuals, an estimated 128 million people are infected 
(Michael et a l, 1996). In a World Health Organisation (WHO) report in 1995, LF was 
named as the second leading eause of permanent and long-term disability worldwide. 
The mosquito transmitted, long-lived nematodes of the genera Wuchereria and Brugia 
are the causative agents of LF with Wuchereria bancrofti aecounting for 91% of 
infections and Brugia malayi and Brugia tiinori responsible for the remaining 9%. 
Infection with B. malayi occurs in South and South East Asia, whereas B. timori has 
only been detected in approximately 40,000 individuals on the Indonesian islands of 
Timor, Flores, Rote and Alor (Scott, 2000). Bancroftian filariasis occurs throughout the 
tropics and subtropics, with the exception of the Middle East where infection is only 
prevalent in Egypt. The widespread occurrence of these filarial infections is 
predominantly associated with the geographical distribution and parasite compatibility 
of the vector mosquito. For example, W. bancrofti can be transmitted by many different 
species of mosquito, however its main vectors are the domesticated, night-feeding urban 
mosquito Culex quinquefasciatus, with Anopheles spp. and Aedes spp. being more 
common in rural areas. It is the ability of this parasite to be transmitted by a number of 
different vectors that results in bancroftian filariasis being so widespread. Conversely, 
the definitive host of W. bancrofti is very specific, the only occurrence of natural 
infection is in humans. Mosquitoes of the genus Anopheles, Aedes and Mansonia, 
transmit Brugian filariasis. B. malayi is predominantly a parasite of man although it is 
also a zoonosis, with monlcey, cat and dog reservoirs and this animal reservoir is very
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important in terms of infection control. B. timori is transmitted via Anopheles 
harbirtostris and natural infection is limited to humans. B. pahangi is a natural parasite 
of wild and domestic animals in South East Asia and has proved to be a useful 
experimental species, as infections in laboratory animals such as the jird, Meriones 
unguiculatus, will develop to patency (Ash and Riley, 1970).
1.1. Parasite Life Cycle
There are no free-living forms of these parasites and the full developmental cycle takes 
place in the mosquito (intermediate) host where larval development occurs and in the 
human (definitive) host where larval and adult development takes place. Like other 
nematodes, the lymphatic filariae have five developmental stages in their life cycle. 
Infection of the definitive host is initiated by the bite of a mosquito which harbours 
mature, infective third stage larvae (L3) (approximately 1.5 x 0.3 mm in size), which are 
present in the head and mouthparts of the mosquito. The L3 is released from the 
mosquito’s proboscis onto the skin and the larvae enter the body via the pmicture 
wound (Denham and McGreevy, 1977). Once the dermis has been penetrated the L3 
enters the lymphatic system of the human host. The moult from the L3 to the fourth 
stage larvae (L4) occurs between days nine and fourteen post infection (p.i.). In a 
process, which can take 3 - 1 2  months (depending on species), L4 develop into sexually 
mature adults which dwell primai’ily in the afferent lymphatics. The adult parasites are 
white, unsegmented and thi*ead-like and the females are approximately double the size 
of the males (e.g. B. pahangi male adult measures 22 x 0.1 mm whereas the female 
measures 48 x 1.5 mm). After mating the females constantly produce sheathed 
microfilarae (MF/Ll) that circulate in the bloodstream, and are available for ingestion 
by a mosquito upon taking a blood meal. An interesting aspect of the microfilaraemic
stage of infection is the dramatic fluctuation in numbers of MF in the blood over the 
course of 24 hours. In most W. bancrofti endemic areas MF are nocturnally periodic, in 
that they are at maximum numhers in the blood at night and virtually disappear' from the 
circulation during the day when they are concentrated in the lungs (Spencer, 1973).
This phenomenon ensures that MF are available in the peripheral blood at high 
concentration when vector species are feeding.
Once ingested by the mosquito the MF (measuring only 210 x 6 pm) migrate from the 
blood meal and penetrate the mid-gut where they pass through the haemoeoel before 
migrating to the thoracic muscles where development is initiated (Agudelo-Silva and 
Spielman, 1985). The development of the parasite into the L2, then subsequently the L3 
is temperature dependent (optimal 28^C and 80% humidity) and by the eighth day the 
majority of the parasites are L3 or in the process of moulting. Within two days the ' I
mature L3 will migrate from the flight muscles and will associate with the feeding 
structures in the head of the mosquito which facilitates their transmission to the 
definitive host.
1.2. The Clinical Spectrum of Disease
There are many different clinical manifestations of LF ranging from asymptomatic 
microfilaraemia to gross pathology. In addition a proportion of exposed individuals 
remain uninfected. These people are termed endemic normals or asymptomatic 
amicrofilaraemics. The clinical manifestations vary from one endemic area to another 
and also differ depending on the parasite involved. The wide spectrum of the disease is 
summarised below.
1.2.1. The microfilaraemic state
The vast majority of infected individuals living in an endemie area display few overt 
eiinieal manifestations of filariasis, despite the presence of high levels of MF in the 
peripheral blood (Kumaraswami, 2000). However, although these individuals appear to 
be clinically asymptomatic, recent evidence suggests that virtually all these individuals 
suffer from some form of sub-clinical disease. For example approximately 40% of MF+ 
individuals have low-grade renal damage which is associated with the presence of MF, 
not adult parasites (Dreyer et a l, 1992) and many patients present with abnormal 
patterns of lymphatic flow (Freedman et a l, 1994; Suresh et a l, 1997). Therefore the 
clinical aspects of the microfilaraemic state are more complex than was first thought. 
However, despite these distinct signs of pathology associated with microfilaraemia, the 
majority of individuals remain in this state for decades without developing either 
chronic or acute pathologies (Kumaraswami, 2000).
1.2.2. Acute manifestation of Lymphatic Filariasis
Adenolymphangitis (ADL) is the term used to characterise recurrent attacks of fever 
associated with inflammation of the lymph nodes and/or lymph vessels. Recurrent 
attacks of fever associated with lymphadenitis are more commonly seen in Brugian 
filariasis than with bancroftian filariasis. In Brugian filariasis the affected lymph nodes 
are mostly situated in the inguinal and axillary regions with inflammation along the 
course of the distal lymphatic vessels (Partono, 1987). These acute attacks may last up 
to 6 weeks, therefore resulting in prolonged periods of inability to work. These episodes 
are characterised by warmth, tenderness and local pain of the limb, breast or male 
genitalia. ADL is generally associated with individuals who are amierofilaraemic 
(Ottesen and Nutman, 1992).
1.2.3. Chrome manifestations of Lymphatic Filariasis
Clironic pathology (CP) only develops in a small proportion of infected individuals and 
rarely occurs before the age of 15 (Partono, 1987). Individuals presenting with 
pathology are generally amierofilaraemic (Ottesen and Nutman, 1992). Pathology 
associated with filariasis manifests as hydrocoele, chyluria, lymphoedema and 
elephantiasis. The symptoms of pathology are primarily caused by living or 
degenerating worms resident in the lymphatic vessels (Dreyer and Piessens, 2000), but 
these conditions are often exacerbated by the presence of fungal or bacterial infections. 
The infected individuals are predisposed to secondary infections due to impaired 
lymphatic drainage (Jamal and Pani, 1990), although some individuals do develop 
lymphoedema without the presence of secondary infections. In these cases it is thought 
that the worms themselves are the primary cause of pathology (Dreyer and Piessens,
2000). Swelling of the limbs is the most common presentation of pathology. In 
bancroftian filariasis the entire limb is normally affected, but in Brugian filariasis the 
leg below the laiee and the arm below the elbow are typically affected.
1.2.4. Tropical Pulmonary Fosinophilia
TPE is a rare clinical manifestation associated with W. bancrofti infection. It is thought 
to reflect an immunological hyper-responsiveness to the parasite (particularly the MF 
stage) which presents as eosinophil counts greater than 3000/ml, increased levels of IgE 
and anti-filarial Abs (Ottesen and Nutman, 1992). MF are typically absent from the 
blood of these individuals, although dead or dying MF have been identified in lung 
biopsies. Symptoms include cough, dyspnoea and wheezing (Spry and Kumaraswami, 
1982). This condition has been shown to respond well to treatment with the anti-filarial 
drug diethylcabazamine (DEC).
1.2.5. Endemic Normals
In most areas where filariasis is endemic, a proportion of individuals do not show any 
clinical manifestations of the disease and are amicrofilai'aemic despite having been 
exposed to infective larvae. With the advent of more sensitive diagnostic teclmiques, i.e. 
circulating Ag tests, the number of endemie normals has decreased, as many individuals 
test positive for filarial Ag despite appearing to be MF free (Moore and Copeman, 
1994). Therefore the absence of MF alone is not satisfactory for determining whether an 
individual is infection h'ee. In addition ultrasound examinations can now determine 
whether an individual is an amierofilaraemic adult worm carrier or a normal, uninfected 
individual (Amaral et a l,  1994).
1.3, Diagnosis and Treatment
Diagnosis of LF can be carried out in two ways. Firstly, it is possible to detect the 
parasite itself or to detect parasite products by circulating Ag tests; secondly, serology 
can be carried out to identify an immune response to the parasite.
1.3.1 Parasitological diagnosis
Detection of MF is the most common form of parasitological diagnosis. In most parts of 
the world MF are periodic (Manson, 1883), in that they appear at their highest load at 
night. Therefore it is imperative that blood be taken for diagnostic purposes when MF 
reach peak levels (between 10 PM and 2 AM). Traditionally this form of diagnosis is 
made by staining blood films for the presence of MF. However patients with low levels 
of MF may not be detected using this method (20 MF / ml of blood required for reliable 
diagnosis). Alternatives to this method have been developed and have proved more
sensitive, such as membrane filtration. This technique involves taking 1 ml of blood and 
passing it through a polycarbonate membrane with a 3 to 5 pm pore size. MF, which 
have been retained on the membrane, can be stained with Giemsa. This method is twice 
as sensitive as carrying out blood films but is more expensive and requires venous 
puncture. Both of these methods have other disadvantages, sueh as colleetion of 
samples at night and the inability to detect occult infection, when MF are not present in 
the circulation (Eberhard and Lammie, 1991).
Circulating Ag detecting tests for Wuchereria infection can be carried out at any time 
therefore eradicating the requirement for nocturnal sampling and this form of diagnosis 
is now recognized as the method of choice for W. bancrofti infection. Previously, 
monoclonal Abs which recognise phosphocholine (PC), a secretory-excretory product 
of filarial parasites, were used in ELISA to determine whether an individual has 
circulating filarial Ag (CFA) in their blood (Weil et a l, 1997). However this method 
was difficult to perform in the field, therefore a rapid-format filarial Ag test using an 
ICT (immunocliromatographic test) card was designed by ICT Diagnostics (Balgowlah, 
New South Wales, Australia). Human serum or plasma is added to a pink sample pad 
that contains dried polyclonal antifilarial antibodies coupled to colloidal gold. Antigen- 
antibody complexes form and the gold-labelled conjugate eoncentrates to form a pink 
line visible after 5 minutes. This assay has a reported sensitivity of 96-100% and a 
specificity of 100% (Weil et a l, 1997). Since the advent of this technique, many 
individuals thought previously to be endemic normals have proved to harbour infection.
1.3.2 Serodiagnosis
Serodiagnosis is useful for the detection of Brugian infections, as circulating Ag 
detecting tests are not available for Brugian infection. Serological detection is generally 
carried out using the ELISA format. However, such techniques have proved to be 
problematic due to poor specificity, as extensive eross-reactivity is found in the sera of 
individuals infected with closely related parasites (Voiler and De Savigny, 1981); 
(Maizels et a l, 1985). In addition, serodiagnosis does not distinguish between past and 
current infections. However, greater specificity can be achieved by detecting Brugia- 
specific antibodies of the IgG4 subclass. IgG4 levels are greatly up-regulated in actively 
infected individuals, but not in those who have had previous infections. In addition this 
assay can be useful in assessing the effectiveness of treatment, as levels of IgG4 fall 
after chemotherapy (Terhell et a l, 1996); (Atmadja et a l, 1995). However this form of 
diagnosis is not as specific as parasitological diagnosis.
1.3.3. Treatment and control of Lymphatic Filariasis
In 1998, a Global Programme to Eliminate LF was initiated and is active in 18 of the 80 
endemic countries worldwide. The two principle goals of the Programme are to 
interrupt transmission of the infection and to treat and prevent the disability caused by 
the disease. However, it is of great importance to ensure that these goals are reached in a 
cost effective and socially acceptable manner. To eliminate, or more realistically reduce 
the level of transmission, all at-risk individuals are treated with a yearly, single dose of 
a two-drug regime to reduce levels of MF in the circulation below those required to 
sustain transmission, and to kill adult worms. The drugs of choice are; albendazole (400 
mg) plus diethylcabamazine (DEC) (6 mg/kg), or albendazole (400 mg) plus ivermectin 
(200 pg/kg) in sub-Saharan Africa. This regimen will require to be administered for
several years to correspond with the reproductive life span of adult worms. 
Alternatively DEC can be added to cooking/table salt to ensure daily consumption of 
the drug over a 6-12 month period (Ottesen, 2000). In addition, transmission of the 
parasite can be affected by reducing the nmnber of mosquitoes in an endemie area by 
spraying breeding grounds with biocides, or by reducing the biting activity of the 
mosquitoes using insecticide impregnated bednets.
In terms of relieving physical pain and suffering associated with the disease, the main 
strategy involves treatment of secondary opportunistic bacterial and fungal infections, 
which are the primary cause of the worsening of lymphoedema. The basic components 
of managing lymphoedema are meticulous hygiene, prevention and cure of entry 
lesions, exercise, elevation and wearing proper shoes. Treatment of the affected limb 
with antibiotics and antiseptics will alleviate bacterial infections. Proper management of 
lymphoedema should result in increased quality of life for the patient, therefore 
educating the community on these basic measures should make a significant difference 
towards the control of filariasis (Dreyer et a l, 2002).
1.4. Immunology of Lymphatic Filariasis
Filarial parasites cause clii’onic infections which evoke host responses and immuno- 
pathological changes. The wide spectriun of disease associated with filariasis reflects an 
equally wide range of host responses to infection. Most studies have involved 
comparing the immune response of microfilaraemies, chronic pathology patients and 
endemic normals. In general it has been shown that peripheral blood mononuclear cells 
(PBMC) from individuals with patent microfilaraemia are unable to generate cellular 
immune responses to filarial antigens, thus distinguishing their immune response from
that of non-infected individuals in an endemic area. In contrast, PBMC from patients 
with cinonic pathology (who are typically MF negative) display increased cellular 
reactivity to filarial Ag (Ottesen et a l,  1977; Piessens et a l, 1980a; King et a l, 1992). 
However, despite these differences in responsiveness between clinical groups, there are 
eertain features of the immune response whieh each group have in common, for 
example, a certain degree of Ag-specific proliferative suppression (Piessens et a l, 
1980a; Ottesen, 1992; Yazdanbakhsh et a l, 1993a; Sartono et a l, 1995a), high levels of 
IL-4 (King et a l, 1992; Mahanty et a l, 1991; Mahanty et a l, 1993; Yazdanbakhsh et 
a l, 1993b), and down-regulated levels of IFN-y (King et a l, 1992; Raviehandran et a l, 
1997).
1.4.1. Proliferative suppression
T cell hyporesponsiveness is a characteristic of human filaiial infection but many other 
infectious diseases show a similar pattern of down-regulated immune responses. For 
example in visceral leishmaniasis, lepromatous leprosy, tuberculosis and 
schistosomiasis, PBMC show poor Ag-specific proliferation. In general this 
unresponsiveness is attenuated upon treatment (Maizels et al., 2000). In terms of LF, 
this defect is most profoundly observed in individuals who are microfilaraemic (Ottesen 
et a l,  1977; Piessens et a l, 1980a; Yazdanbakhsh et a l, 1993a). PBMC taken from 
microfilaraemic individuals fail to proliferate to filarial Ag whereas in most studies, 
mitogen stimulated responses remain intact (Ottesen et a l, 1977). These depressed 
levels of proliferation may be regarded as a form of immunological tolerance. In 
contrast, PBMC taken from EN and chronic pathology patients will proliferate to 
varying degrees (Maizels et a l, 1995), although all clinical groups display a certain 
degree of suppression (Yazdanbaklish et a l, 1993a). However in a study by King et al
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(2001), T cells from individuals who lived in a high intensity transmission village in 
Papua New Guinea (PNG) exhibited depressed levels of proliferation in response to 
non-filarial Ag and phytohaemagglutin (PHA) compared to individuals who lived in a 
low transmission area. These results suggest a role for the incoming L3 in mediating 
uni'esponsiveness as the subjects were matched for levels of infection. In addition, a 
series of studies carried out by Cooper et al (1998, 1999) demonstrated that infection 
with Onchocerca volvulus effects the efficacy of vaccines. Notably, post-vaccination 
with tetanus toxoid (TT), proliferative, antibody and IFN-y levels were significantly 
greater in individuals who were not infected. Infected individuals did however produce 
TT specific IL-10 (while non-infected individuals did not), suggesting that IL-10 has a 
role in down-regulating non-filarial Ag responses.
The precise mechanisms underlying the proliferative suppression are not yet fully 
elucidated but may include clonal deletion, induction of anergy, an imbalance in 
cytokine production, clonal exhaustion or the development of regulatory cell 
populations (Maizels et a l, 2000). The induction of this “tolerance” is however, likely 
to be only partial as some studies have shown that it can be reversed with ehemotherapy 
(Piessens et a l, 1981; Sartono et a l, 1995b).
1.4.2 In utero exposure to filarial Ag
As referred to above one possible explanation of the proliferative defect in LF is a form 
of immunological tolerance. In support of this hypothesis, Haitian children born to 
mothers infected with W. bancrofti were observed to be more susceptible to filarial 
infection than those born to uninfected mothers (Lammie et a l, 1991). In an additional 
study carried out in the Cook Islands, the offspring of mothers who were MF+ remained
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unresponsive to MF Ag tlii'oughout their lives, suggesting that clonal deletion of Ag- 
reactive T cells may occur due to in utero exposure to parasite Ag (Steel et a l,  1994). In 
a recent study in an area of Kenya where W. bancrofti is endemic, children of infected 
mothers had a three to four-fold increased risk of filarial infection as determined by 
CFA, compared to children born to uninfected mothers. In addition, ehildren of infected 
mothers exhibited elevated levels of IL-5 and IL-10, and depressed levels of 
proliferation in response to MF Ag compared to children of uninfected mothers. 
However, the response to adult Ag was markedly different as there was no difference in 
cytokine production or proliferation between the groups. These results support the 
concept that in utero exposure to filarial Ag increases the offspring’s susceptibility to 
W. bancrofti infection and polarises the immune response towards Th2 (Malhotra et a l , 
2003). However some studies have shown that treatment with DEC can result in the 
recovery of Ag-specific proliferative responses, at least in the short term, thus arguing 
against clonal deletion (Lammie et a l, 1992; Sartono et a l,  1995a). However this is a 
controversial area as other studies have shown no recovery of proliferative responses 
post-chemotherapy (Steel and Ottesen, 2001), indieating that clearance of infection is 
not sufficient to restore immune responsiveness, at least to a comparable level with EN 
individuals. Therefore infection with filarial parasites appears to induee long-term 
defects in the ability to respond to parasite Ag. These findings underline the fact that 
there are many different pathways whieh may result in Ag-specific unresponsiveness in 
LF.
1.4.3. IL-4 in Lymphatic Filariasis
Although PBMC from microfilaraemies do not proliferate in response to parasite Ag 
they have the ability to produce cytokines. T cells from these individuals, along with
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EN and cln'onic pathology patients secrete significant amounts of Ag-specific IL-4, with 
a resultant down-regulatioii in IFN-y responses (Nutman et a l, 1987; Mahanty et a l, 
1996b). This has been demonstrated at the protein level (Mahanty et a l, 1996b) and at 
the mRNA level (Dimock et a l, 1996). In the latter study it was shown that levels of IL- 
4 mRNA did not differ between PBMC from MF+, MF-, CFA+ or CFA- individuals 
upon in vitro stimulation with parasite Ag. As PBMC from putatively immune CFA- 
individuals also express elevated levels of IL-4 in the absence of infection, the L3 to 
which all individuals are exposed may be the stimulus for IL-4 production in this group.
Levels of IL-4 correlate inversely with levels of IFN-y in filarial infected individuals, 
however when the cells that produce IL-4 and IFN-y were enumerated and compared 
between patients with chronic pathology and those with an active infection, it was 
observed that the ratio of IFN-y:IL-4 producing cells was higher in patients with CP and 
lower in MF+ individuals (King et a l, 1993). Therefore it has been suggested that 
despite elevated levels of IL-4 in individuals from all clinical groups, it is the down- 
regulation of IFN-y producing cells in microfilaraemic individuals that may be the 
important factor in maintaining parasite infeetion (Maizels et a l, 1995; Sartono et a l, 
1997). The presence of the parasite is clearly associated with down-regulation of IFN-y 
production as MF+ individuals who are given chemotherapy can produce IFN- 
y (Sartono et a l, 1995a).
Interestingly, although IL-4 responses are elevated in active infection, IL-5 is not co- 
ordinately up-regulated (Sartono et a l, 1997). When Ag-specific IL-5 responses were 
examined as a function of clinical status and age, it was shown that MF- individuals had 
higher levels of IL-5 than MF+ and that IL-5 decreased significantly with increasing age
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in both MF+ and MF- individuals. This is quite different to the situation with IL-4 
where levels of IL-4 were not different between MF+ and MF- individuals. In addition, 
IL-4 levels increase with age in MF+ individuals and decrease in MF- individuals. 
Therefore the cytokine disregulation observed in LF is observed in both Thl and Th2 
subsets suggesting that immune responses to filarial parasites do not fall neatly into the 
Thl/Th2 paradigm. This theory was discussed in a review by Allen and Maizels (1997), 
which notes that even though the Th2 bias in the immune response to filarial infection 
makes the Thl/Th2 model attractive, it does not account for the mechanisms of 
hyporesponsiveness observed in filarial patients.
1.4.4. IL-10 in Lymphatic Filariasis
As discussed above, the exact nature of Ag-specific hyporesponsiveness has yet to be 
elucidated. The role of IL-10 has been of interest in LF due to its capacity to block 
activation of cytokine synthesis and several accessory macrophage functions. These 
functions render IL-10 a potent suppressor of the effector functions of macrophages, T 
cells andNK cells, at least in murine models (Fiorentino et a l, 1989). Initial studies into 
the role of IL-10 in LF were carried out by neutralizing IL-10 in cultures of PBMC from 
W. bancrofti infected MF+ individuals. The characteristic T cell hyporesponsiveness 
was reversed when IL-10 was neutralized. In addition a similar but less pronounced 
effect was observed when TGF-P was neutralized (King et a l, 1993). In another study, 
it was found that PBMC from MF+ individuals secreted large amounts of spontaneous 
IL-10. Levels of IL-10 increased when cells were re-stimulated with mixed sex adult or 
microfilarial Ag but not adult male Ag, suggesting that IL-10 production is regulated by 
MF Ag, but also may suggest a role for adult female Ag. IL-10 levels were inversely
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correlated with levels of Thl cytokines, indicating a role for IL-10 in down-regulating 
Thl responses in these individuals (Mahanty et a l, 1996b).
In a more recent study, Mahanty et al investigated the regulation of antigen specific 
immune responses by IL-10 and IL-12. These two cytokines have opposing functions as 
IL-12 has a critical role in the stimulation of IFN-y from NK cells and T cells (D'Andrea 
et a l, 1993). Confirming the previous findings of King el al (1993), neutralizing anti- 
IL-10 was shown to enhance proliferation in response to restimulation with B. malayi 
adult antigen in 78% of MF+ infected individuals (Mahanty et a l,  1997). These studies 
indicate that IL-10 plays a critical role in the hyporesponsiveness to antigen that is 
associated with MF+. As a result of IL-10 blockade, levels of IFN-y increased two-fold 
in 73% of MF+ subjects studied, in keeping with the hypothesis that IL-10 inhibits IFN- 
y secretion in response to antigen (Mahanty et a l, 1997). However these results also 
demonstrate that MF+ individuals have antigen-specific T cells capable of moimting a 
Thl response under the appropriate conditions. In the same study, when IL-12 was 
neutralized, levels of IL-5 increased in Ag stimulated cultures while levels of IFN-y 
decreased. Augmentation of Type 2 responses by anti-IL-12 suggests that there are 
significant amounts of IL-12 in the Ag-driven cultures but that the inhibitory effects of 
endogenously secreted IL-10 on Type 1 responses to Ag are not effectively attenuated 
by IL-12.
To gain understanding of the molecular basis of the Thl hyporesponsiveness, 
Raviehandran et al (1997), performed RT-PCR to determine the levels of cytokine 
mRNA in PBMC from W. bancrofti infected MF+, CP and endemic normal individuals. 
Unstimulated PBMC from EN individuals had a purely Thl pattern with no IL-4 or IL-5
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expression. In PBMC from MF+ there was a marked decrease in the expression of Thl 
cytokines (IFN-y and IL-2), paralleled by increased expression of IL-10. Comparatively 
little IL-10 expression was observed in CP patients and a ten-fold increase in levels of 
IFN-y and IL-2 was observed between CP and MF+ individuals. PBMC and adherent 
cells in MF+ patients stimulated with Ag or medium only were also shown to express 
greater levels of IL-10 mRNA in comparison to individuals with elephantiasis. When 
IL-10 expression in response to parasite antigen was examined it was found that only 
MF+ individuals expressed IL-10 and that there was a significant negative correlation 
between IL-10 mRNA expression and PBMC proliferation in the MF+ individuals in 
comparison with CP and EN patients (Raviehandran et a l, 1997). This study lends 
further support to the hypothesis that IL-10 is involved in the down-regulation of the 
Thl response. However when studying individuals infected with Brugia malayi a 
similar phenomenon was not observed. PBMC from MF+, CP and EN individuals were 
cultured with B. malayi antigen and a range of different reagents were added in an 
attempt to reverse the proliferative defect. These included IL-2, IL-7, anti-IL4, anti-IL- 
10, anti-CD2, anti-CD27, anti-CD28, indomethacin, phorbol myristate acetate (PMA) or 
calcium ionophore. Co-culture with IL-2, IL-7 and PMA were the only conditions 
which resulted in enhanced proliferation to parasite antigen, but only in a few cases. 
Neutralizing antibodies to IL-10 did not restore responsiveness to antigen (Sartono et 
a l, 1995b). Furthermore, higher levels of IL-10 mRNA expression were observed in CP 
patients infected with W. bancrofti than in MF+ patients using PBMC re-stimulated 
with fractionated B. pahangi Ag (Dimock et a l , 1994).
These contrasting findings may be due to a number of different factors, e.g. different 
species of parasite studied (W bancrofti or Brugia species), different geographical
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strains of parasites i.e. studies by Dimock et al, King et al and Sartono et al were 
carried out in different endemie regions (Haiti, Madras, India and Indonesia, 
respectively). In addition, the use of different antigens for restimulation {B. malayi, B. 
pahangi), possible differences in past chemotherapy, differences in transmission rate or 
the use of cryopreserved cells (Sartono et a l, 1997) may all contribute to the conflicting 
results described above.
IL-10 has also heen postulated to play an important role in the regulation of CD4^ T cell 
responses induced by the parasitic trematode Schistosoma. In a recent study, the 
contribution of IL-10 and IFN-y to the regulation of Thl and Th2 cytokine responses 
was investigated in individuals with differing clinical forms of S. mansoni. It was 
demonstrated, by the use of cytokine neutralization procedures, that early disease is 
associated with a significant IFN-y response and that IL-10 contributes to the 
suppression of that response during both early and chronic infection. This is due to the 
measurable cross- regulation between IL-10 and IFN-y, with IL-10 neutralization up 
regulating IFN-y production and vice versa (Montenegro et a l,  1999). Broadly similar 
results were obtained in a study in which responses to adult worm Ag (AWA) were 
investigated using fresh or cryopreserved PBMC from individuals clironically infected 
with Schistosoma haematobium (Grogan et a l, 1998). Neutralizing IL-10 alone resulted 
in increased background levels of proliferation of PBMC, but did not increase levels of 
AWA-specific proliferation in freshly isolated cells or cryopreserved eells. Also, IFN- 
y levels were increased when IL-10 was neutralized, however this increase was 4-fbld 
greater in freshly isolated cells compared to cryopreserved cells. IL-4 was unaffected by 
anti-ILlO MAb. IL-10, therefore has a down-regulatory effect on Thl responses in S. 
haematobium infection but plays no role in modulating IL-4 responses. This study was
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also informative in that it demonstrated a difference in the use of cryopreserved and 
freshly isolated cells (Grogan et al., 1998).
1.4.5. The role of Antigen Presenting Cells in Lymphatic Filariasis
One of the major ways in which IL-10 modulates T cell responses is via an indirect 
effect on antigen presenting cells (AFC). Evidence from several studies has indicated 
that defeets in antigen presentation are critieal for development of peripheral tolerance 
in LF (Ottesen, 1979; MacDonald et a l, 1999). For example, an important study 
indicated that IL-10 from infected individuals may be produced by adherent cells 
(Mahanty et a l, 1996b). The role of impaired APC function in LF was investigated by 
examining the expression of the costimulatory ligands B7-1 (CD80) and B7-2 (CD86), 
which are present on the surface of professional APC. The importance of the “second 
signal” in the activation of responder T cells which initiate Ag-specific responses is 
outlined in Section 1.6. Raviehandran et al addressed the possibility that T cell 
hyporesponsiveness in individuals infected with W. bancrofti could result from the 
absence of costimulatory signals delivered by APC. mRNA levels of B7-1 were 
compared in PBMC from EN, CP and MF+ individuals. Levels of B7-1 expression on 
unstimulated PBMC from MF+ individuals were very low compaied to the basal level 
observed in CP individuals. However, most significant was the baseline expression of 
B7-1 in EN, in which cells from every individual expressed spontaneous B7-1. In 
response to parasite Ag, there was a general up-regulation of B7-1 in both MF+ and CP 
individuals but the level of B7-1 expression in EN individuals did not increase. It was 
suggested that high Ag-load down-regulates the expression of spontaneous B7-1 in 
MF+ individuals. Interestingly, it was shown that IL-10 levels do not correlate with B7- 
1 expression. B7-2 was not examined and this molecule may be of major interest in
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future studies on the role of costimulatory molecules in filariasis (Raviehandran et a l, 
1997). In individuals infected with Loa loa levels of B7 were found to be similar 
between MF+ and MF- groups, however this study failed to discriminate between B7-1 
and B7-2 (Baize, 1997). In a study using experimental animals (Giambartolomei et a l, 
2001), monkeys infected with B. malayi were divided into two groups depending on the 
ability of their PBMC to divide in response to BmAg -  responders and non-responders. 
All of the responders were found to express significantly higher levels of B7-1, whereas 
half of the non-responders showed no increase in B7-1 and the other half only showed a 
marginal increase. High levels of B7-2 were observed in all monkeys, regardless of 
stimulation. Therefore this study demonstrates an association between BmAg induced 
proliferative responses and expression of B7-1 but not B7-2. The general consensus 
from these experiments appears to be that proliferative capacity is associated with an 
up-regulation of B7-1 expression, although not all the studies reviewed above examined 
the role of B7-1 and B7-2 as separate ligands.
As described above, many studies have attempted to discover the underlying cause of 
proliferative suppression but none have found a single factor which is universally 
successful at restoring proliferation. Recently, the impact of transmission intensity on 
the host immune response in two villages in PNG where the transmission intensity of W. 
bancrofti differed by 63-fold was investigated (King, 2001). Residents of the high 
transmission village had impaired lymphocyte proliferation and IFN-y production in 
response to parasite Ag, to the non-parasite Ag streptolysin-0 and to the APC- 
dependent mitogen phytohaemagluttanin. By contrast, lymphocyte proliferation and 
IFN-y production in response to the mitogen PMA and ionomycin (which directly 
activates protein kinase C and facilitates influx of Ca'  ^into the cell and does not require
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APC help) was similar between individuals from both areas. In addition, CD4^ cells 
which had been purified from individuals living in the area of high transmission could 
be activated with immobilised anti-CD3 (that cross-links the T cell receptor) and anti- 
CD28 (which provides an important costimulatory signal). This study provides further 
evidence that impaired APC function modulates the ability of PBMC to proliferate in 
response to filarial Ag.
Other studies have shown that Ag-specific hyporesponsiveness is mediated, in part, by 
diminished APC function and is most obvious when PBMC are stimulated with MF Ag 
(Semnani et a l, 2001; Semnani et a l,  2003). DC exposed to live MF up-regulate the 
expression of ICAM-1 and undergo increased levels of apoptosis compared to 
unexposed DC. While MF exposed DC up-regulate IL-8, RANTES, IE -la , TNF-a and 
IL-P, levels of IL-12 and IL-10 were down-regulated. Soluble excretory secretory (ES) 
products from MF also resulted in this down-regulation of cytokine production but to a 
lesser degree. In addition, exposed DC were less able to stimulate CD4^ cells to produce 
IFNy and IL-5 (Semnani et a l, 2001; Semnani et a l, 2003). The eonsensus from the 
studies reviewed above is that infection with filarial parasites has a marked effect on the 
ability of professional APC to present Ag to CD4^ cells effectively, thus inhibiting the 
ability of immune cells to mount appropriate responses.
1.4.6. T regulatory cells in Lymphatic Filariasis
T regulatory cells (Treg) are a family of CD4^ cells that are anti-inflammatory and 
profoundly suppressive. Tlnee populations of Treg cells have been identified to date: 
Th3 (Weiner, 2001), Trl (Roncarolo et al., 2001b) and, perhaps the best characterised, 
CD4^CD25^ cells, which typically co-express CTLA-4 and OX-40 (Read and Powrie,
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2001). These regulatory T cells have the ability to inhibit potentially harmful immune 
responses via cell-to-cell contact dependent mechanism or by the secretion of eytokines 
such as TGF-j3 and IL-10. Most studies to date investigating the role of Treg cells in 
filariasis have been carried out in humans and indeed it has been proposed that many of 
the features of LF could be accounted for by the induction of Treg eells, rather than a 
Tli2 bias (Maizels and Yazdanbakhsh, 2003). One sueh study investigated the role of 
CTLA-4 in mediating diminished levels of Ag-specific T cell responsiveness that is 
characteristically observed in filariasis patients. It was observed that individuals who 
inhabited endemic areas had a higher frequency of CD4^CTLA-4^ cells than expatriate 
infected or uninfected individuals. In addition MF+ patients had a higher frequency of 
CD4^CTLA-4^ cells than MF- individuals. These studies suggest that length of 
exposure to the L3 and patency of infection are factors associated with the expression of 
CTLA-4. In addition the greatest intensity of CTLA-4 expression occurred on 
CD4’*’CD25'*' cells. Neutralizing CTLA-4 in vitro resulted In increased levels of IL-5 and 
decreased levels of IFN-y, indicating a role for this molecule in regulating host 
responses to filarial infections (Steel and Nutman, 2003).
Further studies have examined the role of regulatory T eells in chronic infection with 
the related filarial nematode O. volvulus. Individuals with a patent infeetion i.e. 
generalised onchocerciasis (GEO), display an Ag-specific proliferative 
hyporesponsiveness similar to that described above for LF. It was shown that IL-10 and 
TGF-p mediate this response, as neutralizing these cytokines resulted in the reversal of 
the proliferative defect. O. volvulus-s^Qcific T cells cloned from GEO PBMC produced 
no IL-2 and high IL-10 and TGF-p, similar to Th3/Trl cells, indicating that these cells 
may be involved in maintaining O. volvulus hyporesponsiveness (Doetze et a l, 2000).
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In an additional study, it was found that these Treg cells display elevated levels of 
CTLA-4 after stimulation and are able to inhibit proliferation of other T cells in eo- 
culture (Satoguina et a l, 2002). More reeently it has been found that S. mansoni 
specific lyso-phosphatidylserine (PS) activated the Toll-like receptor 2 and affected DC, 
such that mature DC gained the ability to induce the development of IL-10-producing 
Treg cells (van der Kleij et a l, 2002), Taken together, the evidence outlined above 
suggests a role for Treg cells in the maintenance of hyporesponsiveness in helminth 
infection.
1.4.7. The importance of the L3 in Lymphatic Filariasis
Defining the role of individual life cycle stages in polarising the immune response in 
human infection can be very difficult as individuals living in an endemic area are 
exposed to multiple different life cycle stages simultaneously. As the L3 is the first life 
cycle stage to which the host is exposed, the immune response elicited by the L3 is 
likely to influence both the establishment of the parasite and the development of 
immunity.
Evidenee in humans that an immune response is directed against the L3 comes from the 
observation that a percentage of individuals inhabiting an endemic area will remain 
infection-free (endemic normals) despite exposure to L3. The presence of EN has given 
rise to the theory of concomitant immunity (whereby individuals are resistant to 
incoming L3 but camiot clear their adult parasites) (Day et a l, 1991). Despite a lack of 
knowledge regarding the parasitological state of endemic normals, it was previously 
thought that these individuals were resistant/immune to infection with the L3, whereas 
microfilaraemic individuals were susceptible. However with the advent of more
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sensitive diagnostic procedures it appears that the endemic normal is a very rare 
individual, at least in areas of high transmission (Day, 1991; Freedman et a l,  1989; 
Lalitha et a l, 1998).
Population dynamic studies (Day, 1991; Vanamail et a l, 1989) have argued that the 
concept of the endemic normal should be replaced by the hypothesis that concomitant 
immunity exists in the majority of the adult population in filariasis-endemic areas. For |
example, the rate of gain and loss of W. bancrofti infection was estimated duiing a 
control programme in Pondicherry, South India. The results suggested that the age 
distribution of bancroftian filariasis is primarily determined by age-dependency in the 
rate of acquisition of infection. The rate of gain of infection, based on levels of MF, was 
shown to peak in the 16-20 year age group and then decline in adulthood. This was 
proposed as evidence for acquired resistance to new infection (Vanamail et a l, 1989). A 
longitudinal study of the age-specific dynamics of W. bancrofti infection in a 
community of East Sepik Province, PNG was carried out. MF density and levels of PC- 
containing Ag in individuals were used as measures of adult worm burden. Over a 12 
month period significant increases in the levels of circulating PC-Ag was noted in 
subjects less than or equal to 20 years of age, but not in subjects greater than 20 years of 
age (Day et a l, 1991). These data are therefore consistent with the acquisition of 
resistance to superinfection with age. Further analysis indicated that resistance was 
directed at the L3 as, when the age-specific dynamics of the Ab response to the L3 
surface was examined in this population, a correlation was established between age and 
prevalence of Ab. Adults, but not children, had detectable anti-L3 surface Ab 
irrespective of adult worm burden (Day et al, 1991). In conclusion, it appears that 
children living in this endemic area continued to accumulate adult worms, whereas
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worm burden was stable in adults. These studies support the notion of concomitant 
immunity, directed at restricting incoming larval parasites but ineffective at eliminating 
existing adult parasites.
Clear evidence of acquired resistance to trickle infection of L3 in B. pahangi infected 
cats also supports the hypothesis of concomitant immunity. Cats trickle-infected with 
L3 become resistant to re-infection and this resistance is directed at the L3, with the 
majority being destroyed within 24 hours of infection. Adult worms in these animals 
can be long-lived with a life expectancy of two years and arise from early infections 
when the animals are naïve (Denham ei al., 1983). More recent studies involving the 
relationship between the levels of transmission of the L3 and the development of 
infection and disease in bancroftian filariasis have been carried out in two endemic 
villages in East Africa. One village had an ATP (annual transmission frequency, 
determined by the number of L3 to which an individual is theoretically exposed to per 
year), nine times higher than that of the other (Michael et a l, 2001). A particular focus 
of this work was to understand the contribution of host immunity in regulating infection 
and in the development of chronic disease, and the role of exposure rate in generating 
such immunity. In the high ATP village, prevalence and mean intensity of MF and 
incidence of pathology (hydrocele and lymphoedema) were significantly higher. In 
addition, the geometric mean MF count was also significantly higher (almost 20 times) 
in the higher transmission community. These data were interpreted to suggest that while 
immunity against infection reflects past experience of adult worms acting against the 
establishment of L3, the immunopathological component of lymphoedema is apparently 
more related to cumulative experience of larvae rather than adult worms. Flowever this 
interpretation requires further investigation.
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The importance of the L3 in modulating the immune responses of individuals living in 
an area of high transmission compared to responses of individuals living in a loAV 
transmission area was investigated study populations from villages in PNG (King,
2001). High levels of L3 transmission were shown to affect Th2 responses with levels 
of IL-5 being significantly elevated compared to that of the low transmission area. 
However, levels of IL-4 and IL-10 secreted from PBMC were not significantly different 
between groups. It was notable that in this study, levels of IL-10 and TGF-(3 did not 
correlate with depressed levels of proliferation or IFN-y levels, a result in contrast to a 
previous repoit from India (King et a l, 1993). One of the other interesting results from 
the PNG study was the identification of elevated plasma IL-4 in individuals from the 
high transmission village (almost two-fold higher). However, it was notable that this 
increase in IL-4 was not observed in PBMC culture. It was suggested that the IL-4 is 
likely to derive from mast cells and basophils in the skin, as these cells are abundant in 
dermal tissues where the L3 are inoculated. These cells may therefore play a critical role 
in host defence, particularly across epithelial barriers such as the skin. Together, the 
studies summarised above strongly indicate that the L3 evokes an early immune 
response in the human host. Further information on the role of the L3 in generating a 
response will be discussed with reference to work carried out using the mouse model of 
infection.
1.5. Mouse model of Brugian filariasis
Immunological studies of human filariasis are complicated by many factors, including 
exposure to multiple life cycle stages, differences in worm burdens and infection status, 
prior and current exposure to L3, use of chemotherapy and the presence of concomitant 
infections. The use of laboratory animals allows some of these factors to be controlled
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and has provided invaluable information on the immune response to filarial parasites. 
The ideal animal model would be inbred, would harbour the full developmental cycle of 
the parasite, display similar pathology to that seen in humans and mimic the 
immunological characteristics of the human infection. A model with all these traits is 
not available, therefore most studies have been carried out in mice. A surprising amount 
has been leaimt from the mouse model. Although not fully permissive to filarial 
infection (with the exception of Litomosoides sigmodoniis), mice can support single life 
cycle stages of Brugia sp for a limited time, allowing investigation of the immune 
response to each stage. Unfortunately a suitable animal model for W. bancrofti has not 
been found, as it will not survive in intact or immunocompromised mice.
There are several features of the immune response which are similar in the hmnan and 
mouse infections, such as the characteristic proliferative defect and skewing of the 
immune system towards a predominantly Th2 type response. Each life cycle stage of the 
parasite can elicit differing immune responses and thus the ability to implant the various 
stages of development into the mouse model allows the responses to be interpreted 
independently of each other. It is notable that different life cycle stages elicit different 
immune responses in the murine host, suggesting that natural infection with filarial 
pai'asites induces a complex array of immunological responses in the infected 
individual.
1.5.1. Murine infection with MF
Experiments caiTied out by Pearlman et al (1993b) examined cytokine production in 
BALB/c mice inoculated i.p. with live MF of B. malayi. At early time points (12-14 
days) splenocytes from these animals produced an Ag~specific ThI-like response with
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elevated levels of IFN-y and little IL-5. However at later time points levels of IL-5 
increased, with a resultant decrease in levels of IFN-y. Peritoneal exudate cells (PEC) 
from mice which had been immunized three times with soluble microfilarial Ag were 
recovered four days after MF challenge and were cultured with MFAg. These cells 
produced elevated levels of IL-4 and IL-5 with no increase in Ag driven IL-2 or IFN- 
y. Depletion experiments demonstrated that CD4^ cells were the main source of IL-4 
and IL-5. In addition IL-10 was shown to have a role in controlling IFN-y production in 
splenic and lymph node cells from mice chronically exposed to live MF or immunized 
multiple times with soluble Ag. Addition of neutralizing IL-10 MAb resulted in 
increased levels of IFN-y production in splenic and lymph mode cells from these 
animals (Pearlman et a l,  1993a). In similar experiments from a different laboratory in 
which BALB/c mice were infected with MF i.v, IFN-y was detected at early time points 
with a gradual increase in IL-4. It was also found that the IFN-y response to MF was 
independent of the dose of MF administered, in the range of 10  ^to 10  ^(Lawi*ence et a l, 
1994). Furthermore, popliteal lymph node cells from BALB/c mice infected via the 
footpad with MF of B. pahangi express IFN-y in the absence of IL-10 or IL-4 at day 
four post infection (Osborne and Devaney, 1998). These results indicate that an early 
IFN-y response to MF is accompanied by a later more modest Th2 response.
Interestingly, recent data identified a MF-specific protein (Bm-SPN-2, a secreted 
serpin) which is a prominent T cell Ag. It was found that mice infected with MF of B. 
malayi mounted a strong Bm-SPN-2 specific Thl response which was short-lived. By 
day 35 responsiveness to Bm-SPN-2 was lost. These findings are important as Bm- 
SPN-2 was recognised by mouse and human T and B cells and is the first example of a 
MF-specific secreted molecule that acts on T cells (Zang et a l, 2000). Studies in the
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mouse model demonstrated that the proliferation of splenocytes from MF infected 
BALB/c mice was suppressed in an Ag-specific manner, in contrast to splenocytes from 
L3 infected mice, which proliferated well under identical conditions (Osborne et a l, 
1996). Cells from MF infected animals had been activated as demonstrated by elevated 
levels of IFN-y in Ag-stimulated cultures. Similar to the situation observed in human 
infection, levels of mitogen stimulated proliferation were not suppressed. Further 
studies carried out in MF infected mice demonstrated that the proliferative defect was 
associated with elevated production of NO, induced by IFN-y (O'Connor et a l  
2000). Inhibition of iNOS or infection of IFN-y receptor laiock-out mice resulted in 
normal levels of Ag-specific proliferation. Moreover it was shown that elevated levels 
of NO in these cultures induced apopto sis of CD4^ T cells (Jenson et a l  2002). It was 
hypothesised that the apoptosis of activated T cells represents a negative feedback 
system, which limits the expansion of potentially harmful pro-inflammatory cells 
(O’Connor and Devaney, 2002).
1.5.2. Murine infection with adult parasites
Although immunocompetent mice are resistant to natural infection with B. malayi or B. 
pahangi, adult worms can be implanted and survive for up to 90 days. In contrast to the 
situation observed in mice infected with MF, mice implanted with the adult stage of 
Brugia develop a profound Tli2 response with elevated levels of IL-4 and good Ag- 
specific proliferative responses (Lawrence et a l, 1994). Mice implanted with female 
worms displayed a stronger immune response than those Implanted with adult males, 
although the response of both groups of animals followed a similar pattern. Levels of 
IL-2 and IFN-y remained low in these animals. This is in stark contrast to responses 
observed in MF infected animals, where levels of IFN-y remained high until 28 days
2 8
post-infection, and although an IL-4 response was observed at this time point, levels of 
this cytokine remained less than 10% of that observed in response to adult female 
worms. Furthermore CDA^ cells were identified as the source of the IL-4 produced in 
response to adult worms (Lawrence et a l, 1994). These results are interesting as they 
demonstrated that the IL-4 (Th2) response is dominant despite the continual release of 
IFN-y inducing MF from the adult females.
Studies which have attempted to unravel the ways in which adult parasites modulate the 
immune system have demonstrated a multitude of mechanisms, ranging from 
suppressive ES products, the generation of a suppressive APC population and the 
induction of suppressor cytokines IL-10 and TGF-|3. Using the filarial parasite 
Acanthocheilonema viteae an ES product (ES62) was identified which was 
immunomodulatory and down-regulated immune responses. ES62 is a phosphoryl- 
choline (PC)-containing glycoprotein to which PC is covalently attached via an N-type 
glycan. PC is found on components of the ES of all human filarial nematodes examined 
to date, (reviewed by Harnett et a l,  1999; Harnett and Harnett, 1999). It was further 
shown that ES62 interacts directly with APC, signalling dendritic cells to acquire a 
phenotype which drives the development of Th2 cells (Whelan et a l,  2000). In these 
studies the responses of GM-CSF matured DC exposed to EPS or ES62 were compared. 
It was shown that exposure of DC to LPS results in a phenotypic Thl response 
compared to the Th2 response generated by ES62. ES62 also appears to inhibit B cell 
stimulation and proliferation (Harnett and Harnett, 1993). These results indicate that the 
production of ES62 by adult parasites modulates the immune response towards a Th2 
phenotype and can reduce levels of proliferation of the B cell population.
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The role of the adult parasite in eliciting a population of suppressive APC has been 
extensively studied by the Allen group. Intraperitoneal implantation of adult worms or 
L3, but not MF, leads to the generation of PEC which suppress the proliferation of T 
cell clones without blocking Ag-specific cytokine production in vitro (Allen et a l, 
1996). It was demonstrated that IL-4 was essential for the induction of this non-specific 
suppressor cell population but that IL-10 was not a key component. IL-4-/- mice were 
unable to generate a suppressive PEC population while mice given anti-IL-4 at the time 
of infection still developed Th2 responses but were unable to generate the suppressive 
PEC population. Therefore it appears that early IL-4 production, and not necessarily 
Th2 establishment, is the essential factor in the development of the proliferative block. 
In these experiments, infection of IL-10 -/- mice generated fully suppressive PEC. A 
partial role for IL-10 was suggested as compared to the wild type mice, PEC from IL- 
10-/- mice induced less profound suppression of hybridomas. These IL-4 dependent 
suppressor cells were later described as F4/80+ alternatively activated macrophages and 
their suppressive function was found to operate via a cell-cell contact dependent 
mechanism. Interestingly, these cells were found to suppress proliferation of various 
transformed cell lines, including many human tumour cell lines, thus indicating that the 
suppressive mechanism was neither species nor cell type specific (Loke et a l,  2000a).
1.5.3. Murine infection with L3
Studies from many groups have highlighted the importance of the L3 in modulating 
host immune responses in mouse models. Infection of mice with the L3 of Brugia 
malayi (Lawrence et a l, 1995) or B. pahangi (Osborne and Devaney, 1998) results in a 
Th2 type response with elevated production of IL-4 and low IFN-y and IL-2, similar to 
adult parasites. To further investigate the role of this Th2 response, experiments were
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carried out in IL-4-/- mice. C57BL/6 IL-4 deficient mice or their corresponding WT 
counterparts were infected with 100 L3 of B. malayi i.p. Cytokine responses from these 
animals showed slightly decreased levels of IL-5 compared to WT mice, but no 
elevation of IFN-y levels. These data were interpreted to suggest that Thl cells were not 
primed in response to infection with L3 (Lawrence et a l, 1995). However in 
experiments in which IL-10 was neutralized in vitro, splenocytes from L3 infected 
BALB/c mice produced IFN-y and IL-2 without altering levels of IL-4 or IL-5, 
suggesting that Thl cells were primed by L3, but suppressed by IL-10 (Osborne and 
Devaney, 1999).
Further studies on the role of the adherent APC population in mice infected with B. 
pahangi, demonstrated that replacement of the resident APC population with APC from 
control mice reversed the inliibition of Thl responses (Osborne and Devaney, 1999). 
The precise phenotype of the suppressive APC in this system was not identified. 
However it was notable that the irradiation of resident APC had the same effect, 
suggesting that the suppressive population may be B cells, as these cells are more 
susceptible to y irradiation that other APC (Sopori et a l,  1985). Although these 
experiments also showed that neutralizing IL-10 resulted in elevated levels of IFN-y and 
IL-2, no link between the role of IL-10 and the suppressive APC population was sought 
(Osborne and Devaney, 1999). Therefore the data presented above demonstrate that Thl 
and Th2 cells are primed in response to the L3 but Thl cells are suppressed by IL-10 
and the APC population.
The cytokine environment at the point of T cell priming is very important in 
determining the differentiation of precursor (p) Th cells into Thl or Th2 cells (see
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section 1.7). In light of this, experiments were carried out to investigate the pattern of 
cytokine mRNA expression within the draining lymph node shortly after infection with 
L3. Mice were infected via the footpad and at 24 hours p.i. the popliteal lymph nodes 
were removed and cytokine gene expression was measured by semi-quantitative RT- 
PCR. These experiments showed that the L3 elicited a dramatic burst of IL-4 
transcription within 24 hours of infection, defining the L3 as a potent stimulator of the 
Th2 response. Cell separation experiments demonstrated that an ap  ^CD4'CD8" (a 
double negative) T cell population was responsible for the production of early IL-4 
(Osborne and Devaney, 1998). Further characterisation of these cells indicated that this 
population may be NKl.F^ T cells (Balmer and Devaney, 2002). It is not known what 
components of the L3 stimulate the early IL-4, but the surface of the L3 contains both 
lipid and carbohydrate moieties and the components of the surface are known to turn 
over within 24 hours of entry into the mammalian host (Carlow et a l ,  1987). Therefore 
one of these moieties may be involved in priming NK cells for IL-4 production.
Experiments carried out by the Raj an group have concentrated on factors which 
contribute to the clearance of a primary infection when L3 of Brugia are administered 
i.p. Primed B cells from mice immunized with the L3 of B. pahangi adoptively 
transferred into athymic recipients protected these animals from challenge infection 
(Paciorkowski et a l, 2003). Further investigation showed that B cells were required for 
the early production of Th2 cytokines. These results were inteipreted to suggest that 
primed peritoneal B cells were sufficient to transfer protection against B. pahangi 
infection in mice. IgE has also been shown to have a role in determining the 
susceptibility of the host strain. IgE-/- mice were more permissive to primary infection 
with L3 of B. malayi than WT mice. Infected IgE-/- mice also displayed defective IgGl
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production suggesting that there may be other contributing factors to the permissiveness 
observed in the KO animals (Spencer et a l, 2003b).
The data presented above indicate that the host-parasite interaction is complex and 
highly evolved. However it remains unclear whether the Th2 response to the parasite 
protects the host from pro-inflammatory pathology or whether the parasite induces Tli2 
responses to maintain its survival. Whatever the case, analysis of the responses to 
different life cycle stages has led to the conclusion that there are many different ways in 
which the parasite can modulate host responses and that each life cycle stage exploits a 
different mechanism of modulation.
1.6. Immunoregulation
1.6.1. T cell phenotype and effector function
In a seminal study, Thl and Th2 cells were first distinguished as two different subsets 
(Mosmann ei a l, 1986). A panel of mouse helper T cell clones were characterized into 
two groups according to their lymphokine production. Type 1 helper cells (Thl) 
produced IL-2, IFN-y, GM-CSF and IL-3 in response to Ag and APC or to ConA. T 
helper 2 cells (Th2) produced IL-3, BSFl, and two other activities unique to the Th2 
subset, a mast cell growth factor distinct from IL-3 (now known to be IL-5) and a T cell 
growth factor distinct from IL-2 (now known to be IL-4). A subsequent study showed 
that Th2 clones also have the ability to synthesise IL-4 and IL-5 (Cherwinski et a l, 
1987). Thl and Th2 cells are derived from ThO cells which have the capacity to produce 
all these cytokines. ThO cells are thought to be derived from naïve T cells (pTh) as they 
differentiate towards the Thl or Th2 pathway. This new paradigm changed the way in 
which the immunology of infectious disease was studied, with particular regard to
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Leishmania infection in mice, which was instrumental in establishing the functional 
relevance of disease models in understanding these pathways. However, it has become 
increasingly clear that the concept of Thl/Tli2 cannot account for every aspect of the 
immune response. In this section, I review the mechanisms by which T cells are 
activated to effector status or tolerized to result in suppression of immune responses, the 
role of APC and cytokines in determining the phenotype of differentiated T cells and 
finally, the role of Treg cells.
1.6.2. T cell activation and tolerance
Lymphocytes have to distinguish self from non-self while at the same time directing 
immune responses. To avoid damage to self, these responses must be tightly regulated. 
The ‘two signal’ concept of lymphocyte activation was proposed to explain 
discrimination of self from non-self (Bretscher and Cohn, 1970; revised Bretscher,
1999) and has been a useful model of activation and tolerance ever since. Naïve 
preciu'sor Th (pTh) cells are activated after interaction of the T cell receptor (TCR) with 
the peptide antigen major histocompatability complex (MHC) (signal 1). Signal 2 is 
generated via an interaction between costimulatory molecules on the antigen presenting 
cell (APC) and counter receptors on the T cell, such as the B7-CD28 interaction. In the 
absence of signal 2, the generation of signal 1 alone results in a state of inactivation and 
the pTh cell is rendered anergic. The 2 signal model oversimplifies the various ways in 
which a T cell reacts to each signal; in some cases T cell activation can occur in the 
absence of signal 2, if the TCR signal is very strong. In addition, positive and negative 
signals can be received by the T cell via the costimulatory receptors expressed on their 
surface (e.g. CTLA-4-B7 interaction). Also, the 2 signal model was designed with the 
activation of naïve pTh cells in mind, however the immune response to foreign Ag is a
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diverse process in which costimulatory signals can be delivered to Ag-experienced T 
cells. It has become clear in recent years that the balance of protective immunity and 
tolerance relies on a tightly regulated regime of stimulation and inhibition signals 
(Sharpe and Freeman, 2002).
There are a growing number of T-cell costimulatory molecules, but the best 
characterized system is the B7-1/B7-2-CD28/CTLA-4 pathway (see Figure 1), 
discussed in detail below (Karandikar et a l, 1998; Oosterwegel et a l, 1999; Sansom, 
2000; Salomon and Bluestone, 2001; Chambers et a l, 2001). B7-1/2 and CD28/CTLA- 
4 are now known to be pail of a much larger family of molecules as at least two new 
pathways have been discovered in recent years. The first involves the interaction of 
ICOS (a member of the CD28 family, inducible T cell co-stimulator) with ICOSL 
(ICOS ligand) (Hutloff et a l, 1999). The second involves the PD-1 receptor which 
interacts with two new B7 family members, PD-Ll and PD-L2 (Ishida et a l, 1992; 
Freeman et a l, 2000). ICOS interaction with ICOSL enhances all basic T cell responses 
to a foreign Ag, namely proliferation, secretion of lyniphokines, up-regulation of 
molecules that mediate cell-cell interaction and effective help for Ab secretion by B 
cells. Unlike CD28, ICOS is not constitutively expressed on the surface of T cells but 
has to be induced, and does not up-regulate the production of IL-2 but induces the 
synthesis of IL-10 (Hutloff et a l,  1999).
The PD-1 pathway is thought to be critical for the induction and/or maintenance of 
peripheral T cell tolerance to self-Ag. Expression of PDL is induced by IFN- y and 
recent data suggests that this might mediate some negative regulatory effects of IFN- 
y (Latchman et a l, 2001). Interaction of PD-1 with PD-Ll or PD-L2 results in inhibition
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of TCR-mediated proliferation and cytokine production, although levels of IL-4 and IL- 
13 were not easily down-regulated, suggesting that Th2 cytokine expression may be less 
sensitive to the effects of the PD-1 pathway (Latchman et a l, 2001).The properties of 
the best characterised system, B7 interaction with CD28 or CTLA-4, are discussed 
below.
1.6.3. B7-I/B7-2-CD28/CTLA-4 pathway
CD28 and CTLA-4 (CD 152) are transmembrane proteins, both of which are found on 
the surface of T cells. CD28 is abundantly expressed on the majority of resting T cells 
whereas CTLA-4 appears predominantly after T cell activation. These molecules share 
30% homology and bind to the B7 family members with high affinity (Alegre et a l, 
1996). The complexity of the CD28/CTLA-4 receptor interactions results from the fact 
that there are two natural ligands for these receptors, namely B7-1 (CD80) and B7-2 
(CD8 6). Both of these molecules can interact with either receptor, however as they 
share only 25% homology, it has been postulated that these molecules have differing 
functions. B7-1 and B7-2 are found on the surface of APC such as DC, monocytes and 
activated B cells (Razi-Wolf et a l, 1992; Azmiia et a l, 1993; Inaba et a l, 1994). B7-1 
is induced slowly after activation, whereas B7-2 is abundant on the surface of APC and 
its expression is rapidly increased after stimulation. However, experiments in B7-1/B7- 
2 -/- mice, indicated that B7-1 is more potent in terms of activation, as naïve cells 
respond less well to B7-2 and this is perhaps associated with B7-2 binding to CD28 for 
a shorter time than B7-1. However, primed cells respond to both molecules equally 
(Fields et a l, 1998; Schweitzer and Sharpe, 1998).
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1.6.4. CD28 and CTLA-4 -  opposing functions
CD28 receives signals from both B7-1 and B7-2, which ultimately results in the co­
stimulation which is required for efficient T cell activation. In the absence of this signal, 
the cells will become unresponsive and tolerant to Ag. This theory was substantiated 
when it was shown that APC, which were highly impaired in Ag presentation, were 
unable to activate T cells to respond to the same Ag (Jenkins et ah, 1987; Jenkins and 
Schwartz, 1987). Along with other experiments, which described the rescue of T cell 
anergy by the addition of a costimulatory signal, these studies are consistent with the 
notion that CD28-B7-1 interactions are critical for T cell activation (Gimnii et a l,  1991; 
Linsley ei a l, 1991). Recently results have come to light that suggest that CD28 may 
play a role in the development and homeostasis of Treg cells. CD4^CD25^ cells, which 
control autoimmune diabetes, are profoundly decreased in CD28-/- and B7-1/B7-2-/- 
NOD (nonobese diabetic) mice. Adoptive transfer of this regulatory population into 
CD28 deficient animals can prevent or delay diabetes (Salomon et a l, 2000). Therefore 
a substantial amount of data suggests that CD28 is a critical molecule in T cell 
activation and regulation.
Several studies have shown that blocking CTLA-4 results in increased T cell 
proliferation (Krummel and Allison, 1995). The most convincing data set, however, 
comes from experiments carried out in CTLA-4-/- mice, which develop lympho- 
proliferative disease suggesting a key role for CTLA-4 in maintaining self-tolerance 
(Tivol et a l, 1995; Waterhouse et a l,  1995). However despite the undeniable 
importance of CTLA-4, its inhibitory pathway is still not fully understood. Interestingly, 
within 24 hours of activation (when surface levels of CTLA-4 are very low) CTLA-4 
has been found to block T cell function, preventing the up-regulation of activation
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markers, entry into the cell cycle and the generation of IL-2. CTLA-4 is detected post­
activation on activated T cells at higher levels, however these are not typically the cells 
upon which it acts, suggesting that there may be an alternative function for CTLA-4 
expression on the surface of activated T cells (Krummel and Allison, 1996; Walunas et 
a l, 1996). While it has been shown that CTLA-4 is crucial in maintaining a balance in 
T cell activation, matters are somewhat complicated by the fact that CD28 and CTLA-4 
have opposite functions but share the identical ligands, B7-1 and B7-2.
Thus, it is of interest to decipher how T cells “decide” whether to use CTLA-4 or CD28. 
Various mechanisms have been described in different model systems, none of which are 
mutually exclusive. Firstly, the idea of ligand competition has been proposed in many 
studies. This model suggests that CTLA-4 acts as a competitive inhibitor for the ligands 
B7-1 and B7-2, so as to limit T cell activation. This concept is more likely to occur 
during secondary stimulation of T cells as resting T cells express undetectable amounts 
of CTLA-4. The ligand competition model of CTLA-4 regulation would require that 
CTLA-4 be expressed in sufficient levels to sequester ligands away from CD28, thus 
preventing a costimulatory signal being received. This model does not require a 
signalling component as it would rely on the higher affinity of CTLA-4 for B7-1 and 
B7-2 than CD28 (Chambers et a l, 1998; Chambers et a l,  1999).
Alternatively CTLA-4 signalling is a possible mode of action, whereby CTLA-4 is 
proposed to interfere with TCR signalling events (Marengere et a l,  1996; Brunner et 
a l, 1999). This hypothesis is supported by the observation that inhibition via CTLA-4 
can occur in the absence of CD28 (Fallarino et a l, 1998). Finally it has been shown that 
a population of Treg cells express CTLA-4 on their surface (Takahashi et a l,  2000), so 
it is possible that these cells regulate T cell activation, a concept which is supported by
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the development of spontaneous autoimmune disease when these cells are removed 
(Sakaguchi et a l, 1995; Itoh et a l, 1999) (these cells will be discussed in more detail in 
Section 1.9). For a schematic representation of the interactions of CTLA-4 and CD28 
with their ligands refer to Figure 1.1.
;
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Figure 1.1. Diagram of CD28 and CTLA-4 interactions with their ligands
B7-2 is typically expressed at higher levels on the surface of APC and is found more 
widely than B7-1. B7-1 is induced on the surface of APC via a number of stimuli and is 
expressed at lower levels. B7-2 is therefore the primary ligand for CD28. CD28 
expression is constitutive on the surface of T cells whereas CTLA-4 is not expressed on 
resting T cells. Interaction of B7 with CD28 and T cell receptor stimulation result in the 
up-regulation of CTLA-4, however CD28 stimulation is not absolutely required for up- 
regulation of CTLA-4. CTLA-4 expression is thought to be transient at the cell surface 
and rapidly re-intemalised by a clathrin pit mechanism. It should be noted that both 
ligands can interact with both receptors.
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1.7. Factors influencing the pathway of T cell differentiation
1.7.1. The role of the APC
Gajewski et al (1991) examined the ability of distinct APC populations to stimulate 
proliferation of OVA- specific Thl and Th2 clones. It was shown that both subsets 
proliferated well in response to OVA in the presence of whole spleen cells, however, 
purified B cells stimulated optimal proliferation of Th2 clones. Optimal proliferation of 
Thl clones was observed when adherent cells were used as APC. These results 
indicated that co-factors produced by professional APC influenced the differentiation of 
Thl and Th2 cells, with B cells preferentially inducing a Th2 response whereas adherent 
cells induce a more Thl-like response. Further studies investigated the roles of various 
APC in driving a Thl or Tli2 response. In a study using the SCID mouse and the 
nematode parasite Nippostrongylus brasiliensis, it was shown that DC had the ability to 
prime both Thl and Th2 cells (Ronchese et a l, 1994). However a subsequent study 
disputed this and demonstrated that DC predominantly produce IL-12, an important 
cytokine in driving the Thl response. Furthermore, in this study it was shown that DC 
could induce the development of Thl cells from Ag-specific naïve LECAM-1 
(leukocyte endothelial adhesion molecule, CD62L) bright CD4^ T cells obtained from 
ap-T C R  Tg mice, indicating that DC play a direct role in the development of IFN- 
Y producing Thl cells (Macatonia et a l, 1995). Other studies have examined the role of 
macrophages in stimulating a biased response. Although macrophages are dedicated 
APC in vitro, they exert this activity only after activation with IFN-y. However 
macrophages are an important source of IL-12 and may therefore favour the 
development of Thl cells. Indeed, depletion of macrophages in vivo supports a Th2
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response in BALB/c mice sensitized with bovine serum albumin (BSA) or ovalbumin 
OVA (Brewer et al., 1994).
Since these discoveries, research into the role of APC has become much more advanced 
with the discovery of the “alternatively activated” APC (APC2). In parallel to the 
Thl/Tli2 dichotomy, APC may be subdivided into pro-inflammatory, classically 
activated APC such as mature dendritic cells or IFN-y activated effector macrophages 
and anti-inflammatory, alternatively activated APC such as IL-10 activated immature 
dendritic cells and IL-4 induced suppressor macrophages. These APC2 have now been 
shown to mediate an indispensable pathway of APC function. It is believed that 
classically and alternatively activated APC secure the balance between pro- 
inflammatory and anti-inflammatory immune reactions.
Classically activated macrophages are activated by exposure to IFNy, TNF-a, or LPS 
whereas exposure to IL-4, IL-10 or PGE2 elicits a population of alternatively activated 
macrophages. These cells are known to be important in the inhibition of T cell 
proliferation. One study examined the role of IL-4-iiiduced alternatively activated 
macrophages in a human co-culture system in vitro. It was found that alternatively 
activated macrophages had the ability to inliibit mitogen-mediated proliferation of CD4^ 
T cells independently of IL-10. The expression of costimulatory molecules, NO or 
prostaglandin synthesis was also down-regulated. Inhibition of phenotypic 
differentiation of T cells by alternatively activated macrophages is paralleled by a lack 
of maturation of T cells (Schebesch et a l,  1997). Alternatively activated macrophages 
have also been identified in helminth infection. Clironic infection of mice with Taenia 
crassiceps led to the generation of a macrophage population which could suppress the
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proliferation of T cells and drive T cells to produce IL-4 and not IFN-y (Rodriguez-Sosa 
et a l, 2002). These data are similar to those where PEC, recruited in response to B. 
malayi, were used to stimulate naïve Tg T cells. Upon primary stimulation, proliferation 
of these cells was inhibited, but upon secondary stimulation the cells proliferated 
normally and produced IL-4. In these studies the PEC were found to be dependent on 
IL-4 as they did not develop in IL-4-/- mice. Further characterisation of these cells 
identified them as alternatively activated macrophages (MacDonald et a l, 1998; Loke et 
a l, 2000a).
The DCl and DC2 dichotomy was originally proposed to describe the capacity of 
monocyte-derived myeloid DC to stimulate allogenic T cells to produce IFN-y and 
plasmacytoid DC to prime T cells to secrete IL-4 (Rissoan et a l, 1999). However, 
subsequent reports have shown that the induction of a distinct Th phenotype is not 
dependent on the particular DC lineage but instead depends on the state of activation 
and maturation of the DC (Celia et a l, 2000; Manickasingham et a l, 2003). 
Interestingly, recent data has suggested that, not only is there a role for DC in the 
differentiation of Thl and Th2 cells, but that DC also have an important role in 
controlling the differentiation of Treg cells (see Figure 1.2) (Jonuleit et a l, 2000; 
Roncarolo et a l, 2001a; Maluike et a l, 2002; van der Kieij et a l, 2002).T cells primed 
by tolerogenic DC (such as immature or IL-10 treated DC) can develop into Tregs. In 
general, however, the functional properties of DC are dependent on their matuiational 
state. This was demonstrated in a seminal study, in which immature CD83" and mature 
CD83‘^ human DC were used for stimulation of naïve, allogenic CD4"  ^ cells (Jonuleit et 
a l, 2000). Repetitive stimulation with mature DC resulted in the expansion of the CD4^ 
cells with the production of Thl-type cytokines. After stimulation with the immature
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DC the T cells displayed an inability to proliferate which could not be reversed by the 
addition of iiL-2, restimulation with PBMC or with mature dendritic cells. These cells 
displayed an up-regulation of CTLA-4 and despite losing their ability to produce IL-2, 
IL-4 and IFN-y, could produce IL-10. In addition, in co-culture these cells had the 
ability to suppress Ag-driven proliferation of Thl cells in a cell-contact dependent 
mechanism. These data strongly indicate that DC (depending on their state of 
activation) can drive the differentiation of Treg cells. In another important study it was 
shown that DC matured in the presence of a lipid derived from S. mansoni eggs (lyso- 
phosphatidylserine), results in the induction of IL-10-producing Treg cells via an 
interaction with TLR2 (Toll-like receptor). These data therefore suggest a role for 
tolerized/immature DC in inducing a Treg population in helminth infection (van der 
Kleij et a l, 2002).
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Figure 1.2. DC Maturation
Immature DC capture Ag from dying cells (self matter) and foreign Ag. In the steady 
state, DC remain immature but enter lymph nodes and prime resting T cells to become 
Treg cells. Post-infection with a microbe, pro-inflammatory cytokines stimulate the 
differentiation of DC and these cells mature. Mature DC efficiently prime resting T cells 
to develop into T effector cells. However the function of the mature DC can be 
significantly altered if matured in the presence of IL-10 or TGF-p. This results in the 
conversion of immunostimulatory DC into tolerizing DC (adapted from Mahnke et ai ,  
2002).
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1.7.2. B7-1 and B7-2 can bias towards the Thl or Th2 phenotype
In an initial study in the mouse model (Freeman et a l, 1995), it was shown that B7-1 
and B7-2 do not deliver identical co stimulatory signals. B7-1 and B7-2 co stimulation 
induces equivalent levels of IL-2 and IFN-y, but B7-2 induces significantly more IL-4 
production than B7-1, with the greatest difference observed in naïve T cells. Repeated 
stimulation of CD4^CD45RA^ T cells with B7-2 resulted in moderate levels of IL-4 and 
IL-2, but repeated stimulation with B7-1 resulted in IL-2 with minimal levels of IL-4. 
Therefore, this study concluded that B7-2 provides an initial signal to induce naïve T 
cells to become Th2, IL-4 producing cells, whereas B7-1 is a more neutral 
differentiative signal. These data were further substantiated by experiments carried out 
using anti-B7 MAb in vivo in a mouse model of experimental allergic encephalitis 
(EAE). Anti-B7-1 reduced the incidence of disease, whereas anti-B7-2 increased disease 
severity. Administration of anti-B7-l at immunization resulted in the generation of Th2 
clones, which, when adoptively transferred prevented the induction of EAE and cleared 
the established disease. Therefore B7-1 and B7-2 interactions with CD28 or CTLA-4 
results in different clinical outcomes by influencing the differentiation of pTh cells 
towards a Thl or Th2 phenotype (Kuchroo et a l, 1995).
The role of B7-1 and B7-2 in mice sensitized with S. mansoni eggs was investigated to 
determine whether either ligand effects expression of Tli2 cytokines and the 
development of Th2-mediated pathologic reactions, or induction of pulmonary 
granuloma by i.v. injection of eggs. Anti-B7-2 treatment resulted in decreased levels of 
IL-4, IL-5 and IL-13 but had no effect on IFN-y in animals that were inoculated with S. 
mansoni ova, B. malayi MF, or circulating filarial Ag (CFA). In contrast, when B7-1
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was neutralized, IFN-y was inhibited in mice sensitized with S. mansoni ova. In 
addition, anti-B7-2 treatment inhibited pulmonary granuloma formation by 74% and 
levels of IL-5 and IL-13 transcripts were decreased by 20- and 5-fold respectively 
compared to mice given Ig control only. Anti-B7-1 had no such effect (Subramanian et 
a l, 1997). These data therefore support the hypothesis that B7-1 tends to promote the 
differentiation of Thl responses whilst B7-2 interactions promote Th2 differentiation.
1.7.3. The role of cytokines
The transmission between innate and adaptive immunity is a tightly regulated process, 
which involves both the secretion of soluble mediators and cell to cell contact. In 
particular the cytokine milieu that is established during the innate response to pathogens 
creates a suitable environment for the migration of Ag-specific T cells to lymph nodes 
where they meet APC. As described above Thl, Tli2 and Treg differentiation is 
associated with the phenotype of the APC that is involved in presentation o f Ag to the T 
cell. However T cell responses are also determined by the pattern of cytokines that are 
present during the clonal expansion of T cells (Mosmann and Coffman, 1989) as 
discussed below.
I.7.3.I. The IL-12 family of Thl inducing cytokines
1.7.3.L1. IL-12
IL-12 is a pro-inflammatory cytokine that favours Thl differentiation and forms a link 
between innate and adaptive imnumity (refer to Figure L3A). The main producers of 
IL-12 are phagocytes (i.e. monocytes, macrophages and neutrophils) and DC in 
response to pathogens (i.e. bacteria, fungi, intracellular parasites and viruses). IL-12
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induces T cells and NK cells to produce several cytokines -  for example GM-CSF and 
TNF-a, however it is extremely efficient at inducing the production of IFN-y. It has also 
been shown that IL-12 has a strong synergistic effect with CD28/B7 interactions in 
inducing proliferation and cytokine production (Kobayashi et a l,  1989; Chan et a l,  
1991; Kubin et a l, 1994; Murphy, 1994). The role of IL-10 in regulating IL-12 
production has been the focus of many studies, showing that IL-10 inhibits IL-12 
production and B7 expression on the surface of monocytes. These two effects are 
largely responsible for the ability of IL-10 to down-regulate IFN-y production by 
lymphocytes, because anti-CD28 Ab and IL-12 can reverse the inhibitory effect of IL- 
10 on IFN-y production (Kubin et a l, 1994).
IL-12 is expressed as a heterodimer formed by a 35-kDa light chain known as p35 and a 
40-kDa heavy chain known as p40 (Kobayashi et a l, 1989). Recently it was discovered 
that IL-12 p40 associates not only with IL-12 p35 but also with another molecule p i9, 
to form a new heterodimeric cytokine, IL-23 (Oppmann et a l, 2000). Another newly 
discovered cytokine is IL-27, which consists of Epstein Barr virus-induced gene 3 
(EBÏ3), a p40 related protein, and p28, a newly discovered IL-12 p35 -  related 
polypeptide (Pflanz et a l , 2002). Because of these recently discovered cytokines, it is 
now thought that the role of IL-12 has been over-interpreted. Many in vivo experiments 
caii'ied out in the past used IL-12 p40-/- mice to investigate the role of IL-12. However 
when experiments were carried out in IL-12 p35 mice many discrepancies were found 
between the p40 and p35 -/- mice (Becher et a l, 2002). It now seems probable that at 
least some of these discrepancies are due to the fact that IL-23 also utilises the IL-12 
p40 protein subunit.
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I.7.3.I.2. IL-23 and IL-27
IL-23 is secreted by mouse and human DC, however the biological activities of IL-23 
differ from that of IL-12, at least in the murine model. For example, unlike IL-12, 
murine IL-23 does not induce IFN-y. IL-23 is also reported to induce strong 
proliferation of memory T cells but not of naïve T cells, whereas IL-12 has no effect on 
memory T cells (Oppmann et a l,  2000). In addition, it has been recently shown that 
murine IL-23 can induce the production of the pro-inflammatory cytokine IL-17 from 
memory T cells. However, in humans the function of IL-23 is less distinct from IL-12 
(Oppmann et a l, 2000). Data from pl9-deficient mice are clearly required to fully 
elucidate the role of IL-23 in the murine model. Studies on EAE (experimental 
autoimmune encephalitis) in p40-/- and p35-/- mice give contrasting results and suggest 
that IL-12 may not be as important for the establishment of disease as was once thought. 
Instead IL-23 fulfils this role. Recently, transgenic p i9 (IL-23 deficient) mice have been 
shown to develop multi-organ inflammation, infertility and premature death. These 
mice display lymphocyte and macrophage infiltrates in organs and increased numbers of 
circulating neutrophils (Wiekowski et a l, 2001). These data clearly indicate a role for 
IL-23 in IL-12 related responses.
IL-27 is produced early by activated APC and has been shown to be functionally very 
similar to IL-12 in that it is able to induce clonal proliferation of naïve T cells and 
synergises with IL-12 in IFN-y production by naïve T cells (Pflanz et a l,  2002). 
Interestingly IL-27 binds to a newly discovered receptor expressed in large amounts on 
the surface of naïve T cells, named WSX-1 (Yoshida et a l, 2001). This receptor does 
not associate with IL-12 (Chen et a l, 2000; Pflanz et a l, 2002) and has been shown to
4 9
be required in the early initiation, but not the maintenance, of the Till response 
(Yoshida et a l, 2001). This indicates that IL-27 may interact with naïve T cells before 
IL-12, driving Thl development, but IL-12 is then required in the maintenance of this 
response (Yoshida et a l, 2001; Pflanz et a l, 2002).
In summary the expression of the receptors on T cells for the IL-12 family of cytokines 
is an important factor in the differentiation of Thl cells. Expression of the receptor for 
IL-27 on naïve T cells enables the initiation of Thl responses (Chen et a l,  2000; Pflanz 
et a l, 2002) and subsequent up-regulation of IL~12Rp2 (Szabo et a l,  1997) allows IL- 
12 to become active in the induction and maintenance of effector Thl responses (Park et 
a l, 2000; Yap et a l,  2000). However, activation of Thl memory cells appears to be 
restricted to IL-23 (Oppmann et a l,  2000). IL-18 then synergizes with IL-12 after IL-12 
has induced the IL-18R (Afkarian et a l, 2002) and this cascade of events will 
eventually lead to the production of IFN-y and the resultant activation of macrophages 
and DTH responses. For a diagrammatic representation of the role of IL-12, IL-23, IL27 
and IL-18 in the differentiation of Thl type response, see Figure 1.3 A.
I.7.3.2. IL-4 and IL-13
IL-4 was identified as a cytokine that was instrumental in the generation of the Th2 
responses when it was shown that IL-4 and IL-2 are required for the in vitro generation 
of IL-4 producing T cells (see Figure 1.3B) (Le Gros et a l,  1990). When stimulated 
with either Con A or Ag in the presence of IL-4, CD4^ cells become primed to follow 
the Th2 differentiation pathway and after 48 hours these cells switch off IFN-y gene 
transcription (Nakamura et a l, 1997). These data indicated that IL-4 was important in 
directing pTh cells down the pathway of Th2 differentiation. Th2-driven responses are
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important in disease processes including allergies, asthma and helminth infection. 
Although IL-4 is a key cytokine in the development of Th2 responses, recent studies of 
IL-4 receptor (IL-4R)-mediated signalling pathways have implied the presence of 
alternative routes for Tli2 induction (Kaplan el a i, 1996; Shimoda et al., 1996; Takeda 
et al., 1996; Earner et al., 1998). One other way in which Th2 development can be 
affected is via IL-13, posing the question of how these cytokines can compensate for 
one another (McKenzie, 1998).
IL-13 shares -30%  homology with IL-4 and appears to have overlapping biological 
activities. This is due, in part, to these two cytokines utilising the common IL-4Ra 
chain as a component of their receptor complexes and signalling through a shared signal 
transducer and activator of transcription (STAT) 6-dependent pathway (Zurawski et a l , 
1993). IL-4 and IL-13 are produced mainly by Th2-like cells and mast cells (Burd et a l, 
1995) and it has been demonstrated that they share many biological functions. They 
both have the ability to suppress the production of IL-1 and TNF-a from monocytes and 
macrophages (de Waal Malefyt et a l, 1993a) and can induce B cells to undergo Ig 
isotype switching (Punnonen et a l, 1993). There are however differences in their 
molecular function, notably the ability of IL-4 to induce cellular proliferation. The 
functions of IL-13 and IL-4 are best described when examining their role in infection 
with L. major and T. muris (discussed in Section 1.8). For a diagrammatic 
representation of the pathway of Th2 development, see Figure 3B.
I.7.3.3. IL-10 and TGF-p
IL-10 was originally identified as a molecule secreted by Th2 cells that could inhibit the 
synthesis of Thl cytokines. IL-10 is produced by most haemopoitic cells and its
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expression is regulated both transcriptionally and at the level of niRNA stability. The 
functional receptor for IL-10 consists of a heterodimer between IL-lORl and IL-10R2, 
(reviewed Moore et a l,  2001). The expression of IL-1 OR determines whether cells will 
respond to the effects of IL-10. For example, T cells can down-regulate expression of 
IL-lORl to become resistant to the suppressive effects of IL-10, whereas activated 
monocytes can up-regulate IL-lORl and become susceptible to a negative feedback 
pathway (Liu et a l, 1994). Like other cytokines from this family, IL-10 mediates its 
effects via the activation of the Jalc/STAT pathway (Moore et a l,  2001). The principal 
role of IL-10 is to down-regulate overwhelming and dangerous inflammatory immune 
reactions. To do this IL-10 has the ability to suppress virtually all pro-inflammatory 
cytokines and chemokines, while at the same time inhibiting the expression of B7-1 and 
B7-2 on the surface of APC (Moore et a l, 2001).
TGF-P belongs to a large family of proteins, which are highly conserved tluoughout 
evolution. In mammals, three members of this family, TGF-pl - |33, have an important 
role in regulating immune responses. All three molecules signal through the same 
receptor complex which consists of TGF-pRl and R2 (Letterio and Roberts, 1998). The 
effect of TGF-j3 is mediated by activation of the SMAD family of transcription factors 
(Attisano and Wrana, 2002). TGF-p is synthesised as a precursor protein and is released 
in an inactive form as either a small or large latent complex (Gleizes et a l, 1997). In the 
small complex, a homodimer of active TGF-(3 is associated with a protein, known as 
latency associated protein (LAP), which consists of a homodimer of inactive TGF-p. In 
the large complex, LAP is additionally associated with the latent TGF-p binding protein 
(LTBP), which then allows the complex to associate with the extracellular matrix. 
Activation of TGF-p in vitro can be achieved by disruption of the non-covalent
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interaction between TGF-p and LAP by heating or acidification. In vivo activation 
occurs extracellularly and likely involves the cleavage or conformational modification 
of LAP (Gleizes et a l,  1997). TGF-p has anti-proliferative effects on CD4^ T cells as it 
has the ability to block production of IL-2 and to up-regulate cell cycle inhibitors 
(Gorelik and Flavell, 2002). This suppressive cytokine also has the ability to block the 
differentiation of Thl and Th2 cells via effects on the transcription factors required for 
expression of IFN-y (T-bet) (Gorelik et a l, 2002) and IL-4 (GATA-3) (Heath et a l,
2000). In terms of APC, TGF-p can inhibit the activation of macrophages and their 
ability to produce pro-inflammatory cytokines (Gorelik and Flavell, 2002).
TGF-p and IL-10 were shown to work synergistically with one another in down- 
regulating immune responses. In studies in mice, IL-10 has been shown to regulate the 
production of TGF-p and vice versa and it was initially shown that exogenous IL-10 can 
stimulate TGF-P in vitro (Seder et a l, 1998). This observation was further substantiated 
by experiments examining intestinal epithelial cells transgenic for IL-10 (De Winter et 
a l, 2002), which display increased levels of TGF-p. Furthermore, IL-10-/- mice 
produce less TGF-p than wild-type mice (De Winter et a l, 2002). In a reciprocal 
fashion TGF-p can also enhance levels of IL-10. For example, treatment of colitis by 
administration of a plasmid encoding TGF-p provides a beneficial effect via elevated 
levels of IL-10 production (Kitani et a l, 2000). These studies indicate that blocking one 
of these suppressive cytokines has a corresponding effect on the other.
T cell anergy is described as a continuous state of unresponsiveness to rechallenge with 
fully competent APC. There are two ways in which a T cell can be rendered anergic. 
The first way has been discussed previously (section 1.6.2) and involves the absence of
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co-stimulation (“signal 2”). Alternatively T cell anergy can be induced when T cells are 
activated in the presence of IL-10 or are stimulated with APC which have been pre­
treated with IL-10 (Groux et al., 1996; Steinbrink et a l, 2002). These results show that 
not only can IL-10 effect T cell function via the APC, but IL-10 can also have a direct 
effect on T cells themselves. After cells have become anergized by the presence of IL- 
10, they acquire regulatory properties which are cytokine independent (Steinbrink et a l, 
2002). In addition this level of unresponsiveness cannot be reversed by the addition of 
rIL-2 (Groux et a l, 1996; Perrin et a l, 1999). IL-10 anergized cells are unable to 
produce cytokines, but when “forced” to proliferate with high concentrations of anti- 
CD3, a population of T cells which has the ability to produce cytokines arises. These 
cells produce IL-10 and TGF-p and have been termed TiT cells (as discussed in Section 
1.9) (Groux et a l, 1997). Therefore it appears that these regulatory cells go through two 
stages of differentiation to become Trl cells. It has been suggested that these are the 
most powerful regulatory cells, because of their direct effect on other T cells, and their 
ability to affect proliferation via APC by the production of IL-10.
In the mouse, IL-10 alone is not sufficient to induce a state of hyporesponsiveness 
equivalent to that seen in human cells. Only mouse T cells primed with IL-10 and TGF- 
p are hyporepoiisive in vivo (Zeller et a l,  1999). However, studies into human T cell 
anergy reported that IL-10 was fully capable of inducing anergy without TGF-p . In 
addition, rTGF-pi or 2 added to IL-10 did not increase the level of anergy induced by 
IL-10, nor synergize with IL-10 to promote the differentiation of Trl cells (Levings et 
a l, 2001). The reason for the differing role of TGF-P in the mouse and in the human 
remains to be elucidated. In conclusion it appears that both IL-10 and TGF-P are 
required for the differentiation of Trl cells in the mouse model, whereas IL-10 has the
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ability to function independent of TGF-p in the generation of these cells in the human 
system.
5 5
Figure 1.3. Differentiation processes of Thl and Th2 cells
A. The delivery of Ag to the TCR via the APC, results in an up- 
regulation of IL-12R. APC derived IL-12 and IL-27 results in the priming of 
naïve T cells toward a Thl phenotype. IL-27 binds to WSX-1 and IL-12 
signals via STAT4 to initiate the up-regulation of IFN-y. IFN-y activates 
STATl,which induces the transcription factor T-bet. IL-12 induces the IL-18 
receptor, which allows binding of IL-18 which results in lL-18 synergizing 
with IL-12 to increase IFN-y. IL-18 can activate NFkB which can also 
amplify the IFN-y response. Memory T cells respond to IL-23 which 
enliances proliferation of effector cells and increases IFN-y responses 
(adapted from Robinson and O'Garra, 2002).
B. The mechanisms involved in Th2 differentiation are less well 
understood. IL-4 is the key cytokine involved in inducing Th2 differentiation, 
however the early source of IL-4 varies in different models. NK cells, mast 
cells or differentiating T cells themselves have been proposed to produce 
early IL-4. Early IL-4 activates STAT6, which induces GATA3. GATA3 has 
many important effects including involvement in cliromatin remodelling of 
the IL-4/IL-13 locus. Also, c-Maf and NFAT transcription factors are 
important in regulating production of IL-4, IL-5 and IL-13 (adapted from, 
Agnello et al., 2003).
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1.8. Parasitic models of Thl/Th2 development
In terms of parasite immunology, the first demonstration of the importance of the Thl 
/Th2 balance in the regulation of disease outcome in vivo came from studies in the 
mouse model of Leishmania major. Infection of inbred strains of mice with L  major 
demonstrated that the differential development of Thl or Tli2 cells during experimental 
cutaneous ieislnnaniasis determines the outcome of infection (Reiner and Locksley, 
1995). Infection of resistant mice (C57BL/6, CBA and C3H/He) with L  major results in 
the onset of an IL-12 dependent Thl response, which results in elevated levels of IFN- 
y and healing. BALB/c mice, on the other hand, are susceptible to infection and develop 
a parasite specific Th2 response, with elevated levels of IL-4, progressive lesions and 
eventually die. It has been shown that early production of IL-4 results in Th2 
polarisation and therefore the suppression of the Thl IFN-y response which is 
responsible for activating infected macrophages for parasite killing (Green et aL, 1990; 
Liew et a l,  1990). Early IL-4 is produced by a population of CD4"  ^ cells with a 
V(34Va8 T cell receptor, as VJ34-deficient BALB/c mice mount a stronger Thl response 
than wild-type mice and appear to control lesion development (Launois et a l,  1997).
However the role of IL-4 in disease progression is controversial as demonstrated by 
experiments in IL-4Ra mice (Mohrs et a l, 1999; Noben-Trauth et a l, 1999), STAT6, 
and BCL6 deficient mice (Dent et a l, 1999). The complex interplay of IL-4 and IL-13 
was dissected using IL-13 transgenic mice and IL-13 -/- mice (Matthews et a l, 2000). 
In this study it was shown that over expression of IL-13 in transgenic mice makes the 
normally resistant C57BL/6 mouse strain susceptible to L. major infection even in the 
absence of IL-4. In addition IL-13 -/- BALB/c mice are resistant to infection. This
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resistance is independent of IL-4, however when IL-4 was deleted along with IL-13 
there was an additive effect (Matthews et a l, 2000). The healing response of L. major 
infection is characterised by an early Thl response with elevated levels of IFN-y and IL- 
12 (Nacy et a l, 1991; Swihart et a l, 1995). Interestingly a recent study has reported a 
role for WSX-1 in the initiation of Thl responses and resistance to L. major infection. 
WSX-1-/- mice were remarkably susceptible to L. major infection, showing impaired 
IFN-y production in early phases of infection. However, IFN-y production during the 
later stages of infection was not impaired in the WSX-/- mice. These data therefore 
indicate that WSX-1 is essential for the initiation of Thl responses but dispensable for 
their maintenance (Yoshida et a l, 2001). The role of IL-10 in promoting disease 
progression in Ieislnnaniasis was investigated by examining lesion development 
following L. major infection of susceptible BALB/c mice deficient in IL-10. Where 
normal BALB/c mice develop unhealing progressive lesions containing many parasites, 
IL-10-/- mice controlled disease progression and relatively small numbers of parasites 
were recovered.
The importance of the Thl response in clearing infection with L. major has been widely 
demonstrated whereas IL-4 and IL-13 have been shown to be important in maintaining 
infection. In contrast, resistance to the gastrointestinal nematode T. muris is dependent 
on the Th2 pathway. When IL-4 was blocked in resistant mice, a Thl response was 
generated with the development of chronic disease. In addition, administering IL-4 to 
strains of mice which are susceptible to infection with T. muris resulted in the expulsion 
of worms (Else et a l, 1994). These results were later confirmed in IL-4-/- mice infected 
with T. muris. These animals failed to mount a sufficient Th2 response and therefore 
could not expel the parasite (Bancroft et a l, 1998). In further experiments it was found
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that the background strain of mouse was important in whether worms were expelled or 
not. For example, C57BL/6 mice deficient in IL-4 develop chronic uniesolving 
infection, while BALB/C mice deficient in IL-4 clear infection suggesting an IL-4 
independent pathway of immunity, at least in BALB/c mice (Bancroft et al., 1998; Artis 
et a l, 1999; Bancroft et a l, 2000). This led to studies which investigated the role o f IL- 
13 in T. muris infection. As discussed in Section 1.7.3.2, IL-4 and IL-13 have 
overlapping biological activities, therefore it was important to understand the function 
of this cytokine in regulating Th2 responses. IL-13 was neutralized in vivo in IL-4-/- 
C57BL/6 mice and it was shown that these mice could expel their parasites, thus 
indicating that IL-13 is an important cytokine in regulating resistance to T. muris.
In contrast, mouse strains that are susceptible to T. muris respond to infection by 
producing IFN-y and IL-12 and develop chronic infection (Else et a l,  1992). The 
importance of IFN-y in the maintenance of infection in susceptible strains of mouse (e.g. 
BIO.BR, AKR) was demonstrated by neutralization of this cytokine in vivo, resulting in 
the expansion of Th2 cells and clearance of infection (Else et a l , 1994). In addition, 
when rIL-12 was administered to a resistant strain of mice (BALB/K), these mice 
developed elevated levels of IFN-y and were unable to clear their parasites (Bancroft et 
a l,  1997). IL-18 has been shown to work in synergy with IL-12 in promoting Thl 
priming (Okamura et a l,  1995) and has a role in the regulation of responses to T. muris. 
In susceptible animals infected with T. muris, IL-12, IL-18 and IFN-y mRNA were 
detected in sequence. IL-18-/- mice expelled their worms faster than IL-12-/- mice. IL- 
18-/- mice did not produce significantly different amounts of IFN-y compared to their 
wild type counterparts but they did produce significantly more IL-13. Interestingly, 
when resistant mice were given rIL-18, the mice developed a chronic infection. Similar
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results were obtained in IFN-y-/- mice indicating an important role for IL-18 in 
regulating immune responses to T. muris (Helmby et a l, 2001).
The role of IL-10 in regulating immune responses to T. muris has also been 
investigated. It was found that normally resistant mice (C57BL/6) mice were rendered 
susceptible to infection with T. muris when IL-10 was knocked out. This susceptibility 
correlated with an increase in levels of Thl cytokines (Schopf et a l,  2002). Taken 
together, these data demonstrate the importance of a Thl response for establishment of 
infection, whereas the production of Th2 cytokines plays a vital role in the expulsion of 
this parasite. Interestingly, additional experiments have identified a role for TNF-a in 
the regulation of IL-13 mediated expulsion of T. muris (Artis et a l, 1999). Using mice 
deficient in TNF-aR signalling or anti-TNF-a MAh treatment has demonstrated a role 
for TNF-a in regulating Th2 cytokine-mediated responses. In vivo blockade of TNF- 
a  in normally resistant mice did not alter IL-4, IL-5 or IL-13 production in the draining 
lymph node, but levels of worm expulsion were significantly delayed. TNFR -/- mice 
failed to expel T. muris, producing high levels of Thl cytokines suggesting that the 
absence of TNF-a at the onset of infection alters the phenotype of the response elicited.
1.9. Treg cells
Although evidence for polarized CD4^ T cell cytokine secretion profiles that define Thl 
and Th2 subsets is indisputable, these extremely polarized responses are usually 
observed under highly contrived experimental conditions. The real challenge to the Thl- 
Th2 paradigm comes when attempts are made to apply this simplistic dichotomy in 
explaining immune system-dependent disease conditions. These and other issues have 
recently caused a spate of interest in a recently re-discovered group of cells, namely the
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Treg cells. These cells have a suppressive function and are distinguishable by their 
cytokine profile (IL-10 and TGF-P) and mechanism of suppression. So far at least three 
separate T regulatory cell types have been characterised. Th3 cells were first discovered 
during studies into oral tolerance, where low dose administration of Ag was Imown to 
result in active suppression of immune responses. These cells are IL-4 independent and 
CD8 6  dependent, requiring interaction with APC. Th3 differentiation is enlianced by 
culture with TGF-p, IL-4, IL-10 and anti-IL-12, and matme Th3 cells predominantly 
secrete TGF-p and varying amounts of IL-10 and IL-4. In addition, these cells express 
CTLA-4 on their surface (Weiner, 2001). Trl cells were initially discovered in studies 
of CD4^ cells which were activated in the presence of IL-10 and rendered anergic. 
Analysis of this population at the clonal level showed a subset of T cell clones with a 
unique cytokine profile, secreting high levels of IL-10 and TGF- p, moderate IFN-y and 
IL-5 with little or no IL-2 or IL-4. These cells have been shown to be involved in the 
down-regulation of immune responses in vivo and in vitro via the production of IL-10 
and TGF-p (Roncarolo et a l,  2001a) Lastly, the third group of Treg cells are the 
naturally occurring CD4^CD25^ cells which have potent suppressor functions in vivo 
and in vitro. Removal of these cells from normal rodents is associated with the 
development of various autoimmune diseases. Although it has been suggested that 
suppression by these cells is cytokine independent, they are known to produce IL-10, 
TGF- p and low levels of IL-4 or IL-2. Consequently the role of these cytokines is 
controversial. One study suggested that the production of IL-10 from CD4‘^ CD25’^ cells 
may lead to the induction of CD4’*’CD25' cells which suppress immune responses via 
the production of IL-10 (i.e. CD4^CD25^ cells induce Trl like cells) (Dieckmaim et a l, 
2002). CD4^CD25^ cell suppression is thought to be linked to their ability to inhibit IL- 
2  production but also requires cell to cell contact to induce suppression which may be
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associated with surface bound TGF-P, LAP, CTLA-4 or GITR. In addition these cells 
differ from Th3 and Trl cells in that CD25^ cells exist in the thymus as suppressor cells, 
while Th3/TiT cells can arise from any naïve peripheral CD4^ cell (Read and Powrle, 
2001). Until recently very little was known about the molecular mechanism of the 
development of CD25^ regulatory cells, but in a study by Hoii et al (Hori et a l, 2003) 
the gene Foxp3 was shown to encode a transcription factor which is specifically 
expressed in naturally arising Treg cells (see Figure 1.4A).
Regulatory cells have the capacity to inhibit potentially harmful immune responses and 
have been described in various experimental systems. Best characterised aie the 
CD4^CD25^ cells which have been shown to prevent inflammatory bowel disease (Read 
et a l, 2000) and inhibit autoimmune diabetes in rats (Stephens and Mason, 2000). 
Treatment with monoclonal Ab specific for CD25 has been shown to suppress a variety 
of tumours in mice (Onizuka et a l, 1999). In addition, several studies have indicated the 
role of CD4’^ CD25’^ cells in transplant tolerance, by preventing auto immunity and 
enabling the development of tolerance to organ, tissue and cell transplants (Wood and 
Sakaguchi, 2003). Regulatory T cells also function in immune responses to various 
infectious agents, whether it be fungal, viral, bacterial or parasitic infections and these 
studies are reviewed in Chapter 5. Figure 1.4 illustrates the pathways leading to the 
development of Treg cells.
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Figure 1.4. Diagrammatic representation of the development of Treg 
cells
A. Treg cells which express Foxp3 aie produced in the thymus, however 
CD4+ cells which are found in the periphery may also acquire regulatory 
properties. Loss of function mutations of Foxp3 results in wasting disease 
and lymphoproliferative disorders. Treg cells inhibit activation of CD4+ 
effector cells, therefore have an important role in the prevention of these 
disorders (adapted from O'Garra and Vieira, 2003).
B. Naïve T cells differentiate in the thymus and cells which are selected 
include low-affinity TCR T cells and high affinity TCR natural CD4'^CD25’^ 
Treg cells (Trn). Conventional T cells and Tregs are exported to the 
periphery where they respond to Ag. Conventional CD4+ cells become either 
T helper or Treg cells depending on the affinity of their- TCR to Ag, the 
strength of co-stimulatory signals and the cytokine environment. Stimulation 
of naïve T cells with regulatory DC can result in the generation of a 
population of Treg cells (Trl cells), in addition IL-10 can also induce this 
population. TGF-p and IL-2 can cause Thp cells to differentiate towards a 
Th3 phenotype. These two Treg cells produce IL-10 and TGF-p and can 
suppress T cell prolferation in a cytokine dependent mamier. CD4^CD25^ 
cells (Trn) suppress T cell proliferation in a cytokine independent, contact 
dependent manner in vitro (adapted from, Horwitz et a l,  2003).
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1.10 Aims of thesis
The infective third stage larvae of filarial worms have potent immuno-modulatory 
effects on the host immune system. The aims of this thesis were to define how L3 
modulate cytokine and cellular immune responses in a well-characterised mouse model 
of infection.
The specific aims are detailed below.
• IL-4 is a prototypic Th2 cytokine and is secreted by PBMC of all individuals in 
an endemic area. Ag-specific IL-4 is produced by splenocytes and lymph node 
cells from L3 infected BALB/c mice, therefore it was of interest to investigate 
whether IL-4 had a role in worm survival and to analyze immune responses in 
IL-4-/- mice.
• IL-10 is Imown to be important in maintaining hyporesponsiveness in MF+ 
individuals and is up-regulated in L3 infected mice. However, as the cellulai* 
sources of IL-10 have not been defined, I set out to investigate the role of IL-10 
in L3 infection and to identify the major source of IL-10 in the mouse model.
Recent data suggests the presence of Treg cells in chronic infectious disease. 
Although the L3 of Brugia is the infective form, the production of elevated IL- 
10 suggests that the L3 may induce a suppressor cell population. Therefore 
experiments were carried out to determine whether infection with L3 elicits Treg 
cells.
There are many immune cells which ar e known to present Ag to T cells and the 
capacity of B cells to carry out this function, along with their ability to produce 
modulatory cytokines was investigated in the L3 BALB/c model.
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Chapter 2. Materials and Methods 
2.1. The Parasite
2.1.1. Mosquito life cycle
Mosquitoes {Aedes aegypti) were kept in mesh cages in a purpose built insectary 
maintained at a temperature of 28”C and relative humidity of 75-80%. To maintain 
stocks, mosquitoes were fed twice weekly with heparinized rabbit blood using an 
artificial membrane feeder. Eggs were collected on moist Whatman 3 mm filter papers 
which were placed in cages. The papers were then removed and dried and stored until 
required. Eggs were hatched by placing the egg papers in plastic trays containing tap 
water with yeast tablets to feed the developing larvae. Pupae were picked daily and 
placed in cages. Adult mosquitoes were fed on a diet of sucrose before being starved 24 
hours prior to receiving a blood meal.
2.1.2. Parasite life cycle
Adult parasites and microfilaria were obtained from the peritoneal cavity of infected 
jirds {Meriones unguiculatus), which had been infected intraperitoneally with 250 L3 
of B. pahangi for at least tlnee months. Jirds were killed by CO2 inhalation. Worms 
were obtained by repeated peritoneal lavage with Hanks Balanced Salt Solution (HBSS, 
Invitrogen) at 37®C. Adult worms were washed in HBSS and transferred to liquid 
nitrogen until they were required for the preparation of parasite extracts. The MF 
contained in the peritoneal washings were given a further wash in HBSS before being 
resuspended in heparinized rabbits blood at a concentration of 400/20 pi. The infected 
blood was then fed to mosquitoes using an artificial membrane feeder.
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2.1.3. Recovery of infective larvae and microfilariae
Microfilariae were obtained from the peritoneal cavity of infected jirds by extensive 
washing with HBSS. 1ml ddH2 0  was added to lyse any erythrocytes present. MF were 
then washed in HBSS at 37°C and separated from host cells by centrifugation twice 
over Histopaque-1077 (Sigma, Poole, Dorset) at 1200 rpm for 15 minutes with no 
brake. MF were washed twice, resuspended in HBSS and coimted. L3 were extracted 
fi'om infected mosquitoes at day 9 p.i. using standard methods (Devaney and Jecock, 
1991).
2.1.4. Preparation of adult antigen extracts
Soluble extract of B. pahangi adult worms, for use in cell culture, was prepared by 
extensive homogenisation on ice of frozen mixed sex adult worms in RPMI-1640 
(Dutch Modification, containing 5 mM glutamine, 5 mM HEPES, 100 U/ml penicillin 
and 100 pg/ml streptomycin, all Invitrogen, UK). The homogenate was incubated on ice 
for a further 60 minutes with occasional agitation. The suspension was transferred to an 
Eppendorf tube and centrifuged at 4°C at 10,000g for 30 minutes. The supernatant was 
removed and sterilized by centrifugation through a 0.45 pm Spin-X filter unit (Co-star, 
UK) and assayed for protein concentration using the BioRad method. Aliquots were 
then stored at -70°C.
2.2. Animals and infection protocols
2.2.1. Standard infections
6 -week-old male BALB/c mice were purchased from Harlan-Olac (Bicester, U.K.) and 
were maintained in filter-topped cages. Unless stated otherwise, groups of 5 BALB/c
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mice were infected sub-cutaneously (s.c.) with either 50 L3 or 1 x 10  ^ MF or an 
equivalent volume of HBSS in the scruff of the neck. Syringes used for inoculation of 
L3 were flushed with HBSS after use and the remaining L3 counted. If ten or more L3 
remained, these were re-injected. Mice were typically culled on day 12 post-infection 
(unless otherwise stated) by CO2 inhalation and spleens were removed.
2.2.2. Mosquito infections with L3
In some experiments, mice were infected by allowing mosquitoes to feed directly. 
Mosquitoes were infected as described above and blood fed females were removed to a 
separate cage. On day 9 p.i., 20 mosquitoes were dissected and the numbers of L3 
counted to give an average number of L3 per mosquito. The appropriate number of 
infected mosquitoes were then allowed to feed on the shaved abdomen of an individual 
mouse, so that each mouse would receive a minimum of 50 L3. The fed female 
mosquitoes were dissected after feeding to confirm that most L3 had been transmitted. 
Controls in these experiments were mice infected by syringe inoculation or given HBSS 
alone in the scruff of the neck.
2.2.3. Adult implants
Groups of 5 BALB/c mice were also infected with adult worms by implanting 10 adult 
female worms into the peritoneal cavity. Adult worms were obtained from the 
peritoneal cavity of infected jirds as described previously. Mice were anaesthetized 
using Halothane and 10 female worms were introduced into the peritoneal cavity 
through a small incision, using a sterile glass probe. The incision was clipped and mice 
allowed to recover in warmed boxes. These animals were housed individually for the 
duration of the experiment. Mice were killed by CO2 inhalation and spleens were
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removed. In addition the peritoneal cavity of these mice was washed extensively with 
HBSS to assess adult worm and MF recovery.
2.2.4. Other mouse strains
In additional experiments, 6 -week-old IL-4 deficient mice on the BALB/c background 
were infected with MF, L3 or adult worms using the same protocols as described above. 
Groups of 10-week-old male B cell deficient (IgM transmembrane domain) pMT or IL- 
10-/- mice on the C57BL/6 backgromid were infected with L3 by the s.c. route. IL-10-/- 
mice were obtained from Dr. R. Lawrence at the University of Manchester and pMT 
mice were obtained from either Dr. J Allen at the University of Edinburgh or Dr. R. 
Lawrence. Appropriate controls were used in all experiments.
2.3. Preparation of spleen cells
Spleens were removed aseptically and single cell suspensions were prepared in RPMI 
by homogenising the tissue tlnough Nytex mesh using sterile syringe barrels (Cadisli 
and Sons, London U.K.). Remaining tissue debris was removed by passage of the 
suspension through Nytex mesh. Erythrocytes were lysed using 0.83% NH4CI (pH 7.2) 
following which the single cell suspension was washed twice in RPMI. The number of 
viable lymphocytes was assessed by the Trypan Blue exclusion method. The cells were 
resuspended at 1 x 1 0  ^ / ml (for proliferation assays) or 2  x 1 0  ^ / ml (for cytokine 
assays) in RPMI containing 20% heat inactivated FCS (Invitrogen) to give a final 
concentration of 1 0 %.
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2.3.1. Proliferation assay
Proliferation of splenocytes was measured by the incorporation of thymidine. 
Triplicate 100 pi cultures (5 x 10  ^ cells / well) in 96-well flat-bottomed half-area plates 
(Costar) were incubated in the presence or absence of 10 pg/ml adult antigen. This 
concentration of Ag was shown to be optimal in previous experiments (Osborne, 
1997a). Cells were cultured at 37°C in an atmosphere of 5% CO2 and pulsed with 0.5 
pCi of thymidine/well (Amersham) during the last 16 hours of incubation. The cells 
were harvested and radioactivity measured in a “Topcount” Microplate Scintillation 
Counter (Canberra Packard Instrument Company).
2.3.2. In vitro treatments
In certain experiments rat anti-mouse IL-10 MAb (JESS-5, Pharmingen, UK) or IgGl 
isotype matched control MAb (R59-40, Pharmingen) were added to Ag-stimulated and 
medium only culture at a final concentration of 1 pg/ml (anti-IL-10). After such 
treatment, the proliferation and cytokine responses of the cells were assessed. IL-10 was 
measured by cytokine ELISA assay, which demonstrated that this cytokine had been 
successfully neutralized in JESS-5. In addition, in all experiments purified anti-mouse 
CD80 (B7-1, 16-lOAl) and purified anti-mouse CD8 6  (B7-2, GLl) were added to Ag- 
stimulated culture at a final concentration of 1 pg/ml. When these Ab were added to 
culture simultaneously the final concentration was 2 pg/ml. For experiments in IL-4-/- 
mice, IFN-y neutralizing MAb (XMG1.2) or isotype matched control (R3-34, both 
Phaiiningen) were added to medium only and Ag-stimulated culture at a concentration 
of 100 pg/ml. After such treatment the proliferative responses of the cells were assessed 
as described in 2.3.1.
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In other experiments the following supplements were added to both antigen-stimulated 
and medium only cultures. All concentrations given refer to final concentrations active 
in culture: Recombinant lL-4 (rIL-4, Sigma) at 500 pg/ml and 1 ng/ml; Aminoguanidine 
(AMG, Sigma) at 500 mM. The proliferative and cytokine responses of these cells were 
compared to those in unsupplemented cultures.
2.3.3. In vivo treatments
In some experiments mice were injected intraperitoneally with neutralizing IL-IOR 
MAh (IB 1.3a, Pharmingen) or matched isotype control (GL113) at a concentration of 
10 pg on day 0 and 4 and 7 post infection. In other experiments, mice were injected 
intraperitoneally with neutralizing CD25 MAh (PC61) or isotype matched control 
(GL113) at a concentration of 0.5 mg/ml on day -4  and -2  prior to infection. 
Hybridomas were cultured in RPMl 1640 + 10% PCS, 1% glutamine, 1% 
penicillin/streptomycin, 50 pM 2-mercaptoethanol, 2% petone and glucose solution, at 
37^C with 5% CO2 . PC61 and GL113 Ab were prepai'ed by ammonium sulphate 
precipitation of hybridoma supernatant and subsequent dialysis against PBS (Maizels et 
al 1991). The Ab was sterilized using a syringe filter and protein concentration was 
determined by carrying out a 1:10 dilution and taking an OD280 reading (Perkin Elmer 
U.V. Spectrophotometer). Ab was stored at 4° C. Proliferation assays, cytokine assays 
and FACS analysis were carried out on the splenocytes from each group of animals as 
described in 2.3.1, 2.3.4 and 2.4 respectively.
2.3.4. Analysis of cytokine production by ELISA
Spleen cells were incubated at 1x10^ cells/ml in 1ml cultures in 24-well fiat-bottomed 
plates (Costar) in the presence of Ag (10 pg/ml) or medium only. Supernatants were
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harvested at 48 hours, unless otherwise stated. After centrifugation for 5 mins at 13,000 
rpm the cell-free supernatants were stored in aliquots at -20°C. Levels of IL-2, IL-4, IL- 
5, IL-10 and IFN-y were determined by two-site ELISA using Ab pairs purchased from 
Pharmingen. The optimal concentrations for the capture and detecting antibodies were 
determined in preliminary experiments. Results are expressed as pg/ml in reference to 
commercially available standards (IL-12, IL-4, IL-5 and IL-10 from Pharmingen and 
IFN-y from R and D Systems, UK). The sensitivity of the assay was determined as the 
mean + 3 SD of the 16 wells containing medium only (RPMI 10% FCS). For 
measurement of IL-13, the Murine Quantikine kit (R and D Systems) was used 
according to the manufacturers guidelines. For the measurement IL-2, IL-4, IL-5, IL-10 
and IFN-y, ELISA plates (Corning Easy Wash) were coated with 50 pl/well capture Ab 
in PBS, over-night at 4°C and then blocked with 150 pl/well PBS, 0.5% Tween 20 
(PBS.T20), 10% FCS for 45 minutes at 37°C. During this incubation, samples were 
defrosted and doubling dilutions of the recombinant cytokine standards were prepared 
in RPMI/10% FCS on a separate plate. ELISA plates were then washed twice with 
PBS/T.20 quickly and twice for 3 minutes. Samples, standards and RPMI/10% FCS 
were transferred to plates at 50 pl/well for 2 hours at R.T. Plates were washed as 
described above and biotinylated secondary antibody diluted in 1% BSA PBS/T.20 was 
added at 50 pl/well for 1 hr at R.T. Plates then were washed as before. Streptavidin 
peroxidase (Serotec, UK) diluted 1/1000 in 1% BSA PBS/T.20 was added at 75 pl/weli 
for 1 hr at R.T. Plates were washed as before and TMB peroxidase substrate (KPL, UK) 
was added at 100 pl/well for 10 minutes. Plates were read at 620 nm in a Dynatech 
MR5000 automated ELISA reader.
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2.3.5. Analysis of nitrite by the Greiss reaction
The Greiss reaction was used to measure nitrite levels in culture supernatant, using the 
following protocol. 50 pi of cell culture supernatant and 50pi of Greiss reagent (see 
2.7.8) were mixed in 96 well flat bottomed plates and incubated at room temperature for 
10 minutes before absorbance was determined at 560 mn (all samples were tested in 
duplicate). NO2’ concentration was calculated from a standard curve using two-fold 
dilutions of a stock control solution of sodium nitrite at 10 pg/ml. Sensitivity was 
determined as the mean + 3 SD of the 16 wells containing medium only (RPMI 10% 
FCS).
2.4. FACS staining
2.4.1. Cell surface staining
Cells to be stained were removed from culture, transferred to FACS tubes (Falcon), and 
washed twice in 200 pi of staining buffer (see 2.7.6), by centrifugation at 1000 ipm for 
5 minutes. 2x10^  cells were stained with 2 pg/test of fluroclirome-conjugated antibody 
in staining buffer or staining buffer only (100 pl/sample) on ice for 20 min. Cells were 
washed twice in staining buffer as before and resuspended in 300 pi of fixation buffer 
(see 2.7.6) if not to be analysed immediately. Stained samples were stored in the dark at 
4 °C. Samples were gated on lymphocytes, as determined by size and granularity 
(forward and side scatter). Monoclonal antibodies used were as follows, anti-mouse 
CD4 (L3T4), anti-mouse CD45R/B220 MAb (RA3-6B2), anti-mouse CD8 (Ly-2), anti­
mouse CD152 (CTLA-4, UC10-4F10-11 ), anti-mouse CD25 (PC61), anti-mouse CD80 
(B7-1, 16-lOAl) and anti-mouse CD8 6  (B7-2, GLl) (all Pharmingen). In experiments 
examining the expression of CTLA-4, B7-1 and B7-2, Fc block (Pharmingen) was used
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at a concentration of 1 pg/test to reduce non-specific binding. Fc block was added to 
samples along with the antibody of choice. Isotype controls used were as follows, Rat 
IgG2a-FITC (KLH/G2a-1-1, Southern Biotechnology Associates), rat IgG2a-APC 
(R35-95), rat IgGl-PE (both Pharmingen).
All samples were analysed on a Becton Dickinson FACScalibur (department of 
Immunology, University of Glasgow). Data analysis was carried out by using Becton 
Dickinson’s CellQuest software.
2.4.2. CFSE staining
Splenocytes were harvested from mice as described in 2.3. Cells were labelled with 
CFSE ex-vivo and then cultured with or without stimulation, prior to cell surface 
staining and flow cytometric analysis. After counting the number of viable splenocytes, 
5 X 10  ^cells/sample were washed twice in 5 ml sterile PBS by centrifugation at 1000 
rpm for 5 minutes. Cells were then incubated in 10 pM CFSE in PBS (Molecular 
Probes, Netherlands) at 5 x 10  ^cells/sample for 8  mln at R.T. The reaction was stopped 
by the addition of 5 ml of RPMI containing 20% FCS. All samples were washed twice 
in RPMI 10% FCS. Stained cells were plated out in 1 ml cultures as described 
previously, with or without stimulation, for 96 hr prior to cell surface staining and 
FACS analysis. CFSE labelled cells were hai'vested and surface stained with either an 
anti-mouse CD4 APC conjugated MAb (L3-T7), anti-mouse B220 APC conjugated 
MAb (RA3-6B2), anti-mouse CD8  (Ly-2) or isotype matched control (R35-95) (all 
Pharmingen), as described above, prior to FACS analysis. Samples were gated on total 
lymphocytes, as determined by forward and side scatter and CD4^, B220^ or CD8  ^
lymphocytes for analysis of CFSE staining profiles. Controls in each experiment
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comprised unstained cells, cells stained with anti-CD4 or anti-B220 or isotype matched 
control only and cells stained with CFSE only cultured In medium alone.
2.4.3. FACS gating
Lymphocytes were initially gated by means of their physical properties in terms of size 
and granularity (forward and side scatter) (Figure 2.1 A). The number of positively 
stained lymphocytes [in this example CD4^ cells were stained with FITC (FL-1)] were 
determined using gates set with the isotype control for the particular flurochrome, 
shown in B. Positively stained lymphocytes are shown in panel C. Histogram statistics 
ai'e also shown, indicating that CD4^ cells make up 19.8% of gated lymphocytes.
For three colour staining, lymphocytes were gated as shown in Figure 2.1.D, CD4^ 
cells were stained with FITC and the gate was set on positive cells to create region 2 
(R2)(D). The dot plot shown in E is gated on R2 and an isotype control (for PE and 
APC) was analysed to plot a quadrant, allowing analysis of CD4^ (FITC), CD25’*' (APC 
stained (FL-4)) and CTLA-4+ (PE stained (FL-2) cells as shown in F. Quadrant 
statistics are also shown demonstrating that 5.98% of CD4^ cells also express CD25 and 
CTLA4.
CFSE labelling was used to track the proliferation of specific cell types. Cellular 
division can be visualised by the serial halving of FL-1 fluorescence, therefore if CSFE 
labelling is coupled with cell surface staining (APC, FL-4), the proliferation of specific 
cell types can be analysed by flow cytometry. The gates were set using FL-4 isotype 
control stained cells (G). The example given in H depicts the division of CD4^ cells.
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Histogram statistics are shown and it can be seen that 6.05% of total lymphocytes are 
dividing CD4^ cells.
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2.5. Magnetic Separations
2.5.1. Cell depletion
In experiments to determine the cellular source of IL-10, splenocytes from L3 infected 
animals were depleted of either CD4’*’ or B220^ cells by magnetic separation, prior to in 
vitro culture. Splenocytes were prepared as described previously and pooled from five 
L3 infected mice. Unseparated cells were plated out prior to depletion for proliferation 
and cytokine assays as described in 2.3.1 and 2.3.4 respectively. At this point 5 x 10  ^
cells were removed for FACS analysis and stained with an isotype control antibody 
(KLH/G2a-1-1, Pharmingen) for use in setting gates for FACS. The remaining pooled 
cells were washed in PBS and then stained with either an anti-CD4 or anti-B220 FITC 
conjugated MAb (L3T4 or RM4-5, both Pharmingen) in 500 |l.i1 of PBS on ice for 20 
minutes. Both Abs were used at 2 |al/2 x 10  ^cells. Cells were then washed twice in PBS 
and 5 x 1 0 ^  cells were taken for FACS analysis to determine the percentage of CD4^ 
and B cells in total splenocyte preparations. Cells were then resuspended at 90 |l x 1 of 
buffer/10^ cells in degassed separation buffer (see 2.7.6) prepared to MACS 
specifications, with anti-FITC beads (10 p.1 of beads/10^ cells) and incubated on ice for 
15 minutes. Cells were washed in separation buffer and resuspended in 500 jul of 
separation buffer. Prior to passing cells over the positive selection LS column (Miltenyl 
Biotec), 3 ml of separation buffer was passed over the column. Cells were loaded onto 
the column followed by 9 ml of buffer and collected upon exit from the column. Cells 
were washed in PBS and 5 x 1 0 ^  cells were removed for FACS analysis to determine 
the efficiency of the depletion. Cells were then resuspended in RPMI containing FCS 
2 0 % and plated out as described previously for proliferation and cytokine assays.
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2.5.2. Cell purification
For RNA extraction CD4^ and B220^ cells were purified from splenocytes of L3 
infected animals by magnetic separation. Splenocytes were prepared as described 
previously and pooled from five L3 infected mice. At this point 5 x 10  ^ cells were 
placed in a cryotube and frozen in liquid nitrogen for RNA extraction from whole 
splenocytes. 5x10^  cells were removed for FACS analysis and stained with an isotype 
control antibody (KLFl/G2a-l“l, Pharmingen) for use in setting gates for FACS. The 
remaining pooled cells were washed in PBS and then stained with either an anti-CD4 or 
aiiti“B220 FITC conjugated MAb (L3T4 or RM4-5) both Pharmingen) in 500 pi of PBS 
on ice for 20 minutes. Both Abs were used at 2pi / 2 x 10  ^cells. Cells were then washed 
twice in PBS and 5 x 10  ^ cells were taken for FACS analysis to determine the 
percentage of CD4^ and B cells in total splenocyte preparations. Cells were then 
resuspended in degassed separation buffer (90 pi of buffer/10^ cells) with anti-FITC 
beads (10 pi of beads/10^ cells) and incubated on ice for 15 minutes. Cells were washed 
and resuspended in 500 pi of buffer. 3 ml of separation buffer was passed over the 
positive selection LS column (Miltenyl Biotec) and cells were then loaded onto the 
column followed by 9 ml of buffer and collected upon exit from the column. To collect 
purified CD4^ or B220^ cells, the column was removed from the magnet and placed on 
a new collection tube. 5 ml of buffer was applied to the reservoir of the column and the 
cells were firmly flushed out using the plunger supplied with the column. 5 x 1 0 ^  cells 
were then taken for FACS analysis to determine the efficiency of the purification. The 
purified CD4^ and B220^ cells were placed in a cryotube and stored in liquid Nitrogen.
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2.6. Analysis of cytokine mRNA expression following infection with L3
2.6.1. RNA extraction
Cells from the purification experiments described above were removed from liquid 
nitrogen and total RNA was extracted using TRIzol (Invitrogen), according to the 
manufacturer’s instructions. 1 ml of TRIzol was added to the cryotube containing cells 
and heated to 60“C for 10 minutes. The samples were then vortexed. At this point 3 pg 
of glycogen (Invitrogen) was added to each sample to act as an RNA carrier. 200 pi of 
cholorform was added and the samples were shaken for 15 seconds. After centrifugation 
at 4 °C for 10 minutes at 12,000 rpm the aqueous layer containing RNA was pipetted off 
into a fresh Eppendorf tube. 0.5 ml of isopropanol was added to each sample to 
precipitate the RNA (0.5 ml isopropanol for every ml of TRIzol initially used). Samples 
were then incubated at room temperature before further centrifugation at 4 °C for 10 
minutes at 12,000 rpm. A small pellet of RNA was then formed and the supernatant was 
removed using a Pasteur pipette attached to a suction pump. To enhance subsequent 
solubility, 1 ml of 75% ethanol was added to each tube (1 ml of ethanol for every ml of 
TRIzol initially used) and the sample was vortexed. Samples were then centrifuged at 
4°C for 5 minutes at 7500 rpm. The pellet formed was dissolved in an appropriate 
amount of diethyl pyrocarbonate (DEPC) H2O (10 ql - 30|ul) and incubated at 55 - 60 °C 
for 10 minutes to ensure the RNA was dissolved.
The RNA was then quantified by spectrophotometry at OD260 and checked by ethidium 
bromide staining on 1% agarose mini-gels. Before the gel was poured, the mini-gel tanlc 
and combs were washed in 0.25M HCl, and three times in DEPC treated H2O. For a 50 
ml mini-gel, 0.5 g agarose was melted in a solution containing 5 ml lOX MOPS buffer
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and 39.5 ml of DEPC H2O by boiling in the microwave. The solution was cooled to 55 
°C. In a fumehood, 8.5 ml of 17% formaldehyde was added, mixed and the gel was 
poured. 1 pi of 500 ng/ml ethidium bromide, 1 pi loading buffer and 1 pi of formamide 
was added to 1-5 pg of each RNA sample. Prior to electrophoresis, the RNA samples 
were denatured by heating to 65 °C for 10 minutes. When the gel was set, the RNA 
samples were loaded and the gel was run in IX MOPS buffer at 45V for 30-40 mins. 
RNA was visualised on the UV transilluminator. RNA was aliquoted and stored in 
DEPC-treated El2 0  at -70°C until used.
2.6.2. RT-PCR detection of IL-10 and TGF-p
The reverse transcription reaction was carried out in a total volume of 20 pi. 2 pi of 
random primers (Promega) were added to 10 pi of total RNA (2 pg) and the mix was 
heated to 70 °C for 10 mins and then cooled on ice for 10 mins. 4 pi of first strand 
buffer (Invitrogen), 2 pi DTT (Invitrogen) and I pi 10 mM dNTP mix were added and 
incubated at 42 °C. I pi of Superscript (reverse transcriptase) was added to the mix 
which was heated to 42°C for 50 mins with a final extension of 70 °C. 1 pi of RNase 
was added and the reaction was incubated at 37 °C for 20 mins. The reaction was then 
chilled on ice and stored at -20 °C.
Real time quantitative reverse-transcriptase-PCR was carried out using the TaqMan 
method with gene specific primers and internal probes for IL-10 and TGF-p and HPRT 
(Cruachem) designed to specifically amplify the target cDNA as these primers were 
designed to span an intron/exon boundary and thus anneal specifically to cDNA (primer 
and probe sequences shown in Table 2.1). FIPRT was used as the constitutively
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expressed gene. All primers and probes were HPLC purified and lyophilised. For the 
standard TaqMan protocol, primers were used at a concentration of 10 pM and probes at 
5 pM. Each reaction of 25 pi volume contained 12.5 pi TaqMan Universal PCR Master 
Mix (Applied Biosystems), 1 pi probe, 0.75 pi each primer and 9 pi H^O. Sufficient 
mastermix was prepared to analyse each sample in triplicate including a non-template 
control (water alone). 24 pi of mastermix was then aliquoted into the appropriate wells 
of a Micro Amp Optical 96 well reaction plate (Applied Biosystems). 1 pi of previously 
prepared cDNA (or FUG in the case of the non-template controls) was then added to the 
wells. Once the samples were added the plate was sealed with Optical Caps (Applied 
Biosystems). Plates were then spun at 1400 rpm for 1 min to ensure that there were no 
bubbles in the samples, as this interferes with the laser beam. The plate was then placed 
in the ABI/PRISM 7700 detection system which was set to the following cycling 
conditions; 50 for 2 mins, 95 “C for 10 mins, 95 for 15 secs and 60 ”C for 1 min. 
At the end of the run the software generates a series of amplification plots relating to the 
samples. The graph shows the cycle numbers plotted against fluorescence. Data from 
this software was exported into EXCEL where a series of Ct values (the number of 
cycles at which the amplification plot for the particular sample crosses the threshold 
line) was generated. When these data were pasted into the previously prepared analysis 
template the calculations normalise the data to the HPRT gene. The percentage values 
for each of the samples (IL-10 or TGF-(3) were plotted to determine the relative 
expression levels for the gene of interest. Therefore the normalized value for IL-10 or 
TGF-P mRNA expression in each sample was calculated as the relative quantity of 
either IL-10 or TGF-(3 divided by the relative quantity of HPRT (xlOO). A diagram of 
the TaqMan principle shown in Figure 2.2.
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Figure 2.1. FACS gating 
A-C
2x10^  cells from splenocyte cultures of L3 infected mice were stained with 
FITC labelled anti-mouse CD4 MAb or the isotype matched control. Panel A 
shows typical gating of lymphocytes in terms of size and granularity. Panels 
B and C are gated on this region therefore display events taking place within 
this area. Panel B shows FLI fluorescence of the isotype control from which 
the Ml region can be set. M l is the region in which all CD4^ cells will fall 
when stained with anti-CD4 MAb (panel C).
D-F
2x10^  cells from splenocyte cultures of L3 infected mice were stained with 
FITC labelled anti-mouse CD4, PE labelled anti-mouse CTLA-4 and APC 
labelled anti-mouse CD25. Panel D shows gating on all CD4^ events which 
lie within the total lymphocyte population (see panel A). Panel E shows 
events collected when cells were stained with isotype controls for FITC, PE 
and APC, thus allowing the quadrant to be set which displays CD4‘^  cells 
which co-express CTLA-4 and CD25 (panel F).
G-J
2 X 10® CFSE stained and non-CFSE stained cells from splenocyte cultures 
of L3 infected mice were stained with APC labelled anti-mouse CD4 or the 
isotype matched control. Panel G shows cells which were not stained with 
CFSE and stained with FITC and APC isotype control. Panel H shows cells 
stained with CFSE and anti-CD4. As CFSE loses fluorescence as cells divide, 
dividing CD4^ cells are shown in the upper left hand part of the quadrant. 
Panel I is a histogram which shows the distinct peaks which represent each 
cellular division luidergone by the total lymphocyte population. The overlay 
represents CD4^ cell division. Panel J shows cells which have been cultured 
with medium only and the statistics below represent the percentage of 
dividing cells. It can be seen here that the percentage of dividing 
lymphocytes is much lower in cells horn medium only cultures compared to 
Ag stimulated cultures.
HPRT Forward 5’-GCA GTA GAG CGC CAA AAT GG-3’ 
Reverse 5’-AAC AAA GTC TGG CCT GTA TCC AA-3’ 
Probe 5’-FAM-TAA GGT TGC A AG CTT GOT GGT GAA 
AAG GA-TAMRA-3’
IL-10 Forward 5’-ACA ACA TAG TGC TAA CCG ACT CCT T-3’ 
Reverse 5’-AGG TAA AAC TGG ATC ATT TCC GAT A-3’ 
Probe 5’-FAM-TGG CAA CGC AAG TAA CGC TTA AAG 
TCC TG-TAMRA-3’
TGF-(3 Forwai-d 5 -CGC CAC TGA TAG GCC TGA G T - 3 ’ 
Reverse 5 ’ -  ACA AGA GCA GTG AGC GGT GA -  3 ’
Probe 5’ -  FAM-TGA ACC AAG GAG ACG GA-TAMRA -  
3’
Table 2.1. TaqMan primer and probe sequences
Primer and probe sequences were selected by the using the Primer Express software 
(ABI/Perkin Elmer). Probe sequences were designed according to the following criteria. 
The melting temperature (T„i ) was between 65 and 67 °C, the 5’ end of the probe was 
not a guanosine residue, runs of an identical residues were avoided and the polymorphic 
site was near the centre of the probe. Primer sequences were designed according to the 
following guidelines. The G-C content was within the 20 to 80 % range, runs of an 
identical neucleotide were avoided, the Tm was between 58 and 60 °C, the five 
neucleotides at the 3’ end had no more than two G and/or C bases and the forward and 
reverse primers were placed as close as possible to the probe without overlapping the 
probe.
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Figure 2.2. The TaqMan principle
During PCR annealing, primers and the fluorogenic probe anneal to denatured single­
stranded DNA template. As long as the probe is intact, TAMRA (the 3’ quencher dye) 
absorbs the fluorescent emissions of FAM (5’ reporter dye). During extension, the 
probe is cleaved by the 5’ nuclease activity of the Taq, separating the reporter from the 
quencher signal which results in increased fluorescence of the reporter dye which is 
quantitative for the initial amount of template. F.P. - forward primer; R.P. - reverse 
primer; T.P. - flurogenic probe; Taq - Taq Polymerase.
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2.6. Statistical analysis
The Mann-Whitney [/-test was used to determine the statistical significance of 
differences between groups. p<0.05 was considered to be a significant difference.
2.7. Buffers/Solutions
2.7.1. Cell culture
Ammonium chloride solution: Mix 9 vols of 0.83% w/v NH4 Cl in ddH2 0  with 1 vol of 
2.06% w/v Tris-HCl pH 7.65. pH adjusted to 7.2. Sterilize by autoclaving and store at 
4 T .
2.7.2. General purpose
PBS: 137 mM NaCl, 8.1 mM Na2H P04, 2.7 mM KCl, 1.47 mM KH2PO4 in ddH2 0 . pH 
adjusted to 7.2. Sterilize by autoclaving and store at R.T.
2.7.3. ELISA buffers
0.06 M Carbonate Buffer, pH 9.6: To 45.3 ml of 1 M NaHCO] add 18.2 ml of IM 
Na2C0 3  and make solution to 1 litre with ddH2 0 .
PBS/0.05% Tween 20: 500 pi of Tween 20 was added per litre of sterile PBS.
2.7.4. RNA preparation
DEPC (Diethylpyrocarbonate) -  treated H2O: add 900 pi of DEPC to 900 ml of ddH2 0  
and dissolve by autoclaving. Store at R.T.
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Ethidium Bromide for RNA Work: 500 ng/ml stock solution dilute in DEPC-treated 
H2O. Store in the dark at R.T.
Loading Buffer (5x): 10% Ficoll, 0.5 % SDS, 0.06% bromophenol blue in ddH2 0 . Store 
at R.T.
MOPS (MOPS (3-[N-Morpholino]propanesulphonic acid) buffer (lOx): 0.05 M Na 
acetate, pH 7, 0.01 M EDTA, 0.2 M MOPS in dd H2O, Store at R.T. Dilute to Ix for 
working concentration.
2.7.5. DNA preparation
Ethidium Bromide for DNA Work: 10 mg /ml stock in dd H2O. Store in the dark at R.T. 
Working concentration 100 pg/ml diluted in dd H2O.
TAE buffer (50x): 2 M Tris-HCl, 5.17% glacial acetic acid, 0.05M EDTA pH 8.2 in dd 
H2O. Store at R.T. Dilute to Ix for working concentration.
2.7.6. FACS buffers
Staining Buffer: PBS/2 % FCS, 0.2 % sodium azide, pH 7.4-7.6 , filter sterilize and store 
at 4 T .
Permeabilization Buffer: PBS/2 % FCS, 0.2 % sodium azide, 0.1 % saponin (Sigma) pH 
7.4-7.6, filter sterilize and store at 4°C.
Fixation Buffer; 14 ml lOx PBS, 10.8 ml 37.5% formaldehyde, 75.2 ml H2O, filter 
sterilize and store at 4*^ 0.
2.7.7. MACS buffer
50 ml PBS, 250 mg BSA, 200 pi EDTA. Degass,
2.7.8. Greiss reagent
Mix equal volumes of 0.1% a-naptyl-amine and 1% sulphanilamide, 5% phosphoric 
acid. Store at 4
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Chapter 3. Infection of IL-4-/- mice with L3 of pahangi results in inereased 
microfilaraemia and a skewed immune response
3.1. Introduction
IL-4 is a central Th2 cytokine because of its ability to drive naïve T cells towards the 
Th2 pathway while diverting Th cells from differentiation down the Thl pathway. In 
recent years the use of mice in which the IL-4 gene has been deleted has provided an 
important tool in analysing the role of IL-4 in parasitic infection. As reviewed in the 
general Introduction, studies into murine infection with Leishmania major and Trichuris 
muris have highlighted the role of IL-4 in driving Th2 responses and the role of the Thl 
vs Th2 balance in host immunity or susceptibility to infection. In this chapter I 
examined the role of IL-4 in murine infection with the filarial nematode B. pahangi.
The rodent filarial nematode, Litmosoides sigmodontis is a useful model for examining 
host immune responses to filarial parasites over the course of infection, as L3 develop 
into MF producing adults in some inbred strains of mouse, such as the BALB/c. 
Experiments carried out in IL-4-/- mice on the BALB/c background, have shown that 
MF levels are up to 100-fold greater and that microfilaraemia is significantly prolonged 
in KO mice compared to WT BALB/c mice. The difference in MF levels is thought to 
relate to the fecundity of the adult worms because there is no difference in the recovery 
of MF when injected directly into mice (Volkmann et al,, 2001). The importance of the 
genetic background of knockout mice was highlighted in a study examining 
susceptibility of L. sigmodontis BALB/c mice and IL-4-/- mice on the C57BL/6 
background. WT BALB/c mice are susceptible to infection with L. sigmodontis, while 
WT C57BL/6 mice are resistant. However infection of IL-4-/- C57BL/6 mice results in 
a susceptible phenotype with worm recovery comparable to that of WT BALB/c mice.
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However despite similar levels of susceptibility, the immune responses of these animals 
are remarkably different with WT BALB/c mice exhibiting a strong Th2 response and 
IL-4-/- C57BL/6 mice exhibiting a Thl response. These data suggest that parasite 
clearance in a resistant host is Tli2 dependent but a susceptible host can allow parasite 
development despite a Th2 response (Le Goff et al., 2002).
IL-4 is also thought to play a role in susceptibility to Brugia infection. Again, the 
studies carried out to date emphasize the importance of the background strain of mouse 
used. The original study reported no difference in the recovery of L3, MF or adult 
worms from IL-4-/- mice on the C57BL/6 background, despite profound alterations in 
the immune response in these animals (Th2 to Thl switch in the case of adult and L3 
infection) (Lawrence et a l,  1995). However C57BL/6 mice are not susceptible to 
Brugia infection and one of the aims of the work of the work described in this chapter 
was to investigate the role of IL-4 in the susceptible BALB/c mouse. Infection of 
BALB/c mice with L3 of B. pahangi results in an early burst of IL-4 transcription from 
a population of CD4'CD8“a|3 T cells in the draining popliteal lymph nodes and this IL-4 
functions primarily to promote Tli2 responses (Oshorne and Devaney, 1998). However 
Spencer et al showed that in the absence of IL-4, IL-4R or Stat6 , BALB/c mice were 
significantly more susceptible to infection with either B. malayi or B. pahangi 
Somewhat surprisingly the transfer of T cells from IL-4-/-, IL-4R-/- and Stat6 -/- mice 
into SCID recipients induced host protection comparable to that mediated by T cells 
from a WT origin. These data suggest that while T cells are required for host protection, 
they need not respond to or produce IL-4 (Spencer et a l , 2003a).
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There are many unanswered questions regarding the role of IL-4 in lymphatic filariasis. 
The L3 has been shown to direct an early hurst of IL-4 post-infection, but the 
importance of this remains unclear. Is IL-4 correlated with resistance or susceptibility? 
If so, which life cycle stages are affected by IL-4 mediated responses. In this chapter, I 
set out to determine whether IL-4 had any affect on the development of Brugia L3 in the 
mouse model and to investigate whether Ag-specific immune responses varied 
significantly between L3 infected IL-4-/- and WT BALB/c mice.
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3.2. Results
3.2.1. Investigating the role of IL-4 in vivo
(i) Worm recoveries from IL-4-/- mice
The worm recovery experiments were carried out in collaboration with Prof. E. 
Devaney. For these experiments, mice were infected with 50 L3 of .S .pahangi by the
i.p. route, so that worms could be recovered easily. At the following time points the 
numbers of larvae were recovered and counted: day 6  (moulting L3-L4), day 8  (L4), 
day 15 (L4), day 27 (L4 to adults) or days 71-77 (patent adults). As shown in Tahle 3.1, 
there was no significant difference in recovery of the larvae from the IL-4-/- mice 
compared to WT mice at any of the time points. The recovery of worms from both 
strains remained very steady at 30-40% until after the final moult (post-day 27). At day 
70 plus, more adult worms were recovered from the IL-4-/- mice than the wild-type 
mice but this difference was not statistically significant {p >0.05).
(ii) MF recovery from IL-4-/- and WT mice
Mice were infected i.p. with 50 L3 of B. pahangi and at day 71 or day 77 post-infection 
the levels of MF produced by adult worms in each strain of mouse were determined. 
The results from the experiment carried out on day 77 post-infection are presented. As 
shown in Table 3.2, seven of ten infected BALB/c mice contained adult worms, while 
five of ten contained MF. In contrast, six out of six IL-4-/- mice contained adult worms 
and MF. MF recoveries were significantly different between the strains of mice {p = 
0.0318) with IL-4 -/- mice containing ~ 8  fold more MF than WT mice. It can be seen 
from Figure 3.1 that there was a wide range in the numbers of MF recovered from
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individual animals. This was correlated with the numbers of adult females in ÏL-4-/- 
mice (r = 0.993, p^O.OOl), but not in wild type mice. When WT mice contained the 
same numbers of adult worms as IL-4-/- mice, significantly fewer MF were recovered 
from WT mice by comparison. By expressing the data as mean MF per adult female 
worm it can he concluded that the worms from IL-4-/- mice are more fecund than those 
from WT mice (3329 vs 722 MF per adult female, respectively, Table 3.2). In addition, 
dissection of individual female worms from IL-4-/- mice showed that these worms 
contain many more MF at all stages of development than did adult female worms from 
WT mice. Even in WT mice that had MF in the peritoneal cavity, the adult female 
worms contained very few developing stages or mature MF. Similar results were 
obtained from an experiment analysed on day 71 post-infection.
(iii) Recovery of MF after implantation of adult worms
The results from the experiment described above could relate to an increased rate of MF 
killing or reduced fecundity of female worms in WT BALB/c mice. In order to 
distinguish between the two possibilities, ten adult female B. pahangi were implanted 
into the peritoneal cavity of five BALB/c mice and five IL-4-/- mice. The results of this 
experiment are presented in Table 3.3. Adult worms and MF were recovered 2 weeks 
post-infection. At this time point IL-4-/- mice contained more adult female worms than 
WT mice and this difference just reached statistical significance (worm recovery, 7.8 ± 
0.8 in IL-4-/- mice and 6.2 + 0.8 in WT mice, p < 0.05). However levels of MF were 
not significantly different between the two strains of mice. When these results are 
expressed as MF per adult female worm it can be seen that there was no difference in 
MF levels, suggesting that IL-4 does not affect MF survival or the ability of sexually
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mature female worms to continue producing MF, but rather acts to the fecundity of 
developing worms.
3.2.2. Cellular recruitment into the peritoneal cavity of IL-4-/- mice
Mice were infected i.p. with 50 L3 of B. pahangi and at day 27 post-infection the 
peritoneal washings were analysed for cell counts and cell phenotype. The peritoneal 
washings from BALB/c mice contained significantly more cells than those from IL-4-/- 
mice (Figure 3.2A). The recruitment of individual cell types was analysed by staining of 
cytospin preparations (carried out in the Haematology Lab, Veterinary Pathology, 
University of Glasgow). Infected WT mice contained more eosinophils and 
macrophages, compared to IL-4-/- mice, but there was very little difference in the 
numbers of lymphocytes and neutrophils, while mast cells accounted for a very small 
proportion of the total cells found in the peritoneum. At day 71 post-infection, the total 
cell number was greatly reduced compared to day 27 p.i. but the wild type mice still 
contained more eosinophils and macrophages than the IL-4-/- mice (see Figure 3.2B).
3.2.3. Ag-specific immune responses of splenocytes from L3 infected and IL-4-/- 
BALB/c mice
In order to investigate whether Ag-specific immune responses in L3 infected IL-4-/- 
mice were significantly different to these of WT mice, groups of five IL-4-/- mice and 
five WT mice were infected s.c. with 50 L3 of B. pahangi. In these experiments the 
mice were infected s.c. to better mimic the natural route of infection with L3. At day 12 
p.i. spleens were removed from these animals and in vitro analysis was carried out.
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(i) Ag-specific cytokine responses
Cytokine responses of splenocytes from L3 infected IL-4-/-, BALB/c wild type mice 
and control uninfected mice were measured after 72 hours of in vitro restimulation with 
10 pg/ml B. pahangi adult Ag. These experiments were carried out on several occasions 
and similar results observed in each. The results of a representative experiment showing 
levels of Ag-driven cytokines are presented in Figure 3.3. Splenocytes from L3 infected 
IL-4-/- mice generated an altered cytokine profile compared to those of their wild type 
counterparts, with a significant increase in Ag-specific IL-2 and IFN-y, cytokines which 
were only ever seen at very low levels in L3 infected wild-type mice. In addition a 
reduction in IL-5 and IL-10 was observed in IL-4-/- mice. IL-5 was reduced to 
significant levels in all experiments while the reduction in IL-10 reached significant 
levels in only one of five experiments. In all experiments, levels of IL-13 were not 
significantly different between IL-4-/- and wild-type mice, although there was a 
tendency for IL-13 levels to be higher in IL-4-/- mice.
(ii) Ag-specific proliferative responses
Proliferative responses of splenocytes from L3 infected IL-4-/- and wild type BALB/c 
mice were measured over a time course of in vitro restimulation with 10 pg/ml B. 
pahangi adult Ag. Control mice received HBSS alone. Several experiments were carried 
out each of which gave similar results. In the representative experiment shown in Figure
3.4, levels of Ag-specific proliferation were significantly lower in IL-4-/- mice 
compared to that of their wild-type counterparts after 72 and 96 hours incubation with 
Ag. The time-course from 48 to 96 hours indicates that the differences in proliferative 
responses are unlikely to reflect a difference in the kinetics of the Ag-specific
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proliferative response in IL-4-/- mice. There are a number of possible explanations for 
this apparent decrease in proliferation. One possibility is that the cells which proliferate 
in response to the L3 may use IL-4 as a growth factor. Alternatively, the increase in 
IFN-y in these cultures (as shown in Figure 3.3) may be cytostatic or may lead to an 
increase in nitric oxide resulting in the suppression of Ag-specific proliferative 
responses.
(iii) ConA driven proliferative responses
Proliferative responses of splenocytes from L3 infected IL-4-/- and wild type BALB/c 
mice and control uninfected mice were measured at 48 hours of in vitro restimulation 
with 1 pg/ml of ConA. In the representative experiment shown in Figure 3.5, levels of 
ConA driven proliferation were not significantly different between IL-4-/- mice and 
wild-type mice, suggesting that the cells from IL-4-/- mice have the capacity to 
proliferate and that the defect in proliferation described is Ag-specific in nature.
3.2.4. Investigating the proliferative defect observed in IL-4-/- mice
In order to investigate the mechanisms by which Ag-specific proliferative responses 
were decreased in L3 infected IL-4-/- mice compared to wild-type mice, a number of 
experiments were carried out as described below.
(i) CFSE staining of cells from L3 infected IL-4-/- and wild-type mice in Ag 
stimulated culture
CFSE staining is a sensitive technique used for tracking the proliferation of specific cell 
types (see Materials and Methods 2.4.2), and was used in this experiment to investigate
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the phenotype of proliferating cells in IL-4-/- and wild-type mice. CFSE staining was 
carried out prior to in vitro stimulation of splenocytes with 10 pg/ml B. pahangi adult 
Ag. At 96 hours cells were harvested and labelled with anti-CD4 MAh, anti-CD8 MAh 
or B220 MAh. The samples were then analyzed by flow cytometry. The data shown in 
Figure 3.6 and 3.7 are from a representative experiment, with Figure 3.6 showing cells 
from individual mice, with means of five mice shown in Figure 3.7. The first point 
apparent from Figure 3.6 is that the major cell type proliferating in L3 infected mice in 
response to Ag restimulation were B cells with - 1 6 %  of B220^ cells proliferating in 
response to Ag in wild-type mice compared to -  5 % of CD4^ cells. As can be seen in 
Figure 3.7, proliferating B cells account for -  17% of total lymphocytes in wild-type 
mice while proliferating CD4"  ^ cells account for approximately -  5% of total 
lymphocytes in these mice. In the KO mice, proliferating B cells account for only -  7 % 
of total lymphocytes while proliferating CD4"^  cells aecount for -  3 % of total 
lymphocytes. When examining data as mean percentages it can be seen that the
percentage of B cells and CD4^ cells that proliferated in response to Ag were
significantly reduced in L3 infected IL-4-/- mice compared to that of their wild-type 
counterparts. No significant difference in the proliferation of CD8  ^ cells was observed 
during the eourse of these experiments.
(ii) Ex vivo staining of splenocytes from L3 infected and control IL-4-/- and
wild-type mice
One possible explanation for decreased levels of CD4^ and B220^ proliferation 
observed in the splenocyte cultures from L3 infected IL-4-/- mice may be due to 
diminished numbers of these cell populations ex vivo. To investigate whether there were 
differences in the cellular make up of the spleen in wild-type and IL-4-/- mice.
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splenocytes were phenotyped ex vivo using anti-CD4 MAb, anti-B220 MAb and anti- 
CD8 MAb. However, as can be seen from Figure 3.8, the percentage of CD4’*', B220^ 
and CD 8  ^cells were constant between both WT and IL-4-/- mice and control uninfected 
and L3 infected mice. Therefore it can be concluded that the decreased levels of 
proliferation observed in L3 infected IL-4-/- mice compared to that of L3 infected wild- 
type mice is not a reflection of a different cellular make-up in the spleens of the 
respective strains of mouse.
(iii) Production of NO
IFN-y is known to be a potent inducer of iNOS. The production of NO by activated 
macrophages has been identified as a factor mediating suppression in several models of 
parasitic infection (Candolfi, 1994; Dai, 1999, O’Connor 2000). Therefore to assess the 
production of NO in vitro, the Greiss reaction was carried out on supernatants of Ag- 
stimulated splenocytes from L3-infected IL-4-/- and wild type mice. Figure 3.9 shows 
the results of one such assay. This analysis demonstrated that there were elevated levels 
of NO in cultures from L3 infected IL-4-/- mice compared to cultures from infected 
wild-type mice, however this difference did not reach statistical significance in any one 
of tliree experiments.
(iv) Inhibition of iNOS with AMG
Aminoguanidine (AMG) is an iNOS inhibitor and was used to determine whether the 
increased levels of IFN-y produced by cells from L3 infected IL-4-/- mice might 
suppress proliferative responses by induction of iNOS. Ag-stimulated cultures of 
splenocytes from L3 infected IL-4-/- and wild-type mice and control uninfected mice 
were supplemented with 500 pM AMG. As shown in Figure 3.10 the inhibition of NO
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production did not result in increased proliferation in cultures of Ag-stimulated 
splenocytes from L3 infected IL-4-/- animals. Nitrite levels were efficiently reduced by 
AMG in these experiments (data not shown). Therefore, despite the high levels of IFN- 
y in cultures of splenocytes from L3-infected IL-4-/- mice, there was a minimal increase 
in levels of NO and blocking the production of NO had no effect on proliferation.
(v) Neutralization of IFN-y
An IFN-y neutralizing MAb was used to determine whether the increased levels of IFN- 
y produced by cells from L3 infected IL-4-/- mice might suppress proliferative 
responses, as IFN-y is known to have cytostatic effects on T cells as well as inducing 
NO from macrophages. Ag-stimulated cultures of splenocytes from L3 infected IL-4-/- 
and wild-type mice and control uninfected mice were supplemented with 1 0 0  pg/ml 
IFN-y neutralizing MAb. Figure 3.11 shows the Ag-stimulated proliferative responses in 
the presence and absence of anti-IFN-y MAb over a time-course of in vitro culture. It 
can be seen that neutralization of IFN-y did not result in increased proliferation in these 
cultures. Therefore, despite high levels of IFN-y being produced in cultures of 
splenocytes from L3 infected IL-4-/- mice, blocking the production of IFN-y had no 
significant effect on proliferation. Measmement of cytokine levels demonstrated that 
IFN-y was effectively neutralized using this concentration of MAb. A range of 
additional cytokines were also measuied but there were no differences between the +/- 
MAb groups (data not shown).
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(vi) Addition of recombinant-IL-4 to cultures of Ag-stimulated splenocytes from 
L3 infected IL-4-/- and wild-type mice
In an attempt to reverse the defect in Ag-specific proliferation, recombinant (r)IL-4 was 
added to splenocytes from L3 infected IL-4-/- mice at concentrations ranging from 100 
pg/ml to 1000 pg/ml. Proliferative responses were then measured over a time course of 
in vitro restimulation with 10 pg/ml B. pahangi Ag. Three experiments were carried out 
giving similar results. The results of a representative experiment are presented in Figure 
3.12 showing only those cultures supplemented with the highest dose of rIL-4 (1000 
pg/ml). In these experiments there was a trend towards increased levels of Ag-specific 
proliferation when rIL-4 was added to cultures of splenocytes from IL-4-/- mice. 
However this difference did not reach statistical significance at any time point, with any 
concentration of rIL-4. These data suggest that the lack of IL-4 in vivo has a profound 
effect on the proliferation of cells in vitro and although proliferation can be rescued to a 
certain degree by rIL-4, this never reached significance. In addition levels of Ag- 
specific cytokines were not altered when rIL-4 was added to cultures at any 
concentration (data not shown).
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Time post infection BALB/cIL-4-/- BALB/c WT
Day 6 36.8 ± 22.6% (n=6) 36.2+ 13.9% (n=7)
Day 8 28.8+ 11.1% (n=5) 47.3 ±23.9%(n=4)
Day 15 28.9 +21.2% (n=6) 38.5 ± 14.5% (11=8)
Day 27 36.7 ± 11.6% ( n- 6) 34.2 ± 14.2% (n = 6)
Day 71 14.1 + 11.4% (n = 13) 7.4 + 7.7%(n=12)
Day 77 20.5 ± 19.0 % ( n - 6) 10.9 ±7.7% (n= 10)
Table 3.1. The recovery of worms from IL-4-/- or WT BALB/c mice is not 
significantly different at any time point post-infection
IL-4-/- and wild-type (BALB/c) mice were infected intra-peritoneally with 50 L3 of B. 
pahangi. Figures show the mean percentage recovery of worms ± SD from the 
peritoneal cavity of infected mice at different time points post infection. Numbers in 
parenthesis denote the number of animals per group, p  >0.05 at all time points.
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IL-4-/- BALB/c
No. of mice with 
adult worms
6 / 6 7/10
Total no. of 
males: females
38:28 23:30
No. mice with MF 6 / 6 <710*
Mean no. MF per 
mouse with MF
23952 ± 30485 3023 +2139
Mean MF per adult 
female with MF
3329 ± 2794 722 ±510**
Table 3.2. Adult worm and MF recoveries at day 77 p.i. demonstrate that IL-4-/- 
mice contain significantly more MF than WT mice
IL-4-/- and BALB/c wild-type mice were infected intra-peritoneally with 50 L3 of B. 
pahangi. The table shows the numbers of adult worms recovered at day 77 p.i. from the 
two groups of mice, the total numbers of male and female worms recovered from the 
respective group, the numbers of mice with MF, the mean (±SD) numbers of MF 
recovered and the mean nimibers of MF per adult female worm
Two mice with adult females contained no adult males hence no MF 
** Statistical significance between MF recoveries from IL-4-/- mice and WT mice (p= 
0.0318)
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IL-4-/ WT BALB/c
No. of adult females 
recovered
7.4 ± 0.8 6 . 2  ±  0 . 8  *
No. of MF recovered 1.61 ± 0.233x10^ 1.4 ±0.18x10^
No. of MF per adult 
female
2.2 X 10^ 2 . 2  X 1 0 ^
Table 3.3. Implantation of adult worms into the peritoneal cavity of IL-4-/- or WT 
mice results in equivalent production of MF
Ten female B. pahangi were implanted in to the peritoneal cavity of 5 BALB/c WT 
mice or 5 IL-4-/- mice. Adult worms and MF were recovered 2 weeks post-infection. 
The data above shows the niunber of adult females recovered from infected mice and 
the total number of MF in the peritoneal lavage of the mice. MF are also represented as 
the number of MF per adult female recovered.
* Recovery of adult female worms between two strains was significantly different 
ip < 0.05).
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Figure 3.1, Recovery of MF in IL-4-/- mice correlates with the number of adult 
female worms
IL-4-/- mice were infected intra-peritoneally with 50 L3 of B. pahangi. At 77 d.p.i. MF 
and adult worms were recovered. The graph shows the number of MF in the peritoneal 
lavage of five IL-4-/- mice plotted against the number of female worms recovered from 
individual mice. MF levels show positive correlation with adult female worm burden 
(r= 0.993, 0.001).
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Figure 3.2. Cell recruitment into the peritoneal cavity is reduced in infected IL-4- 
/- mice compared to that of WT mice
IL-4-/- and wild-type (WTL3) mice were infected intra-peritoneally with 50 L3 of B. 
pahangi. The graph shows the number of cells per ml in the peritoneal lavage of
BALB/c WT (■) mice or IL-4-/- (□) at 27 days p.i. (A) or 71 days p.i. (B). Total cells 
(1) were enumerated by Coulter counting while numbers of eosinophils (2), 
neutrophils (3), lymphocytes (4), macrophages (5) or mast cells (6) were counted by 
differential staining of slides prepared by cytospin. The results are presented as means 
plus SD of six mice per group.
* significant difference between IL-4-/- and WT mice.
WT vs IL-4-/- tdav 27 p.i.) WT vs IL-4-/- tdav 71 n.i.l
Total cells p  ~ 0.007 Total cellsp  = 0.004
Eosinophils p  = 0.007 Eosinophils p  = 0.0001
Macrophages p  = 0.011 Macrophages p  ~ 0.02
Day 27
No of cells ^ ^
X 10"
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Figure 3.3. Splenocytes from L3 infected IL-4-/- mice display an altered Ag- 
specific cytokine profile compared to that of their wild-type counterparts
IL-4-/- (K0L3) and wild-type (WTL3) mice were infected sub-cutaneously with 50 L3 
of B. pahangi or an equal volume of HBSS only (C). At 12 d.p.i., splenocytes (I x 
10^/ml) were re-stimulated in vitro with 10 pg/ml B. pahangi adult Ag. Ag-specific 
cytokine responses were measured at 72 hours. Results are expressed as pg/ml and all 
values represent the mean and standard deviation of five mice per group.
* significantly different (p= < 0.05) WT mice vs KO mice 
IL-10, WTL3 vs K0L3 j(?=0.102
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Figure 3.4. Splenocytes from L3 infected IL-4-/- mice display significantly lower 
Ag-specific proliferation compared to that of their wild-type counterparts
IL-4-/- (K0L3) and wild-type (WTL3) mice were infected sub-cutaneously with 50 L3 
of B. pahangi or an equal volume of HBSS only (C). At 12 d.p.i., splenocytes from 
individual mice from each group were re-stimulated in vitro with 10 pg/ml B. 
pahangi adult Ag. Ag-specific proliferative responses from whole splenocytes were 
measured at 48 (A), 72 (B) and 96 (C) hours. Results are expressed as cpm.
48 hours p=0.3913 (K0L3 vs WTL3)
72 hours p=0.0373
96 hours y;=0.0304 “ “
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Figure 3.5. Splenocytes from L3 infected wild-type and IL-4-/- mice display similar 
levels of mitogen-driven proliferation
IL-4-/- (K0L3) and wild-type (WTL3) mice were infected sub-cutaneously 
with 50 L3 of B. pahangi or an equal volume of HBSS only (C). At 12 d.p.i, 
splenocytes from individual L3 infected wild-type or IL-4-/- mice or pooled 
cells from control mice were restimultated in vitro with 1 pg/ml ConA. 
Mitogen-driven proliferative responses from whole splenocytes were measured 
at 48 hours. Results are expressed as cpm.
WT vs K 0p=0.8102
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Fig 3.6. CD4^ and B220^ cells proliferate less well in IL-4-/- mice compared to 
wild-type mice
Splenocytes from wild-type (A and B) and IL-4-/- (C and D) mice given 50 L3 of B. 
pahangi or an equal volume of HBSS were labelled with CFSE and cultured with 10 
pg/ml B. pahangi adult Ag for 96 hoins. Cells from control animals did not proliferate 
and, for simplicity, are not shown. Cells were then harvested, stained with anti-CD4 
MAb (A and C) or anti-B220 MAb (B and D) and analysed by flow cytometry. Each 
panel shows the staining profile of CD4^ or B220"  ^splenocytes in an individual mouse. 
The numbers at the top left hand corner of each panel indicate the percentage of CD4"  ^
or B220^ cells displaying reduced fluorescence intensity in FL-1, indicating they have 
divided in Ag-stimulated culture. These figures are representative of the responses of 
five animals per group.
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Figure 3.7. Proliferation of CD4^ and B220^ cells is significantly reduced in IL-4-/- 
mice compared to WT controls
Splenocytes from lL-4-/- (K0L3) and wild-type (WTL3) mice given 50 L3 of B. 
pahangi or an equal volume of HBSS (C), were labeled with CFSE and cultured with 
10 pg/ml B. pahangi adult Ag for 96 hours. Cells were then harvested, stained with 
anti-CD4 MAb or anti-B220 MAb and analysed by flow cytometry. Data shown in A 
and B are mean results from five animals per group (excluding control animals where 
cells were pooled) and results are expressed as a percentage of total dividing 
lymphocytes. Graph A illustrates the mean percentage of total lymphocytes which 
have divided from groups of five mice (WTL3 vs K0L3, jc=0.02). Graph B shows 
division of individual cell types as a percentage of dividing lymphocytes (CD4’^ 
division WTL3 vs K0L3 ;?=0.02; B220^ division WTL3 vs K0L3 ;?=0.02).
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Figure 3.8. E x vivo staining of splenocytes from L3 infected and control IL-4-/- and 
wild-type BALB/c mice showed no significant differences between groups
Splenocytes from IL-4-/- (K0L3) and wild-type (WTL3) mice given 50 L3 of B. 
pahangi or an equal volume of HBSS only (C) were surface stained ex vivo 12 d.p.i. 
with anti-CD4 MAb, anti-B220 MAb and anti-CDS MAb and analyzed by flow 
cytometry. All results represent the mean +/- standard deviation of five animals per 
group.
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Figure 3.9. Levels of nitrite from 96 hour cultures are not significantly different 
between IL-4-/- mice and their wild type counterparts
IL-4-/- (KG) and wild-type (WT) mice were infected sub-cutaneously with 50 L3 of B. 
pahangi or an equal volume of HBSS only (C). At 12 d.p.i. splenocytes from individual 
mice from each group were re-stimulated in vitro with 10 pg/ml B. pahangi adult Ag. 
Nitrite levels from whole splenocytes were measured in supernatants collected at 96 
hours. Results are expressed as ng/ml. (WTL3 vs K0L3 p=  0.7133).
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Figure 3.10, Addition of AMG to splenocytes from L3 infected BALB/c and IL-4- 
/- mice had no significant effect on Ag-specific proliferation of either group
IL-4-/- (K0L3) and wild-type (WTL3) mice were infected sub-cutaneously with 50 L3 
of B, pahangi or an equal volume of HBSS only (C). At 12 d.p.i,, splenocytes from 
individual mice from each group were restimultated in vitro with 10 pg/ml B. pahangi 
adult Ag in the presence or absence of 500 pM AMG. Ag-specific proliferative 
responses from whole splenocytes were measured at 48 (A), 72 (B) and 96 (C) hours. 
Results are expressed as cpm.
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Figure 3.11. Addition of IFN-y neutralizing MAb to splénocytes from L3 infected 
BALB/c and IL-4-/- mice had no significant effect on Ag-specific proliferation of 
either group
IL-4-/- (K0L3) and wild-type (WTL3) mice were infected sub-cutaneously with 50 L3 
of B. pahangi or an equal volume of HBSS only (C). At 12 d.p.i. splenocytes from 
individual mice from each group were restimultated in vitro with 10 p.g/ml B. pahangi 
adult Ag in the presence or absence of 1 pg/ml neutralizing IFN-y MAb. Ag-specific 
proliferative responses from whole splenocytes were measured at 48 (A), 72 (B) and 
96 (C) hours. Results are expressed as cpm.
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Figure 3.12. Addition of recombinant IL-4 to splenocytes from L3 infected 
BALB/c and IL-4-/- mice had no significant effect on Ag-specific proliferation of 
either group
IL-4-/- (K0L3) and wild-type (WTL3) mice were infected sub-cutaneously with 50 L3 
of B. pahangi or an equal volume of HBSS only (C). At 12 d.p.i. splenocytes from 
individual mice from each group were restimultated in vitro with 10 qg/ml B. pahangi 
adult Ag and recombinant IL-4 was added at 1000 pg/ml to each individual culture. 
Ag-specific proliferative responses from whole splenocytes were measured at 48 (A), 
72 (B) and 96 (C) hours. Results aie expressed as cpm.
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3.3. Discussion
The results presented in this chapter used IL-4-/- mice on the BALB/c background to 
study the role of IL-4 in parasite survival and immune modulation. The first 
experiments showed that IL-4 had little effect on worm recoveries from mice infected 
intraperitoneally with B. pahangi L3 as there was no significant difference in worm 
recoveries at any time point between the groups. However, IL-4 appeared to have a 
down-regulatory effect on the numbers of MF produced by adult female worms as IL-4- 
/- animals contained vastly more MF compared to WT mice. As adult female worms 
from IL-4-/- mice contained more MF at all stages of development compared to worms 
from WT mice, it was hypothesised that IL-4 may limit worm fecundity. Implantation .1
of mature, fecund female worms into IL-4-/- and WT mice confirmed this theory, as the 
number of MF recovered was no different between worms from IL-4-/- animals and WT 
animals, thus ruling out the possibility of increased MF killing in WT mice. Therefore, 
although IL-4 does not appear to affect L3 to adult development, it clearly has a role in 
modulating the fecundity of worms. Alternatively, rather than a direct effect on female 
worms, IL-4 may also affect adult male worms. It was shown previously that male 
worms were more susceptible to the effects of irradiation than female worms in gerbils 
infected with irradiated L3 of B. pahangi (Devaney et a l, 1993) indicating that males 
may be less resistant to oxidative or immunological stress. However in the present study 
male worms were recovered, although the ratio of males : females was reduced in WT 
mice compared to IL-4-/- mice. These results are similar to experiments carried out in 
the L. sigmodontis model, where MF in the peritoneum of IL-4-/- BALB/c mice were 
increased 100-fold compared to WT mice post-infection with L3 (Volkmann et a l,
2001). However, whether IL-4 effects adult female fecundity directly or indirectly is not 
known. Infection of IL-5-/- mice with the nematode Strongyloides ratti resulted in
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increased egg production (Ovington et a l, 1998). IL-5 was shown to affect worm 
survival and fecundity as IL-5-/- mice harboured 60% more worms and these worms 
were more fecund that those taken from WT mice. The results presented in this Chapter 
demonstrate that levels of IL-5 are significantly greater in WT mice than in IL-4-/- 
mice. Thus IL-5 may have a similar effect on adult B. pahangi to that described for S. 
ratti. No direct link between IL-5 and worm fecundity could be made during the course 
of these experiments, but it would be interesting to implant adult Brugia into the 
peritoneum of IL-5-/- mice and directly investigate the role of IL-5 in MF production 
and fecundity of adult worms.
It was notable that despite the fact that worm recoveries, following i.p. infection with 
L3 were very similar between mouse strains, the immunological responses were very 
different. Following s.c. infection with L3, splenocytes from WT mice produced Th2 
cytokines with no IL-2 or IFN-y production. However in IL-4-/- mice elevated levels of 
IL-2 and IFN-y and significantly reduced levels of IL-5 were observed. IL-10 levels had 
a tendency to decrease in IL-4-/- mice but this difference only reached statistical 
significance in one out of five experiments. These data demonstrate that the L3 can 
prime Thl cells in response to infection but in WT mice these are suppressed by a 
mechanism involving IL-4. The ability of IL-4-/- mice to produce typical Th2 cytokines 
(IL-5, IL-10 and IL-I3) is interesting. An obvious candidate for Th2 induction in the 
absence of IL-4 is IL-13, although, experiments in L. major infected mice have shown 
that Tli2 priming can occur via an alternative pathway, independent of both IL-4 and IL- 
13 (as judged by the stable Th2 marker ST2L) (Kropf et a l, 1999). In the experiments 
described above, the source of Th2 cytokines was not determined and it is possible that 
cell types other than CD4^ cells may account for IL-5, IL-10 and IL-13. Therefore,
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further experiments would be required to unequivocally demonstrate that Th2 cells are 
expanded in IL-4-/- mice infected with B. pahangi.
In addition, there were major differences between IL-4-/- and BALB/c mice in the 
cellular make up of the peritoneal exudates in infected animals. Numbers of eosinophils 
were significantly higher in WT animals, results similar to those from the L  
sigmodontis model, where levels of eosinophilia were greatly reduced in IL-4-/- mice 
(Vollanami et a l, 2001). This result was not unexpected as levels of IL-5, a growth 
factor for eosinophils are significantly lower in IL-4-/- animals, and, in addition IL-4 is 
known to be chemotactic for eosinophils (Moser et a l,  1993; Johnson el a l,  1998). 
Eosinophils have been shown to be involved in the development of protective immunity 
to the L3 of T. sigmodontis. Worm recoveries were similar during a primary infection of 
IL-5-/- mice or WT mice but during challenge infection, IL-5-/- mice were unable to 
generate protective immunity, whereas intact mice cleared their parasites. Further 
analysis indicated that eosinophils had a role in worm killing (Le Goff et a l, 2000). 
Based on the results of Le Goff et al, it would be interesting to study worm recovery in 
secondary infection in IL-4-/- mice. Macrophage numbers were also reduced in IL-4-/- 
mice. Macrophages have been implicated in worm killing in various experimental 
systems, such as the jird or the mouse infected with B. pahangi, where adherent cells 
are required for MF killing (Karavodin and Ash, 1982; Oxenham el a l, 1984). 
Furthermore, macrophages have long been suspected to modulate immune responses to 
filarial infection. For example, in 1980 it was shown that removal of adherent cells from 
PBMC of filarial infected humans reversed the proliferative defect, suggesting that 
macrophages play a role in maintaining hyporesponsiveness in human infection 
(Piessens et a l, 1980b). More recent studies in the mouse model suggested adherent
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cells may produce IL-10 and thus down-regulate immune responses (Osborne and 
Devaney, 1999). These data clearly indicate that IL-4 is important for recruitment of 
specific cell types into the peritoneal cavity of infected mice. However, despite high 
cellular recruitment in WT mice, worm recovery was not affected. The importance of 
cellular infiltration in pathology in relation to IL-4 has been highlighted in studies on O. 
volvulus where IL-4-/- BALB/c mice develop exacerbated pathology due to increased 
neutrophil infiltration of the corneal stroma (Pearlman et a l, 1996; Hall et a l, 2002).
In terms of Ag-specific immune responses of IL-4-/- and WT mice, one of the most 
interesting results was the reduced levels of proliferation observed in the IL-4-/- 
animals. In order to determine if this defect was Ag-specific, splenocytes from WT and 
L3 infected mice were also stimulated with the mitogen ConA. No differences were 
observed in response to ConA, indicating that the defect in proliferation observed was 
Ag-specific. It was demonstrated by CFSE labelling that the percentage of CDd"*" and 
3220"^ proliferation was significantly decreased in L3 infected IL-4-/- mice, suggesting 
that, in response to Ag, IL-4 may be acting as a growth factor for these cell types. This 
hypothesis was tested by supplementing the medium with concentrations of rIL-4 up to 
1000 pg/ml. However, although there was a slight increase in proliferative responses to 
Ag in splenocytes from IL-4-/- mice, this difference never reached significance. 
Phenotypic analysis of the cellular population in the spleen of L3 infected IL-4-/- or WT 
mice ex vivo revealed no significant difference, ruling out the possibility that differences 
in proliferation relate to diminished numbers of specific cell populations ex vivo.
Splenocytes from L3 infected IL-4-/- mice secrete high levels of IFN-y, which can 
induce NO production from classically activated macrophages and result in a
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consequent reduction in proliferation (Candolfi et a l,  1994; Dai and Gottstein, 1999; 
O'Connor and Devaney, 2002). To assess the production of NO in vitro in my 
experiments, the Greiss reaction was carried out on supernatants of Ag-stimulated 
splenocytes from L3 infected IL-4-/- and wild type mice. These results demonstrated, 
somewhat surprisingly, that there was no significant difference in levels of NO in 
cultures from IL-4-/- mice compared to wild type mice, despite significantly increased 
levels of IFN-y. However, to rule out possible effects of low-level NO, further 
experiments were undertaken. Aminoguanidine (AMG), an iNOS inliibitor, was used to 
determine whether the increased levels of IFN-y produced by cells from L3 infected IL- 
4-/- mice might suppress proliferation responses by induction of iNOS. Inhibition of NO 
production did not result in increased proliferation in cultures of Ag-stimulated 
splenocytes from L3 infected IL-4-/- animals. Finally to ensure that elevated levels of 
IFN-y observed in cells from IL-4-/- mice were not cytostatic, IFN-y was neutralized in 
vitro. However, anti-IFN-y had no effect on the proliferation of cells from L3 infected 
IL-4-/- mice. These results in IL-4-/- mice contrast with those reported from S. mansoni 
infection. In that model, WT mice develop chronic disease but survive, whereas IL-4-/- 
animals suffer fatal disease. Disease severity was seen to correlate with increased levels 
of NO and enhanced IFN-y production. Splenocytes from IL-4-/- mice displayed a 
similar defect in proliferation to that described in this Chapter, and it was shown that in 
the S. mansoni model, NO was largely responsible for impaired T cell function (Patton 
et a l, 2002). In contrast to the results presented here, neutralization of IFN-y in 
splenocyte cultures from S. mansoni infected mice resulted in the rescue of 
proliferation. In addition, when administered in vivo improvements in the gross 
appearance of the liver and reduction in granuloma size resulted. (La Flamme et a l, 
2001). It is notable that the cytokine milieu is very complex in cultures from L3 infected
121
IL-4-/- mice compared to WT mice with IL-2 and IFN-y production as well as IL-10 and 
IL-13 and some IL-5. Therefore, these typically Th2 type cytokines (or in the case of 
IL-10, Treg) may have a role in down-regulating the production of NO from classically 
activated macrophages, despite high levels of IFN-y,
The results presented in this Chapter show that Ag-specific proliferation in IL-4-/- 
animals was significantly reduced but this could not be attributed to NO or IFN-y 
production as has been observed in other model systems. These results present an 
interesting conundrum, in that splenocytes from L3 infected IL-4-/- mice secrete 
substantial levels of IFN-y yet this does not appear to induce significant amounts of NO. 
This situation contrasts with that observed when mice were infected with MF of B. 
pahangi, where high levels of IFN-y (in the same order as observed in L3 infected IL-4- 
/- mice) resulted in NO production and a consequent proliferative defect (O'Connor et 
a l, 2000; Jenson et a l, 2002; O'Connor and Devaney, 2002). As L3 of Brugia are 
reported to direct the activation of alternatively activated macrophages in the peritoneal 
cavity of C57BL/6 mice (Allen and Loke, 2001), it is interesting to speculate whether a 
similar ceil may be induced in this system. Alternatively activated macrophages have 
been shown to suppress the proliferation of T cell clones in a non-specifie manner, but 
are reportedly IL-4 dependent. Whether a similar population may be elicited in L3 
infected IL-4-/- BALB/ c mice remains unlaiown. It is pertinent to note that these cells 
can be activated by IL-13 (Doyle et a l, 1994). IL-13 and IL-4 share certain overlapping 
biological activities, as both cytokines utilise the IL-4Ra chain as a component of their 
receptor complexes and signal though a shared transducer (Zurawski et a l, 1993). IL-13 
is found in large amounts in splenocyte culture from L3 infected IL-4-/- BALB/ c mice 
and perhaps would be sufficient to prime these alternatively activated macrophages. By
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investigating levels of arginase or urea (indicative of alternatively activated 
macrophages) in these cultines in relation to levels of NO (indicative of classically 
activated macrophages), it would be possible to determine whether alternatively 
activated macrophages are present. One possibility for reduced levels of proliferation 
observed in splenocytes from IL-4-/- mice may be due to a reduced capacity of APC 
from KO animals to efficiently present Ag (i.e. via an effect on B7-1, B7-2 or MHC 
class II molecules). One way in which this could be investigated would be to analyze 
cells by FACS or to perform “mixing” experiments, whereby purified CD4^ cells from 
naïve animals are cultured with APC from WT or IL-4-/- mice. These experiments 
would indicate whether APC function is effected in IL-4-/- mice.
Although it was not possible to identify the basis of the proliferative defect observed in 
L3 infected IL-4-/- mice, one possibility yet to be investigated is that splenocytes from 
IL-4-/- mice undergo increased apoptosis when re-exposed to Ag in vitro. Data 
presented in this Chapter show that levels of Ag-specific proliferation in IL-4-/- mice 
are significantly different to that of WT mice only after 72 and 96 hours. The defect is 
not observed at 48 hours suggesting that the cells start to proliferate, but cannot 
maintain cellular divisions. It would be worthwhile investigating apoptosis in these 
cultures using Annexin V staining at various time points to determine whether 
differences exist between L3 infected WT and IL-4-/- cells. It was notable that, when 
carrying out FACS analysis on CFSE stained splenocytes from IL-4-/- mice, fewer 
events were collectable when gating on live lymphocytes compared to WT mice. This 
may provide indirect evidence that these cells are undergoing apoptosis in culture.
The results presented in this Chapter demonstrated that the presence or absence of IL-4 
did not significantly influence the recovery of the parasite from the peritoneal cavity of
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BALB/c mice, despite major differences in cytokine profile and cellular infiltration 
between groups. While these results indicate that IL-4 or IL-4-/- mediated responses are 
not required for killing a primary infection of L3 of B. pahangi, their involvement in 
protective immunity to challenge infection has yet to be demonstrated. Perhaps the most 
significant effect of IL-4 demonstrated by these experiments was its effect on worm 
fecundity, as female worms from IL-4-/- mice were significantly more fertile than 
worms from WT mice. Exactly how IL-4 affects worm fecundity remains unclear and 
will require further investigation.
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Chapter 4. IL-10 down-regulates Thl cytokine production and CD4^ cell 
proliferation in L3 infection
4.1. Introduction
IL-10 was first described as cytokine synthesis inhibitory factor (CSIF), a product of 
mouse Th2 cells that was shown to inhibit activation and cytokine production by Thl 
cells (Fiorentino et a l, 1989). IL-10 inhibits cytokine production via an indirect effect 
on accessory cells, such as monocytes and macrophages. Flowever in the absence of 
APC, IL-10 can affect T cells directly by suppressing production of IL-2 (de Waal 
Malefyt et a l, 1993b; Taga et a l, 1993). IL-10 was found to profoundly down-regulate 
the synthesis of monokines, the production of NO and the expression of class II MHC 
and costimulatory molecules on activated monocytes and macrophages. In vivo and in 
vitro studies have also demonstrated a role for IL-10 in modulating B,T, NK, dendritic 
and mast cell function. IL-10 can also inhibit the production of IL-12, which in turn 
suppresses the stimulation of NK cells, the activation of macrophages, DC and 
IFN-y Thl responses (Moore et al., 2001). These studies therefore indicate the diverse 
effects of this cytokine in dampening and, ultimately, terminating inflammatory 
responses.
In terms of infectious disease, the challenge faced by the immune system is to respond 
to such an extent that infection is eliminated while minimizing the non-specific injury to 
host tissue. Most of what has been learned about IL-10 in infectious disease derives 
from studies carried out in mice, where levels of IL-10 have been manipulated in vivo or 
in vitro. In murine studies of schistosomiasis, rIL-10 inhibited the proliferation of 
schistosome-specific T cell clones (Flores Villanueva ei a l, 1993) and down-regulated
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expression of B7 costimiilatory molecules on APC (Flores Villanueva et a l, 1994). The 
administration of an IL-lO/Fc fusion protein (with a prolonged half-life in vivo) caused 
a decrease in Thl responses in infected mice which resulted in a reduction in granuloma 
size. These results suggest that regulation of Thl responses reduces the 
immunopathologic damage associated with schistosomiasis (Flores-Villanueva et a l, 
1996). Flowever, there is conflicting evidence as to whether IL-10 is required for the 
immune down-modulation, which defines the transmission from the acute to the chronic 
disease state in S. mansoni infection in the mouse model (Wynn et a l, 1998); (Sadler et 
a l, 2003).
As the Thl/Tli2 balance is essential in determining the outcome of L  major infection, 
experiments have also been carried out to examine the role of IL-10 in this model 
system. One particular study gave a clear demonstration that IL-10 contributes to 
susceptibility to L  major in BALB/c mice. It was shown that normal BALB/c mice 
develop progressive lesions, whereas IL-10-/- BALB/c mice control disease progression 
and have 1000-fold fewer parasites by week 5 post-infection (Kane and Mosser, 2001). 
IL-10 has also been shown to be a critical anti-inflammatory molecule in other disease 
models in mice e.g. IL-10-/- mice develop inflammatory bowel disease and other 
exaggerated inflammatory responses (Kuhn et a l, 1993). In human inflammatory 
disease, the therapeutic potential of IL-10 has been tested in specific patient populations 
such as those with Crohn’s disease (van Deventer et a l, 1997), rheumatoid arthritis 
(RA) (Keystone et a l, 1998), psoriasis (Asadullah et a l, 1998) and hepatitis C (Nelson 
et a l, 2000) -  all chronic inflammatory conditions. In both Crohn’s disease and RA, IL- 
10 had a trend towards efficacy and a good safety profile and in cases of psoriasis, after 
a seven week treatment, there was a significant decrease in the psoriatie area in 9/10
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Ipatients (van Deventer et a l, 1997; Asadullah et a l, 1998). Conversely when IL-10 is
neutralized in PBMC from leprosy patients, proliferative responses are entranced
:|
(Sieling cr a/., 1993). JI
IThe role of IL-10 in lymphatic fiiariasis has been the subject of several studies by the ' ' 
Nutman laboratory. In the original study (King et a l, 1993) it was shown that 
neutralizing IL-10 with a monoclonal antibody restored proliferative responses in 
cultures of PBMC from W. bancrofti infected individuals. Interestingly, similar results 
were obtained with neutralizing antibody to TGF-p. In a subsequent study by Mahanty 
et al, T cell proliferative responses were studied in asymptomatic microfilaraemics 
(MF+) and it was shown that MF+ individuals were preferentially hyporesponsive to 
microfilarial derived antigens via induction of IL-10 (Mahanty et a l, 1996a). The 
concurrent reduction in IFN-y and IL-2 observed in this study is in agreement with 
previously reported results of down-regulated Thl cytokine secretion in MF+ 
individuals (King et a l, 1993; Yazdanbakhsh et a l, 1993a) and is consistent with the 
notion that parasite antigen-specific Thl responses are inhibited in MF+ individuals.
These studies were notable in that they illustrated that PBMC from MF+ individuals 
secrete more spontaneous IL-10 (without stimulation) than CP individuals. Spontaneous 
IL-10 was found to be secreted by plastic adherent cells (Mahanty et a l, 1996b), 
suggesting that cells, other than T lymphocytes, are producing IL-10 and that APC 
(adherent cells) have a role in suppressing the immune response in active infection. All 
in all, these data suggest that MF+ individuals preferentially produce IL-10 in response 
to MF-derived Ag, in an inverse pattern to that observed with Thl cytokines. The L3 
stage of B. pahangi is also laiown to induce high levels of IL-10 in antigen-stimulated 
spleen cell cultures from BALB/c mice. Neutralization of IL-10 resulted in the secretion
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of IFN-y and IL-2 without affecting levels of Ag-specific IL-4 or IL-5 (Osborne and 
Devaney, 1999). In addition, APC were also shown to contribute to the suppression of 
mitogen-driven Thl responses in spleen cells from L3-infected animals, although a 
direct role for IL-10 in modulating APC function was not shown.
The aims of the experiments in this chapter were three-fold. Firstly, as deseribed above, 
IL-10 is known to effect in vitro cytokine responses in mice infected with L3, but 
nothing is known of the role of IL-10 in vivo in this model system. Secondly, IL-10 is 
produced by a variety of cell types including T cells, B cells activated mast cell lines, 
activated macrophages and kératinocytes (Fiorentino et a l, 1989) and T regulatory cells 
(Roncarolo et a l, 2001b). Consequently, it was of interest to determine the source of 
IL-10 in mice infected with L3, as a first step to determine whether this life cycle stage 
can elicit a population of Treg cells. Thirdly, studies in L  major infected mice have 
shown that sand fly transmission enhances lesion size and parasite burden within the 
lesion (Titus and Ribeiro, 1988). This effect is thought to be associated with a 
vasodilatory peptide which reportedly up-regulates levels of IL-10 (Bozza et a l,  1998). 
Therefore, it was of interest to examine the role of mosquito saliva on L3 transmission 
using natural feeding methods.
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4.2. Results
4.2.1. Ag-specific immune responses of splenocytes from L3 infected mice +/- anti- 
IL-10 MAb
In these experiments groups of five BALB/c mice were injected sub-cutaneously with 
50 L3 of B. pahangi or an equal volume of HBSS only. At 12 d.p.i. spleens were 
removed for in vitro analysis. 10 qg/ml of neutralizing anti-IL-10 (JESS-25A) or 
isotype matched control (R59-40) was added to Ag-stimulated cultures from L3 infected 
and control mice. In addition, Ag only cultures were set up,
(i) Ag-specific cytokine responses
Cytokine responses of splenocytes from L3 infected and control animals in the presence 
and absence of neutralizing anti-IL-10 were measured after 72 hours of in vitro 
restimulation with 10 pg/ml B. pahangi adult Ag. Figure 4.1 shows levels of Ag-driven 
cytokines in supernatants produced by spleen cells after 72 hours of in vitro culture. 
Cells incubated in medium only did not produce any of the cytokines measured. These 
results confirm that IL-10 is important in regulating IL-2 and IFN-y production, in that 
neutralizing IL-10 significantly up-regulates the production of these Thl cytokines. 
However, although there was a trend for increased levels of IL-4 and IL-5 when IL-10 
was neutralized, these differences did not reach statistical significance. These results 
confirm those previously reported following in vitro neutralization of IL-10 (Osborne 
and Devaney, 1999)
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(ii) Ag-specific proliferative responses
Proliferative responses of splenocytes from L3 infected and control mice in the presence 
and absence of neutralizing anti-IL-10 were measured over a time course of in vitro 
restimulation with 10 pg/ml B. pahangi adult Ag. As shown in Figure 4.2, at no time 
point (48 or 72 hour) did anti-IL-10 have an effect on Ag-stimulated proliferation, as 
previously reported (Osborne, 1999).
4.2.2. Investigating the cellular source of IL-10
Defining the phenotype of the cells responsible for IL-10 production is important in 
terms of understanding how the L3 polarizes the immune response. For example, do 
high levels of IL-10 merely reflect Th2 polarization or is IL-10 produced by cells other 
than Th2 cells?
4.2.2.1. In vitro depletion experiments
In an attempt to characterize the cellular source of IL-10, selected populations were 
depleted from splenocytes from L3 infected BALB/c mice. In these experiments the 
appropriate cellular population was depleted from pooled splenocytes using magnetic 
beads and the relevant cell surface Ab. Depletions were monitored by FACS analysis 
and in all experiments were greater than or equal to 95% efficient. Cytokine responses 
were compared in Ag-stimulated cultures of depleted and non-depleted populations at 
48 hours. Post depletion, cells were cultured at 1 x 10  ^ / ml per sample, thus cell 
numbers in cultures from depleted splencytes did not contain fewer cells than whole 
splenocyte cultures.
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(i) Depletion of CD4^ cells
In three separate experiments, depletion of CD4^ cells resulted in a dramatic decrease in 
levels of IL-10 relative to unseparated splenocytes from the same animals, although 
levels of IL-10 were never reduced to background despite the removal of almost all 
CD4^ cells. The results of a representative experiment are shown in Figure 4.3, where 
levels of IL-10 were decreased by 60% (mean value of three experiments 71% ± 12.3 
reduction in IL-10). In addition levels of IL-4 were reduced by 40% and IL-5 by 60% 
(mean values of tliree experiments 45% ±12 and 73.5 %± 20.5 respectively). No Thl 
cytokines were detected in supernatants from CD4'*' depleted cultures or whole 
splenocyte cultures.
(ii) Depletion of B cells
In four separate experiments, depletion of B220’*' cells resulted in a more modest effect 
on IL-10 production relative to unseparated splenocytes from the same animals. The 
results of a representative experiment are shown in Figure 4.3, where levels of IL-10 
were reduced by 40% (mean data for four experiments 53.5% ± 14.85).
4.2.2.2. Semi-quantitative real time RT-PCR
The results of the depletion experiments suggested that CD4^ cells were the major 
producers of IL-10 with B cells contributing to a lesser extent. However using this 
method it was not possible to rule out indirect effects of depletion, e.g. the depletion of 
one cell type could affect the ability of another cell to produce IL-10. Therefore a more 
direct method of determining the cellular source of IL-10 was required. To address this 
point IL-10 mRNA levels from purified CD4^ cells and B cells were quantified by real­
1 3 1
time PCR using the ABI/PRISM 7700 sequence detection system. Analyses were 
performed using primers and an internal fluorescent TaqMan probe specific to IL-10 
and HPRT. All samples were rmi in triplicate.
(i) IL-10 mRNA expression in CD4^ and B220^ cells
At 12 d.p.i. CD4^ or B cells were purified from the spleens of ten L3 infected mice 
using magnetic separation. Depletions were monitored by FACS and in all experiments 
were greater than or equal to 95% efficient (data not shown). Following RNA 
extraction, real time RT-PCR was carried out on the selected populations. Figure 4.4 
shows IL-10 mRNA levels relative to HPRT and demonstrates that the CD4^ population 
express approximately two-fold more IL-10 mRNA compared to B cells. This 
experiment was carried out tlii'ee times and each data set showed a similar profile. Thus 
the results on mRNA expression in different cellular populations equate reasonably well 
with those from the depletion experiments, measuring levels of IL-10 protein.
4.2.3. Investigating the role of IL-10 in vivo
The in vitro experiments described above demonstrate that IL-10 can suppress the 
production of Thl cytokines in response to the L3 and indicate that Thl cells are 
primed, but are suppressed by IL-10. To investigate the role of IL-10 in vivo, an 
antibody which neutralizes the IL-10 receptor was administered to mice 
intraperitoneally at days 0, 4 and 7 post-infection at a dose of 10 qg each injection. The 
use of this Ab gave further insight into the role of IL-10 in the immune response elicited 
by the L3.
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(i) Ag-specific proliferative responses of splenocytes from L3 infected mice in 
which IL-IOR has been blocked
Data from previous experiments demonstrated that neutralizing IL-10 in vitro had no 
effect on levels of Ag-specific proliferation of splenocytes from L3 infected mice, 
despite a significant increase in levels of Thl cytokines. However, as shown in Fig. 4.5, 
after mice have been infected with L3 and then treated with IL-IOR neutralizing Ab, 
levels of Ag-specific proliferation were significantly increased compared to mice given 
the isotype control, suggesting a role for IL-10 in down-regulating proliferation in vivo. 
This increase in proliferation was shown to be Ag-specific in nature as when cpm from 
medium only cultures were subtracted from cpm in Ag-stimulated cultures, there was 
still a significant difference in the levels of proliferation between mice given IL-IOR 
MAb and mice given the isotype control (p== 0.0122).
(ii) Ag-specific cytokine responses of splenocytes from L3 infected mice in 
which IL-IOR has been blocked
It was shown previously that neutralising IL-10 in vitro resulted in increased levels of 
IL-2 and IFN-y. However, results shown in Fig. 4.6 demonstrate that neutralising IL- 
1 OR in vivo did not result in any changes in cytokine profile, with levels of IL-4, IL-5 
and IL-10 remaining consistent between groups and no Thl cytokines observed.
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(iii) CFSE staining of cells from L3 infected mice in which IL-IOR has been 
blocked
In an attempt to define the phenotype of the cells that proliferate when the IL-IOR is 
blocked, CFSE staining (see Materials and Methods 2.4.2) was carried out prior to in 
vitro stimulation with 10 qg/ml B. pahangi adult Ag. At 96 hours, cells were harvested 
and labelled with anti-CD4 MAb or B220 MAb and the samples were analyzed by flow 
cytometry. The data shown in Figure 4.7 and 4.8 are from a representative experiment 
in which the proliferation of CD4^ and B cells were followed using CFSE. The FACS 
plots in Figure 4.7 show cells from individual mice, which are representative of a group 
of five, with the means of five mice shown in Figure 4.8. These results demonstrate that 
levels of B220^ proliferation are unaffected by the neutralization of IL-IOR, with -15%  
of B cells proliferating in mice given the neutralizing Ab, or given the isotype control 
(Figure 4.8). However, there is a difference in the levels of CD4^ proliferation between 
these groups of mice. In splenocytes culture from isotype control treated mice, -5%  of 
CD4^ cells proliferate compared to -13.5% in cultures from mice given the neutralizing 
Ab (Figure 4.8). However the difference in proliferation of CD4^ cells between the 
groups did not reach statistical significance (p=0.0662). In Figure 4.9, histogram plots 
generated by the flow cytometer are shown to illustrate the division of CD4^ and B220^ 
cells. The plots represent two individual animals from a group of five infected with 50 
L3 of B. pahangi and given either neutralizing IL-IOR MAb (panel A) or isotype 
matched control (panel B). It can be seen from these plots that the division of B220^ 
cells (green overlay) and CD4^ cells (pink overlay) accounts for the majority of dividing 
cells in these cultures. The initial peak which is shown at approximately 10  ^ on the x 
axis reflects undivided cells while the peak to the left represents cells which have
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divided. It can be seen that there are fewer CD4^ cells dividing in panel B, which is 
from the mouse which received GLl 13.
(iv) Ex vivo staining of splenocytes from L3 infected mice in which IL-IOR has 
been bloeked
Ex vivo staining of splenocytes from L3 infected mice given IBL3a or GLl 13 was 
carried out using anti-CD4 MAb, anti-B220 MAb and anti-CD8 MAb, to investigate 
whether there were differences in the cellular make up of the spleen after the 
administration of IBI.3a. One possible explanation for the increased levels of CD4^ cell 
proliferation observed in the splenocytes from L3 infected mice given IBI.3a compared 
to L3 infected mice given GLl 13, may be due to differences in numbers of these cell 
populations ex vivo. However, it can be seen from Figure 4.10 that this is not the case, 
as the percentage of CD4^, B220^ and CD8^ cells are not significantly different between 
groups. Therefore it can be concluded that neutralizing the IL-IOR directly affects 
proliferation of CD4^ cells, following Ag-restimulation.
4.2.4. The role of mosquito transmission on immune responses
In all the afore mentioned experiments, mice were infected with L3 by syringe 
inoculation. In the sand fly-leishmania system there is now evidence that sand fly saliva 
inoculated along with the parasite, has a major effect on the immune response (Ribeiro, 
1987). In particular, the principle vasodilator in sand fly saliva, a peptide termed 
maxadilan (MAX) (Lerner et a l,  1991) has been shown to have the ability to decrease 
levels of IFN-y mainly by up-regulating levels of IL-10 (Bozza et a l,  1998). It is not 
clear- at present whether this effect is specific to the sand fly or might be shared with 
other Diptera. Experiments carried out to investigate the role of mosquito saliva in
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transmission of L3, included analysis of cytokine production in the spleen and 
peripheral lymph nodes following syringe inoculation or natural transmission via 
mosquito bite. The number of L3 administered to the mice by the mosquitoes was 
estimated by counting L3 per mosquito prior to and after feeding (as described in 
Materials and Methods 2.2.2). The relevant controls included mice infected sub- 
cutaneously with 50 L3 and mice given HBBS alone. At 12 d.p.i. spleens were removed 
and cytokine and proliferation assays were carried out.
(i) Cytokine responses of splenocytes and lymph nodes of mice infected with 
L3 via syringe or natural transmission
Cytokine responses of splenocytes and lymph nodes from syringe infected and naturally 
infected and control animals were measured after 72 hours of in vitro restimulation with 
10 qg/ml B. pahangi adult Ag. Figure 4.11 shows levels of Ag-driven cytokines in 
supernatants produced by spleen cells and lymph node cells after 72 hours of in vitro 
culture. These results show that there are significantly higher levels of IL-4, IL-5 and 
IL-10 produced by splenocytes from syringe inoculated mice compared to those from 
mice exposed to infective mosquitoes. In addition levels of IL-4 and IL-10 were 
significantly higher in lymph node cells from syringe inoculated mice compared to 
mosquito exposed mice.
(ii) Ag-specific proliferative responses of splenocytes and lymph node cells of 
mice infected with L3 via syringe or natural transmission
Proliferative responses of splenocytes and lymph node cells from syringe infected and 
naturally infected and control animals were measured after 48, 72 and 96 hours of in 
vitro restimulation with 10 qg/ml B. pahangi adult Ag. Figure 4.12 shows that although
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there are slight differences in the levels of proliferation in splenocytes from syringe 
inoculated mice compared to naturally infected animals, this did not reach significance 
at any time point. However at 96 hours, levels of proliferation were significantly higher 
in lymph node cells from syringe inoculated animals compared to levels in lymph node 
cells from mosquito exposed animals. However levels of proliferation are extremely 
low and indeed were lower than the proliferation of splenocytes from control animals. 
Lymph nodes from control animals were not used in these experiments as they were too 
small.
4.2.5. Infection with different doses of L3
As there were significant differences in the levels of IL-4, IL-5 and IL-10 between 
splenocytes from syringe inoculated and mosquito exposed mice, it was important to 
ascertain whether this was a dose dependent effect (i.e. there was a possibility that 
mosquito exposed animals were not receiving as many L3). In order to investigate this 
possibility, groups of five mice were infected with either 50, 25 or 10 L3 and control 
animals were given HBSS. A tl2 d.p.i. spleens were removed and cytokine assays were 
carried out.
(i) Cytokine responses of splenocytes of mice infected with 50, 25 or 10 L3
Cytokine responses of splenocytes from all groups were measured after 72 hours of in 
vitro restimulation with 10 pg/ml B. pahangi adult Ag. Figure 4.13 shows that there 
were no significant differences in the levels of IL-4, IL-5 and IL-10 between the groups. 
Therefore there was no dose dependent effect on cytokine production.
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(ii) Ag“Specific proliferative responses of splenocytes of mice infected with 50, 
25 or 10 L3
Ag specific proliferative responses of splenocytes from all groups were measured after 
48, 72 and 96 hours of in vitro restimulation with 10 pg/ml B. pahangi adult Ag. Figure 
4.14 shows that despite being infected with different numbers o f L3, there was no 
significant difference in levels of proliferation at any time point between any group.
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Figure 4.1. Neutralizing IL-10 in Ag-stimulated cultures of splenocytes from L3 
infected mice resulted in significantly increased levels of Thl cytokines
Mice were infected s.c. with 50 L3 of B. pahangi or an equal volume of HBSS only 
(C). At 12 d.p.i., splenocytes (1 x lOVml) were re-stimulated in vitro with 10 pg/ml 
B. pahangi adult Ag (Ag). Ag-specific cytokine responses were measured at 72 hours 
in the presence of Ipg/ml neutralising IL-10 Ab (alL-10) or Ipg/ml isotype matched 
control (isoc). Results are expressed as pg/ml and all values represent the mean and 
standard deviation of five mice per group.
IL-2 -  Ag vs aIL-10/?= 0.0122 
isoc vs aIL-10 p=  0.0122
IL-4 - Ag vs nalL-10 p=  0.0947 
isoc vs alL -10p=  0.5309
lL-5 - Ag vs aIL-10 0.0947 
isoc vs aIL-10p=  0.2101
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Figure 4.2. Neutralizing IL-10 in Ag-stimulated cultures of splenocytes from L3 
infected mice did not alter levels of Ag-specific proliferation
Mice were infected sub-cutaneously with 50 L3 of B. pahangi or an equal volume of 
HBSS only (C). At 12 d.p.i., splenocytes (5 x lOVml) were re-stimulated in vitro with 
10 pg/ml B. pahangi adult Ag (Ag) in the presence or absence of 1 pg/ml neutralizing 
IL-10 Ab (aIL-10) or 1 pg/ml isotype matched control (isoc). Ag-specific proliferative 
responses were measured by uptake of  ^H thymidine at 48 hours (A) and 72 hours (B). 
Results are expressed as mean cpm incorporated in triplicate wells and all values 
represent the mean and standard deviation of five mice per group.
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Figure 4.3. Depletion of CD4 or B cells from spleens of L3 infected mice resulted 
in decreased levels of IL-10
Mice were infected sub-cutaneously with 50 L3 of B. pahangi or an equal volume of 
HBSS only (C). At 12 d.p.i. splenocytes from L3 infected mice were then pooled and 
CD4^ or B cells were depleted from culture using MACS anti-FITC beads and passing 
the suspension through MACS magnetic columns. The negative fraction was then 
restimultated in vitro with 10 pg/ml B. pahangi adult Ag. Ag-specific cytokine 
responses from whole splenocytes (L3) and splenocytes depleted of CD4^ (L3-CD4) 
were measured at 72 hours (A-C). Panel D represents IL-10 levels from whole 
splenocytes and splenocytes depleted of B cells. Results are expressed as pg/ml.
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Figure 4.4. Semi-quantitative RT-PCR carried out on ex vivo splenocytes from L3 
infected mice shows that CD4+ cells express more IL-10 mRNA relative to HPRT 
than do B220 cells
Mice were infected s.c. with 50 L3 of B. pahangi or an equal volume of HBSS only (C). 
At 12 d.p.i. splenocytes from L3 infected mice were pooled and magnetically separated 
into purified CD4^ and B220^ cells. Semi-quantitative RT-PCR was carried out on these 
cells (using the TaqMan method) and levels of IL-10 mRNA are expressed relative to 
the constitutive gene HPRT.
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Figure 4.5. In vivo neutralization of IL-IOR resulted in increased levels of Ag-specific 
proliferation in splenocytes from L3 infected mice
Two groups of BALB/c mice were infected sub-cutaneously with 50 L3 of B. pahangi and 
a third group were given an equal volume of HBSS only (C). One of the infected groups 
was injected intraperitoneally with 10 pg neutralizing IL-IOR MAb (IBI.3a) and the other 
group received the same concentration of isotype control (GLl 13) at day 0, 4 and 7 post­
infection. At 12 d.p.i., splenocytes (5 x 10^/ml) were re-stimulated in vitro with 10 pg/ml 
of B. pahangi adult Ag and Ag-specific proliferative responses were measured by uptake 
of ^  H thymidine at 72 hours. Results are expressed as mean cpm incorporated in triplicate 
wells and all values represent the mean and standard deviation of five mice per group.
Data show an increase in levels of proliferation when IL-IOR is blocked.
(L3+IBI.3a Ag vs L3+GL113 Ag /;=0.0216).
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Figure 4.6. In vivo neutralization of IL-IOR resulted in no differences in cytokine 
production
Two groups of BALB/c mice were infected sub-cutaneously with 50 L3 of B. pahangi and 
a third group were given an equal volume of HBSS only (C). One of the infected groups 
was injected intraperitoneally with 10 pg neutralizing IL-IOR MAb (IBI.3a) and the other 
group received the same concentration of isotype control (GLl 13) at day 0, 4 and 7 post­
infection. At 12 d.p.i., splenocytes (1 x 10%rl) were re-stimulated in vitro with 10 pg/ml 
of B. pahangi adult Ag and Ag-specific cytokine responses were measured by ELISA. 
Results are expressed as pg/ml and all values represent the mean and standard deviation of 
five mice per group.
IL-4 -  IBI.3a vs GLl 13/7=1 
IL-5 - IBI.3a vs GLl 13/7 = 0.7728 
IL-10 - IBI.3a vs GLl 13 p = 0.6650
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Figure 4.7. CFSE labelling of splenocytes from L3 infected mice shows that the 
proliferation of CD4^ cells is increased when IL-IOR is blocked
Two groups of BALB/c mice were infected sub-cutaneously with 50 L3 of B, 
pahangi. One of the infected groups was injected intraperitoneally with 10 pg 
neutralising IL-IOR MAb (IBI.3a) (A and C) and the other group received the same 
concentration of isotype control MAb (GLl 13) (B and D) at day 0, 4 and 7 post 
infection. Splenocytes from these mice were labelled with CFSE and cultured with 
10 pg/ml B. pahangi adult Ag. Cells were harvested at 96 hours, surface stained with 
anti-CD4^ MAb (A and B) or anti-B220 MAb (C and D) and analyzed by flow 
cytometry. Each panel shows the CFSE staining profile of CD4"  ^ or B220^ 
splenocytes from an individual mouse. The numbers at the top left hand corner of 
each panel indicate the percentage of CD4'*’ or B220^ cells displaying reduced 
fluorescence intensity in FL-1, indicating they have divided in Ag-stimulated culture. 
These figures are representative of the responses of five animals per group.
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Figure 4.8. CFSE staining demonstrates that mean levels of proliferation of CD4 
cells from L3 infected mice are increased when IL-IOR is blocked
Two groups of BALB/c mice were infected sub-cutaneously with 50 L3 of B. pahangi. 
One of the infected groups was injected intraperitoneally with 10 pg neutralizing IL- 
IOR MAb (IBI.3a) and the other group received the same concentration of isotype 
control MAb (GLl 13) at day 0, 4 and 7 post-infection. Splenocytes from these mice 
were labelled with CFSE and cultured with 10 pg/ml B. pahangi adult Ag. Cells were 
harvested at 96 hours, surface stained with anti-CD4 MAb or anti-B220 MAb and 
analyzed by flow cytometry. Graphs show the mean levels of proliferation of CD4^ or B 
cells calculated from CFSE labelling at 96 hours of 5 mice per group. No difference in 
B cell proliferation was observed while CD4^ proliferation showed a tendency to 
increase when IL-IOR was blocked but did not reach significancep=0.0662.
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Figure 4.9. CD4^ expansion is increased in L3 infected mice given blocking IL-IOR 
Ab
Two groups of BALB/c mice were infected sub-cutaneously with 50 L3 o f# , pahangi. 
One of the infected groups was injected intraperitoneally with 10 pg neutralizing IL- 
IOR MAb (IBI.3a) (A) and the other group received the same concentration of isotype 
control MAb (GLl 13) (B) at day 0, 4 and 7 post-infection. Splenocytes from mice given 
50 L3 of B. pahangi s.c. were labelled with CFSE and cultured with 10 pg/ml B. 
pahangi Ag. After 96 hours the cells were harvested and labelled with anti-CD4 MAb 
or anti-B220 MAb and analysed by flow cytometry. The purple fill shows the CFSE 
staining profile of total splenocytes. The green overlay represents the CFSE staining 
profile of CD4^ cells and the pink overlay shows the CFSE staining profile of B220^ 
cells.
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Figure 4.10. Ex vivo staining of splenocytes from L3 infected mice shows no 
difference in levels of cellular populations in the spleens of mice in which IL-IOR 
was blocked
Two groups of BALB/c mice were infected sub-cutaneously with 50 L3 of B. pahangi. 
One of the infected groups was injected intraperitoneally with 10 pg neutralizing IL- 
lOR MAb (lBI.3a) and the other group received the same concentration of isotype 
control MAb (GLl 13) at day 0, 4 and 7 post infection. Splenocytes from these mice 
were surface stained ex vivo 12 d.p.i. with anti-CD4 MAb, anti-B220+ MAb and anti- 
CD8+ MAb and analyzed by flow cytometry. All results represent the mean +/- 
standard deviation of 5 animals per group.
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Figure 4.11. Cytokine responses to L3 are exaggerated in mice infected via 
syringe compared to mice infected by mosquito bite
One group of mice were infected sub-cutaneously with 50 L3 of B. pahangi via 
syringe inoculation. A second group of mice were infected via mosquito 
transmission, so that each animal was estimated to receive approximately 50 L3. A 
third control group were given HBSS. At 12 d.p.i., spleens and lymph nodes were 
removed. Ag-specific cytokine responses were measured at 72 hours. Results are 
expressed as pg/ml and all values represent the mean and standard deviation of five 
mice per group.
SL3sp -  syringe inoculation, spleen 
ML3sp -  mosquito transmission, spleen 
SLN -  syringe inoculation, lymph node 
MLN -  mosquito transmission, lymph node
IFN-y -  SL3sp vs ML3spp  = 0.2506 
SLN vs MLN p  = 1
IL-4 -  SL3sp vs ML3spp  = 0.0367 
SLN vs MLN p  < 0.05
IL-5 - SL3sp vs ML3sp p  = 0.0122 
SLN vs MLN p  = 0.0947
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SLN vs MLN j!7 = 0.0122
IFN-y IL-4
2000
1500
1000
500 ■
SL3sp ML3sp SLN MLN
400 
350 ! 
300
-  250 
1 ,2 0 0  
150 
100 
50 
0 I I
SL3sp ML3sp SLN MLN
IL-5 IL-10
100000
80000 -
60000
40000
20000
SL3sp ML3sp SLN MLN
  H
C
6000
5000
4000
3000
2000
1000
0 I
SL3sp ML3sp SLN MLN
1 4 9
Figure 4.12. Proliferative responses in spleens and lymph nodes of mice infected 
with L3 via syringe inoculation are exaggerated compared to mice exposed to 
infective mosquitoes
One group of mice were infected sub-cutaneously with 50 L3 of B. pahangi via 
syringe inoculation. A second group of mice were infected via mosquito 
transmission, so that each animal was estimated to receive approximately 50 L3. A 
third control group were given HBSS. At 12 d.p.i., spleens and lymph nodes were 
removed. Ag-specific proliferative responses were measured at 48, 72 and 96 hours. 
Results are expressed as cpm and all values represent the mean and standard 
deviation of five mice per group.
SSP -  syringe inoculation, spleen 
MSP -  mosquito transmission, spleen 
SLN -  syringe inoculation, lymph node 
MLN -  mosquito transmission, lymph node
48 hours -  SSP vs MSP p  = 0.4034 
SLN vs MLN p  =0.5403
72 hours -  SSP vs MSP p  = 0.1437 
SLN vs MLN p  = 0.373
96 hours -  SSP vs MSP p  = 0.067 
SLN vs MLN p  = 0.0200
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Figure 4.13. Cytokine responses of mice given 50, 25 or 10 L3 are not 
significantly different
One group of five mice were infected sub-cutaneously with 50 L3 B. pahangi. A 
second group were given 25 L3 and a third group given 10 L3. A fourth group of 
control mice were given HBSS. At 12 d.p.i., spleens were removed from these mice. 
Ag-specific cytokine responses were measured at 72 hours. Results are expressed as 
pg/ml and all values represent the mean and standard deviation of five mice per 
group.
IL-4- 5 0  vs 25^  = 0.4034 
50 vs p  ~ 0.2963 
25 vs 10^ = 1
IL-5- 5 0  vs 25;? = 0.5309 
50 vs lOp = 0.8345 
25 vs 10p = 0.7540
IL-10- 5 0  vs 25 j!? = 0.8345 
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25 vs 10 p  = 0.4034
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Figure 4.14. Ag-specific proliferative responses of mice given 50, 25 or 10 L3 are 
not significantly different at any time point
One group of five mice were infected sub-cutaneously with 50 L3 B. pahangi. A  
second group were given 25 L3 and a third group given 10 L3. A fourth group of 
control mice were given HBSS. At 12 d.p.i., spleens were removed from these mice. 
Ag-specific proliferative responses were measured at 48, 72 and 96 hours. Results 
are expressed as cpm and all values represent the mean and standard deviation of five 
mice per group.
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4.3. Discussion
The results presented in this Chapter highlight the importance of IL-10 in the regulation 
of immune responses in L3 infected BALB/c mice. Initial experiments carried out using 
a neutralizing anti-IL-10 MAb in vitro confirmed that IL-10 has an important role in 
suppressing the production of Thl cytokines, IL-2 and IFN-y. The increase in IFN-y 
may derive from Thl cells or alternatively could derive from activated macrophages. 
When IL-10 is neutralized, macrophages may become activated and, in turn produce 
IFN-y. This involves a mechanism whereby IL-10 can inliibit IFN-y gene transcription 
within monocytes by controlling aspects of the IFN-y signalling pathway (Ito et a l, 
1999). In terms of Th2 cytokine production, IL-4 and IL-5 also had a tendency to 
increase in the absence of IL-10, however these differences did not reach statistical 
significance in any experiment. These results suggest that IL-10 is suppressing cytokine 
production by Thl cells and possibly Th2 cells, to a lesser extent. In this respect, it 
might be predicted that neutralizing IL-10 in vitro would result in increased levels of 
proliferation. Previously, IL-10 has been shown to down-regulate proliferation of T 
cells via an affect on AFC (Ding et a l, 1993), but IL-10 has also been shown to have a 
direct effect on T cells in the absence of AFC by inhibiting IL-2 production (de Waal 
Malefyt et a l, 1993a). However, in numerous experiments in this study, levels of 
proliferation were never significantly different between cultines where IL-10 was 
neutralized or not. It is possible that neutralizing IL-10 in vitro has an effect on the 
ability of Thl cells to produce cytokines without affecting their proliferation. Other 
studies have described a similar scenario where proliferation and cytokine production 
are differentially regulated (Evavold and Allen, 1991; Allen et a l,  1996). Alternatively, 
as alluded to above, cell types other than CD4^ cells may produce IFN-y but not 
proliferate. This could be investigated using intra-cellular cytokine staining to identify
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the cellular source of IFN-y. Finally, the concurrent production of Thl and Th2 
cytokines may be cross-regulatory, so that no increase in Thl or Th2 proliferation is 
observed in vitro.
As in vitro assays had determined that IL-10 had a role in cytokine regulation but not 
down-regulation of proliferation in cultures from L3 infected mice, it was of interest to 
investigate the role of IL-10 in vivo. An obvious way to examine the role of IL-10 in the 
mouse model of Brugia would be to use IL-10-/- mice. Unfortunately, the conditions in 
the Animal Unit at the University of Glasgow are not compatible with the survival of 
IL-10-/- mice as they are prone to pro-inflammatory pathologies such as inflammatory 
bowel disease. An alternative approach is to neutralise the effects of IL-10 in vivo using 
a blocking IL-IOR Ab (O'Farrell et a l, 1998; Belkaid et a l, 2001). Using this Ab had 
the added benefit of ensuring that the background strain of mouse was the same as used 
in previous experiments. In contrast to the in vitro situation, blockade of IL-IOR in vivo 
showed very little difference in cytokine production. However, there was a significant 
increase in levels of proliferation in splenocytes from mice given the neutralizing Ab 
compared to those receiving the isotype control. These results are intriguing, as the L3 
generates good proliferative responses in the intact mouse in the presence of IL-10. 
However after in vivo administration of this Ab, levels of proliferation were seen to 
almost double. It was therefore of interest to identify the cellular population inhibited by 
IL-10. FACS analysis of CFSE stained cells demonstrated that CD4^ cells were the 
major population which expanded during IL-IOR blockade. As IL-IOR is expressed on 
the surface of APC and on T cells (Asadullah et a l, 2003), blockade of IL-IOR will 
result in altered signals being delivered to CD4^ cells from APC and/or direct effects 
upon T cells both of which could result in increased levels of proliferation. Ligation of
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the IL-10 receptor results in signalling via the Jak/Stat pathway and has multiple 
downstream effects. For example, IL-10 suppresses inflammatory responses via its 
effect on pro-inflammatory cytokines, chemokines, APC and costimulatory molecules 
(Moore et a l, 2001). IL-10 promotes an anti-inflammatory Th2 response by inliibiting 
the production of IL-12 from APC, thus suppressing the production of IFN-y from T 
cells. Macrophages are particularly susceptible to these effects, with IL-10 down- 
regulating the production of TNF-a, IL-1, IL-6, IL-12 and the expression of MFIC class 
II and B7-1 and B7-2 on the cell surface. Altogether, the ability of macrophages to 
present Ag efficiently to T cells is attenuated by IL-10 (Fiorentino et a l, 1989; de Waal 
Malefyt et a l, 1993b). Besides the dominating indirect impact via the APC, IL-10 can 
also exert some direct effect on T cells. Naive T cells are larown to be more sensitive to 
the effects of IL-10 due to the down-regulation of the IL-IOR on activated cells (Liu et 
a l,  1994). IL-10 was shown to inliibit T cell proliferation in the presence of CD28 co­
stimulation (Akdis et a l, 2000). In addition, the presence of IL-10 during the activation 
of naïve T cells results in these cells developing a regulatory phenotype, characterised 
by weak proliferation and absence of IL-2 after repeated stimulation (Groux et a l, 
1997). Thus, increased levels of CD4'^ proliferation observed when IL-IOR is blocked, 
may be attributed to one or more of the suppressive mechanisms of IL-10 mentioned 
above.
Neutralizing IL-10 in vitro resulted in production of Thl cytokines but had no effect on 
proliferation. In contrast blockade of the IL-IOR in vivo produced the opposite effect, no 
difference in cytokines but an increase in proliferation. Interestingly when the IL-IOR 
Ab was used in vitro, the results were identical to neutralizing IL-10 (increased IL-2 and 
IFN-y). How can these differences be reconciled? Perhaps in the in vivo situation IL-
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lOR is blocked very quickly after the administration of L3, allowing little time for the 
down-regulatory effects of IL-10 to be manifest, resulting in more efficient Ag 
presentation to CD4^ cells with a consequent increase in proliferation. However it is 
difficult to account for the fact that no increase in Thl cytokines is observed. This may 
reflect a difference in sensitivity to receptor blockade in different cells. In the case of 
the in vitro system where IL-10 is present during T cell priming in vivo, IL-IO may 
inliibit the ability of Thl cells to divide, but after neutralization of IL-IO in vitro they 
have the ability to release cytokines. For example, cells which have been continuously 
exposed to IL-10 can be rendered anergic and these cells cannot recover from this state 
even with the addition of IL-2. Therefore, it may be the case that cells primed in the 
presence of IL-10 are unable to proliferate even when IL-10 is neutralized in vitro. An 
interesting experiment in this respect would be to examine proliferation by CFSE using 
cell surface markers for Thl and Th2 cells, and to determine whether the CD4"  ^ cells 
that expand following blockade of the receptor are CD25', as it has been shown in 
previous in vitro studies, that CD4^CD25^ cells have the ability to suppress proliferation 
of co-cultured CD4"^CD25"T cells (Takahashi ei a l, 1998).
Defining the phenotype of the cells responsible for the production of IL-10 in response 
to L3 infection is important in terms of understanding how the L3 polarizes the immune 
response e.g. does IL-10 derive from a Th2 or perhaps Treg phenotype or from an AFC 
(B cells or macrophages). Initial attempts to identify the source of IL-10 using intra­
cellular cytokine staining were unsuccessful (data not shown), therefore, to define the 
cellular source of IL-10, depletions of selective populations were carried out on 
splenocytes of L3 infected mice. These experiments showed that CD4^ cells were the 
major producers of IL-10 with B cells contributing to a lesser extent. In addition.
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depletion of CD4^ cells had marked effects on levels of Ag-specific IL-4 and 
particularly IL-5. While it is clear from these experiments that depletion of both CD4^ 
and B cells has a dramatic effect on cytokine production, a more direct method of 
defining the cellulai' soince of IL-10 was required. Quantitative RT-PCR on selected 
cellular populations confirmed the depletion experiments, in that CD4^ cells were 
demonstrated to produce the majority of IL-10 with B cells having a lesser role. As 
there is an additional sub-set of CD4^ cells which have regulatory properties, either by 
their ability to produce IL-10 (Trl and Tli3) or via cell to cell contact dependant 
mechanisms (CD4^CD25^ cells), the finding that CD4^ cells are the major source of IL- 
10 clearly required further investigation (see results presented in Chapter 5).
Finally, the remaining experiments in this Chapter were carried out to determine 
whether mosquito saliva had an effect on the transmission of L3 in the mouse model, 
and if there was an effect, whether IL-10 played a role. These experiments were 
relevant, as it has been reported previously that sand fly saliva has potent 
immunomodulatory functions. When L. major is administered to mice along with sand 
fly salivary gland lysate, disease is exacerbated and the parasite burden is greatly 
entranced (Titus and Ribeiro, 1988). One important vasodilatory peptide in sand fly 
saliva, termed maxadilan (MAX), has been shown to induce elevated levels of IL-10 
(Bozza et a l, 1998), thus down-regulating levels of IFN-y and NO, which in this system 
is beneficial to the parasite (Titus et a l, 1994). Salivary gland lysate also has a profound 
ability to suppress T cell proliferation in a non-specific mamrer (Titus, 1998). Therefore, 
to determine whether the saliva of mosquitoes has any such affect mice were either 
exposed to infective mosquitoes, which were estimated to transmit -50  L3 per mouse, 
or to syringe inoculation (the method of infection used during the course of all
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experiments up to and beyond this point). When examining cytokine responses from 
both groups of animals it appeared that the group which received L3 via natural 
transmission, had a reduced capacity to produce cytokines (it is notable that splenocytes 
in this experiment were producing low levels of IFN-y, a rare occurrence in most 
experiments). This contrasts to the sand fly system, where elevated levels of IL-10 are 
observed. When levels of proliferation were measured in splenocytes and lymph node 
cells, a general reduction in proliferation was observed in cells (lymph node cells and 
splenocytes) from the animals which received L3 via mosquito transmission.
While these differences could be due to an inhibitory effect of mosquito saliva during 
the course of transmission, they may also be accounted for by fewer L3 being 
administered by mosquito transmission than by syringe inoculation. To clarify this 
point, additional experiments were carried out in which varying numbers of L3 were 
administered to mice. Somewhat surprisingly, cytokine analysis of supernatants from 
cultures of splenocytes from mice infected with 50, 25 or 10 L3 showed very little 
difference in levels of IL-4, IL-5 and IL-10. In addition, levels of Ag-specific 
proliferation between the groups was not significantly different at any time point. These 
results confirm that the L3 is an extremely potent modulator of the immune response, in 
that as few as 10 L3 polarised the immune response towards the Th2 phenotype. In 
addition, it casts doubt on the possibility that differences between syringe and mosquito 
administered L3 can be solely accounted for by variation in levels of transmission. 
Whether there is an inmumosuppressive component in saliva injected simultaneously 
with L3 when a blood meal is taken or whether natural transmission of L3 is 
immunologically “silent” requires further investigation. For example, L3 could be 
administered via syringe along with salivary gland lysate from mosquitoes.
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Interestingly, previous studies have shown that mosquito saliva contains factors which 
modulate cytokine expression (Gillespie et a l, 2000). Saliva from the malaria vector 
Anopheles stephensi has a strong neutrophil chemotactic activity (Owhashi et a l, 2001) 
while Aedes aegypti (the species used in this study) salivary gland extracts were 
reported to stimulate TNF-a release from mast cells (Bissomiette et a l, 1993). During 
mosquito transmission, L3 are deposited in the skin where they presumably encounter 
different populations of APC compared to those administered via syringe inoculation. In 
addition, they may migrate to the lymphatics with different kinetics compared to those 
administered by s.c. inoculation. Either factor could influence the subsequent immune 
response.
In conclusion it is apparent that IL-10 has an important role in controlling immune 
responses in the mouse model post-infection with the L3 of B. pahangi. However the 
way in which IL-10 modulates these responses remains inconclusive as there are many 
different ways in which this potent anti-inflammatory cytokine can operate. 
Neutralization of IL-10 in vitro resulted in the production of Thl cytokines, suggesting 
that IL-10 can suppress Thl responses, however it is not clear whether IFN-y is being 
produced by macrophages or T cells. When IL-IOR was neutralized in vivo, a different 
situation was observed where cytokine levels were unchanged but Ag-specific 
proliferation was enlianced. Experiments to examine the cellular' source of IL-10 
demonstrated that a population of CD4^ cells are the main producers of IL-10 with B 
cells contributing to a lesser extent. Further experiments to characterise the phenotype 
of these cells are presented in Chapter 5. Finally, there appeared to be no obvious role 
for IL-10 in the natural transmission of L3, in contrast to the situation observed in the 
sand üylLeishmania model. There may however be immunomodulatory properties in
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mosquito saliva which down-regulate levels of Th2 cytokines but this does not appear to 
be associated with elevated IL-10. Alternatively, natural infection with L3 may be a less 
immrmo - stimulatory route than s.c. inoculation.
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Chapter 5. The L3 of B. pahangi elicits a population of CD4 CD25 CTLA-4^ cells 
which regulate proliferation and cytokine production
5.1. Introduction
Over 40 years ago, experiments demonstrated that thymectomy of mice three days after 
birth leads to systemic autoimmiinity, indicating the importance of T cells in the 
regulation of tolerance. Recently there has been a re-emergence of interest in the theory 
of regulatory T cells. The modern view of these cells is based on research by Sakaguchi, 
who demonstrated that the adoptive transfer of T cells depleted of CD25^ cells resulted 
in multi-organ autoimmunity in recipient animals (Sakaguchi et a l, 1995; Asano et a l, 
1996). Since these seminal studies, an enormous amount has been learnt about Treg 
cells. These cells were demonstrated to induce active suppression of T cell fnnction, 
which is essential for the induction of peripheral tolerance to both foreign and self 
antigens (Roncarolo et a l, 2001b). The different subsets and properties of these cells 
have been outlined in the main Introduction, but it is also important to understand the 
role of Treg cells in relation to infectious disease. Studies carried out on Candida 
albicans have shown that CD4^CD25^ regulatory T cells are essential for memory- 
protective immunity to this fmigal infection in mice (Montagnoli et a l, 2002). Iwashiro 
et al further demonstrated a mechanism of virus-induced immunosuppression by means 
of the generation or expansion of CD4^CD25^ cells in mice persistently infected with 
the Friend retrovirus (Iwashiro et a l, 2001a; Iwashiro et a l,  2001b), while CD4^'CD25^ 
cells were shown to have an essential role in the control of Pneumocystis carinii 
pneumonia in mice (Hori et a l, 2002). In terms of parasitic infections, CD4^CD25^ 
cells have been studied in mice infected with L. major. In this system, they regulate 
progressive disease by controlling production of early IL-4, an essential cytokine
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determining whether an infected animal will progress towards a resistant (Thl) or a 
susceptible phenotype (Th2). Depletion of CD4^CD25^ cells from susceptible BALB/c 
mice resulted in increased levels of IL-4 and exacerbated disease (Aseffa et a l, 2002). 
In an additional study, resistant C57BL/6 mice were infected with L. major and it was 
demonstrated that a population of parasite specific CD4^CD25^ cells accumulate at the 
site of infection in the dermis, where they suppress the ability of effector T cells to 
eliminate the parasite from the skin (Belkaid et a l, 2002). This equilibrium between T 
effector and Treg function enables the host to develop resistance to further infection 
whilst benefiting the parasite by enabling transmission by its vector to continue. 
Removal of the CD4^CD25"^ population resulted in total eradication of the parasite from 
the site of infection, resulting in the loss of concomitant immunity. Thus it appears that 
elimination of CD4^CD25^ cells in L. major infection can make resistant mouse strains 
more resistant and susceptible mouse strains more susceptible. The Belkaid study also 
demonstrated a role for IL-10 in the survival of parasites within C57BL/6 mice, in that 
IL-10-/- mice or mice given IL-IOR Ab, eradicated the parasites resulting in a loss of 
concomitant immunity. IL-10 produced by CD4^CD25^ cells may suppress parasite 
killing by macrophages, but this does not rule out other possible mechanisms of 
suppression, such as cell-contact via CTLA-4 or GITR binding. CD4^CD25"*  ^cells have 
also been shown to have a role in modulating responses in mice infected with 
Plasmodium berghei NK65. Following infection and administration of an anti-CD25 
MAh, the proportion of CD4^CD25^ cells within the CD4~^  population decreased despite 
a general increase in the number of CD4^ cells. Depletion of CD25^ cells resulted in a 
delayed growth of parasitaemia during challenge infection, particularly in immunised 
mice. These findings are interesting in that they demonstrate that CD4"^CD25^ cells are 
able to influence protective immunity to P. berghei NK65 (Long et a l, 2003).
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In terms of fiiariasis most studies to date have considered the function of Treg cells in 
human disease. For example the role of Treg cells in onchocerciasis was examined by 
Doetze et al who demonstrated that hypo-responsiveness observed in O. volvulus 
infected individuals was associated with the presence of these cells (Doetze et a l, 
2000), More recently, analysis of T cells from individuals with lymphatic fiiariasis 
showed that a population of CTLA-4^ cells are expanded in hyporesponsive individuals. 
Addition of neutralizing Ab to CTLA-4 to PBMC culture, resulted in increased levels of 
IL-5 and decreased levels of IFN-y, indicating that CTLA-4 plays a role in maintaining 
the Thl/Th2 balance (Steel and Nutman, 2003). Finally, it has been found that S. 
mansoni specific lyso-phosphatidylserine (PS) activated the Toll-like receptor 2 and 
affected dendritic cells such that mature dendritic cells gained the ability to induce the 
development of IL-lO-producing Treg cells (van der Kleij et a l,  2002).
The experiments in this chapter set out to investigate whether Treg cells were induced 
following infection of BALB/c mice with the L3 of B. pahangi While it is generally 
considered that L3 induce a strong Tli2 response in infected mice, many previous 
observations are consistent with the induction of Tregs. These cells were characterised 
in terms of cell surface markers, cytokine production and their ability to down-regulate 
proliferative responses.
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5.2. Results
5.2.1. T cell characterization
(i) IL-10 and TGF-(3 inRNA expression in CD4+ cells from L3 infected mice
T regulatory cells frequently co-express another suppressor cytokine, TGF-p, along with 
IL-IO. Therefore the first experiments investigated the possibility that CD4"  ^ cells from 
L3 infected mice might also produce TGF- p. To address this point, quantitative RT- 
PCR was carried out using primers and probes for TGF-p, IL-10 and HPRT on RNA 
isolated from CD4^ and B cells purified from the spleens of ten L3 infected mice at 12 
d.p.i. CDd*" and B cells were purified using magnetic beads (as described in Material 
and Methods 2.6.1). In all experiments the efficiency of the purifications was greater 
than or equal to 95% (data not shown). The results of these experiments confirmed that 
CD4^ cells from L3 infected mice produced TGF-p (Figure 5.1) along with IL-10. The 
B220"  ^ population expressed very low levels of TGF-p in the experiment shown. 
However, in a subsequent experiment TGF-p was not detected in the B220^ population. 
It is notable that although the absolute amount of IL-10 expression in this experiment is 
lower than that described previously (Figure 4.5), the relative levels of IL-10 mRNA 
expressed by CD4^ and B220^ cells is similar. This finding confirms that the L3 of B. 
pahangi elicit a population of CD4^ T cells that express both IL-10 and TGF-p in the 
BALB/c mouse model.
(ii) Three-colour FACS analysis of CD4^ cells from L3 infected mice
An alternative way to identify T regulatory cells is to analyse cell surface markers 
which are associated with this population. Such markers include co-expression of CD4
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with one or more of CD25, CTLA-4 (CD 152), GITR, 0X40 (CD134), CD 103 or Ly6 
(McHugh et al, 2002). Therefore three-colour FACS analysis was carried on 
splenocytes from L3 infected, MF infected and control mice using anti-CD4 MAh 
(FITC), anti-CD25 MAb (APC) and anti-CTLA-4 (PE). Mice infected with MF were 
included in these experiments as splenocytes from these animals display a Thl-type 
cytokine profile, and it was therefore of interest to compare the expression of these cell 
surface markers in L3 and MF infected animals. In these experiments, cells were 
cultured with Ag for 72 hours prior to labelling and flow cytometry. The FACS plots in 
Figure 5.2 show results from individual mice, representative of the group of five 
animals, while Figure 5.3 shows the mean percentage of CD4^ cells which co-express 
CD25^ and CTLA-4^ for each group of five animals. These data showed that 
CD4'^CD25'^CTLA-4^ cells were expanded only in cultures from L3 infected mice 
where they comprised ~7 % of total CD4^ cells. In control or MF infected mice, this 
population accounted for ~ 2% of total CD4^ cells.
The results of this same experiment are presented in Table 5.1, and show the percentage 
of CD4"  ^cells that also express each individual marker. As would be expected, there was 
no significant difference in the percentage of lymphocytes expressing CD4^ in either 
group (L3 CD4+ vs MF CD4^, p=  0.0518; L3 CD4"" vs C CDd"", 0.0518). 
Approximately 25% of CD4^ cells from L3 infected mice expressed the activation 
marker CD25, while control uninfected mice and MF infected mice express only low 
levels of CD25 (-6-7%). This is somewhat surprising, as it might be expected that 
infection with MF would cause activation of CD4^ cells. As with CD25, CTLA-4 was 
expressed only on a significant percentage of cells from L3 infected mice. Although 
CD25 is also a marker of T cell activation, the co-expression of CTLA-4 on a
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proportion of the CD25^ population indicates that L3, but not MF, elicit a population of 
T cells with some characteristics of T regulatory cells.
5.2.2. L3 induced CD4 CD25 CTLA4^ cells are IL-4 independent
One population of T regulatory cells, the Tli3 cells have been identified in JL-4-/- 
animals which suggests that these cells do not require the Th2 pathway to undergo their 
process of differentiation (Powiie et al, 1996). It was therefore of interest to carry out 
experiments in IL-4-/- mice and compare the results to those previously described from 
L3 infected wild-type mice.
(i) IL-10 and TGF-p expression is IL-4 independent
In the first analysis, the expression of IL-10 and TGF-p mRNA was quantified from 
purified CD4^ or 8220"^ cells from IL-4-/- or WT mice, as described previously. 
Following RNA extraction and cDNA synthesis (as described in Materials and Methods 
2.6), real-time RT-PCR was carried out on the selected populations. Figure 5.4 shows
tIL-10 and TGF-p mRNA expression relative to HPRT in CD4^ and B220^ cells from L3
infected wild-type and IL-4-/- mice. Although levels of IL-10 and TGF-p mRNA were 
slightly lower in KG mice vs WT mice, the difference was not significant, suggesting 
that the expression of these cytokines are not IL-4 dependent in this model.
(ii) Three-colour FACS analysis of CD4^ cells from L3 infected wild-type and 
IL-4-/- mice
Three-colour FACS analysis was carried on splenocytes from L3 infected wild-type and 
IL-4-/- mice following in vitro re stimulation with Ag, as described previously. The
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FACS plots in Figure 5.5 show data from individual mice, representative of the group, 
while Figure 5.6 depicts the mean percentage of CD4^ cells which co-express CD25 and 
CTLA-4 in splenocytes from five L3 infected wild-type or IL-4-/- mice. This analysis 
demonstrates that there was no difference in the expression of CD25 or CTLA-4 in 
CD4"  ^cells from WT or IL-4-/- mice. Both groups of infected animals showed a large 
increase in this population compared to their uninfected counterparts (see Figure 5.6).
5.2.3. Investigating the regulatory role of CD25^ cells in vivo
The experiments described above demonstrate that a population of T cells with some of 
the characteristics of T regulatory cells was expanded in vitro, only in culture from L3 
infected mice. In order to investigate whether these cells were present in vivo and to 
investigate their function, further experiments were required. To this end, a neutralizing 
Ab (PC61) was used to deplete CD25^ cells in vivo, prior to L3 infection.
(i) Three-colour FACS analysis of CB4^ cells from L3 infected mice given 
neutralizing CD25^ Ab (PC61)
In these experiments, mice were treated with 0.5 mg (total protein) of PC61 (anti-CD25 
MAb) or 0.5 mg of GL113 (isotype matched control) on days -  4 and -2  prior to s.c. 
infection with 50 L3 of B. pahangi Administration of the MAb prior to infection is 
important to ensure that T cells activated by infection are not targeted (Onizuka et al, 
1999). On day 12 p.i., spleens were harvested and splenocytes cultured in vitro for 72 
hours with 10 pg/ml B. pahangi Ag. Three-colour FACS analysis was then carried on 
splenocytes from L3 infected mice given either PC61 or GL113, using the combination 
of anti-CD4 MAb, anti-CD25 MAb and anti-CTLA-4. The FACS plots in Figure 5.7 
show the results from individual mice, with the mean percentages of CDd"*’ cells co­
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expressing CD25 and CTLA-4 in PC61 treated mice and GL113 treated mice shown in 
Figure 5.8. In mice given PC61 MAb, there was a significant reduction in the 
percentage of CD4^CD25"*’CTLA-4'^ cells compared to those given the isotype control, 
indicating that the Ab was effectively depleting these cells. However, at the dose given, 
the PC61 Ab did not completely ablate the CD25^CTLA-4^ population. In most 
experiments, -50%  reduction in the numbers of these cells was observed.
(ii) Ag-specific and spontaneous proliferation of splenocytes from L3 infected 
mice given PC61 and GL113
To determine whether the removal of a significant proportion of the CD25^ CTLA-4^ 
population had any effect on immune responses, proliferation and cytokine assays were 
carried out. Proliferative responses of splenocytes from L3 infected mice given either 
PC61 or GL113 were measured over a time course of in vitro culture with medium only 
or 10 pg/ml B. pahangi adult Ag. Control mice received HBSS alone. Three 
experiments were carried out, each of which gave similar results (see Figure 5.9). Two 
points are immediately obvious from this experiment, firstly, levels of Ag-specific 
proliferation were significantly higher in splenocytes from mice given PC61 compared 
to mice given GL113 after 72 and 96 hours incubation. Secondly, it was notable that 
levels of spontaneous proliferation (medium only) were significantly increased in 
cultures from PC61 treated mice at all time points. The increase in the levels of Ag- 
specific and spontaneous proliferation in cultures from mice depleted of CD25^ cells in 
vivo, indicates a regulatory function for this population
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(iii) Ag-specific and spontaneous cytokine production of splenocytes from L3 
infected mice given PC61 or GL113
Cytokine responses of splenocytes from L3 infected mice given either PC61 or GLl 13 
MAb treatment and control iminfected mice were measured after 72 hours of in vitro 
culture with medium only or 10 pg/ml B. pahangi adult Ag. The results of a 
representative experiment are presented in Figure 5.10. Mice depleted of CD25^cells in 
vivo, produced significantly more IL-10 and IL-4 than animals given the isotype control 
MAb. There was also a trend for levels of IL-5 to increase but this did not reach 
statistical significance. In the experiment shown, splenocytes from mice given the 
isotype control Ab secreted low levels of IFN-y, which were not significantly altered in 
mice given PC61. Interestingly, cells from PC61 treated mice also produced large 
amounts of spontaneous cytokines in medium only cultures. As is shown in Figure 5.11, 
spontaneous IL-2 was detected in medium only culture whereas this cytokine is rarely 
seen in Ag-stimulated cultures. Table 5.2 shows the results of this experiment as the net 
levels of Ag-stimulated and spontaneously produced cytokines from mice depleted of 
CD25^ cells prior L3 infection.
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Figure 5.1. CD4 cells analysed ex vivo from L3 infected mice express more IL-10 
and TGF-p mRNA relative to HPRT mRNA than do B cells
Mice were infected s.c. with 50 L3 of B. pahangi or an equal volume of HBSS only (C). 
At day 12 p.i., splenocytes from L3 infected mice were pooled and magnetically 
separated into purified CD4^ and B220^ cells. Quantitative RT-PCR was carried out on 
these cells and levels of IL-10 and TGF-p mRNA were expressed relative to HPRT. 
Quantitative RT-PCR was carried out using the TaqMan method (as described in 
Materials and Methods 2.6.2).
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Figure 5.2. Three colour FACS analysis demonstrates that a population of CD4^ 
cells which co-express CD25 and CTLA-4 are expanded only in L3 infected mice
Mice were infected s.c. with 50 L3 or 1X10^ MF of B. pahangi, or an equal volume 
of HBSS only. At day 12 p.i., splenocytes from L3 infected (A), MF infected (B) and 
FIBSS control mice (C) were cultured with 10 pg/ml B. pahangi adult Ag for 72 
hours. Cells were harvested and stained with anti-mouse CD4 MAb, anti-mouse 
CD25 MAb and anti-mouse CTLA-4 MAb, each bound to a different flurochrome 
(CD4 -  FITC, CD25-PE, CTLA-4-APC). Cells were analysed by flow cytometry 
using gates set with isotype matched control MAb. Each panel shows the staining 
profile of an individual mouse from each group. The numbers at the top right hand 
corner of each panel indicate the percentage of CD4^ cells which are CD25’^ and 
CTLA-4\ These figures are representative of the responses of five animals per 
group.
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Figure 5.3. L3 infected mice have a higher percentage of CD4 cells which co­
express CD25 and CTLA-4 than MF infected or control animals
Mice were infected s.c. with 50 L3 or 1 X 10^  MF of B. pahangi, or an equal volume of 
HBSS only. At 12 d.p.i. splenocytes from L3 infected (L3), MF infected (MF) and 
HBSS control mice (C) were cultured with 10 pg/ml B. pahangi adult Ag for 72 hours. 
Cells were harvested and stained with anti-CD4 MAb, CD25 MAb and CTLA-4 MAb, 
each bound to a different flurochrome (CD4 -  FITC, CD25-PE, CTLA-4-APC). Graph 
depicts significant differences in the expression of CD4^CD25^CTLA-4^ cells between 
groups. Statistical analysis was carried out on results from 5 mice per group. Results are 
expressed as mean percentage of CD4^ cells expressing CD25 and CTLA-4.
L3 VS M F ,p = 0 .0 3 4  
L3 vs C,/7=0.034
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% CD4
% CD4 
co-expressing 
CD25
% CD4
co-expressing
CTLA-4
% CD4 
co-expressing 
CD25 
CTLA-4
L3 17.7 ± 1.8 24.66 ± 1.17 7.59 ±0.59 6.9 ± 0.44
MF 23 ±2.7 7.93 ±0.65 1.82 ±0.19 1.32 ±0.195
C 20.37 ±0.93 6.77±0.34 3.34 ±0.48 2.13±0.23
Table 5.1. Expression of cell surface markers on the surface of CD4^ cells from 
splenocytes of L3 and MF infected mice
Mice were infected s.c. with 50 L3 or 1 X 10 MF of B. pahangi, or an equal volume of 
HBSS only. At 12 d.p.i. splenocytes from L3 infected (L3), MF infected (MF) and 
HBSS control mice (C) were cultured with 10 pg/ml B .pahangi adult Ag for 72 hours. 
Cells were harvested and stained with anti-CD4 MAb and CD25 MAb and CTLA-4 
MAb, each bound to a different flurochrome (CD4 -  FITC, CD25-PE, CTLA-4-APC). 
Figures shown in Table 5.1 represent the % of splenocytes which express CD4’*', the 
percentage of CD4^ cells which express CD25^ alone, CTLA-4 alone and the percentage 
of CD4^ cells which co-express both of these cell surface markers.
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Figure 5.4. CD4 cells analyzed ex vivo from L3 infected IL-4-/- mice express 
equivalent levels of IL-10 and TGF-P mRNA to WT mice
IL-4-/- (IL-4 KO) and wild-type (WT) mice were infected s.c. with 50 L3 of B. pahangi 
or an equal volume of HBSS only. At day 12 p.i. splenocytes from L3 infected mice 
were pooled and magnetically separated into purified CD4^ and B220^ cells. Efficiency 
of the purification was analysed by FACS at > 95%. RT-PCR was carried out on these 
cells and levels of IL-10 and TGF-p mRNA were expressed relative to HPRT. 
Quantitative RT-PCR was carried out using the TaqMan method (as described in 
Materials and Methods 2.6.2).
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Figure 5.5. Three colour FACS labelling shows that a population of CD4 cells 
which co-express CD25 and CTLA-4 is also expanded in splenocyte cultures from 
L3 infected IL-4-/- mice
Splenocytes from L3 infected wild type (WT) (A) and IL-4-/- mice (B) were cultured 
with 10 pg/ml B. pahangi adult Ag for 72 hours. Cells were harvested and stained with 
anti-mouse CD4 MAb, anti-mouse CD25 MAb and anti-mouse CTLA-4 MAb, each 
bound to a different flurochrome (CD4 -  FITC, CD25-PE, CTLA-4-APC) and analysed 
by flow cytometry. Gates were set on CD4^ cells and these cells were then analysed for 
the expression of CD25 and CTLA-4 Each panel shows the staining profile of an 
individual mouse from each group. The numbers at the top right hand comer of each 
panel indicate the percentage of CD4^ cells which are CD25^ and CTLA-4^. These 
figures are representative of the responses of five animals per group.
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Figure 5.6. Mean percentage of CD4 cells which co-express CD25 and CTLA-4 
from L3 infected and control lL-4-/- mice and wild type mice
Splenocytes from L3 infected and control (C) wild type (WT) and IL-4-/- mice (KO) 
were cultured with 10 pg/ml B. pahangi adult Ag for 72 hours. Cells were harvested and 
stained with anti-CD4 MAb and CD25 MAb and CTLA-4 MAb, each bound to a 
different flurochrome (CD4 -  FITC, CD25-PE, CTLA-4-APC) and analysed by flow 
cytometry. Analysis was carried out on results from 5 mice per group for L3 infected 
animals and results are expressed as mean percentage. Cells pooled from five animals 
for control animals.
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Figure 5.7. Three colour FACS analysis of cells from L3 infected mice given 
neutralizing CD25 MAb show reduced levels of CD4^ cells which co-express 
CD25 and CTLA-4
Splenocytes from two groups of mice given GLl 13 (A) or PC61 (B) prior to infection 
with 50 L3 of B. pahangi, were cultured with 10 pg/ml B. pahangi adult Ag for 72 
hours. Cells were harvested and stained with anti-mouse CD4 MAb, anti-mouse CD25 
MAb and anti-mouse CTLA-4 MAb, each bound to a different flurochrome (CD4 -  
FITC, CD25-PE, CTLA-4-APC) and analysed by flow cytometry. Each panel shows the 
staining profile of an individual mouse from each group. The numbers at the top right 
hand comer of each panel indicate the percentage of CD4^ cells which are CD25^ and 
CTLA-4^. These figures are representative of the responses of five animals per group.
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Figure 5.8. Three colour FACS analysis of cells demonstrates that administration 
of CD25 blocking MAb results in a significant decrease in the percentage of CD4 
cells co-expressing CD25 and CTLA-4
Splenocytes from two groups of mice given GLl 13 or PC61 prior to infection with 50 
L3 of B. pahangi, were cultured with 10 pg/ml B. pahangi adult Ag for 72 hours. C 
represents responses in control animals. Cells were harvested and stained with anti­
mouse CD4 MAb and anti-mouse CD25 MAb and anti-mouse CTLA-4 MAb, each 
bound to a different flurochrome (CD4 -  FITC, CD25-PE, CTLA-4-APC) and analysed 
by flow cytometry. Graph displays mean data from a group of five mice.
L3 + PC61 VS L3+ GLl 13,p=0.0122
L3 + PC61 VS C/? = 0.0369
L3 + GL113 VSC/7 = 0.02
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Figure 5.9. Levels of Ag-specific and spontaneous proliferation of splenocytes 
from L3 infected mice given neutralizing CD25 MAb are significantly increased 
compared to those given isotype matched control MAb
Two groups of mice were given either PC61 (L3+PC61) or GLl 13 (L3+GL113) 
prior to s.c. infection with 50 L3 of B. pahangi. At day 12 p.i., splenocytes from 
these groups of mice and control mice (C) were cultur ed with medium only and 10 
pg/ml B, pahangi adult Ag for 48 (A),72 (B) and 96 (C) hours and proliferative 
responses were measured. Results are expressed as cpm.
Spontaneous proliferation (medium culture)
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Figure 5.10. Ag-stimulated cytokine responses of splénocytes of L3 infected mice 
given neutralising CD25 MAb are significantly increased compared to those 
given isotype matched control
Two groups of mice were given PC61 (L3+PC61) or GL113 (L3+GL113) prior to 
s.c. infection with 50 L3 of 5. pahangi. At 12 d.p.i. splenocytes from these groups of 
mice and control mice (C) were cultured with 10 pg/ml B. pahangi adult Ag. Ag- 
specific cytokine responses were measured at 72 hours. Results are expressed as 
pg/mi and all values represent the mean and standard deviation of five mice per 
group.
L3+PC61 vs L3+GL113
IL-5, ^ =0.1437
IL-4,p=0.0369
IL-10,j)=0.0216
IFN-y, p =0.8354
* significantly different.
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Figure 5.11. Spontaneous cytokine responses of splenocytes from L3 infected 
mice given neutralising CD25 MAb are significantly increased compared to 
those given isotype matched control
Two groups of mice were given PC61 (L3+PC61) or GL113 (L3+GL113) prior to 
s.c. infection with 50 L3 of B. pahangi. At 12 d.p.i. splenocytes from these groups of 
mice and control mice (C) were cultured with medium only. Spontaneous cytokine 
responses were measured at 72 hours. Results are expressed as pg/ml and all values 
represent the mean and standard deviation of five mice per group.
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Ag-stimulated 
cytokine levels 
(pg/ml)
Spontaneous 
cytokine levels 
(pg/ml)
Net amount of Ag- 
specific cytoldne 
production (pg/ml)
IL-2 0 370.06 -370.06
IFN-y 465.455 724.425 -258.97
IL-4 305.56 110.945 194.055
IL-5 12405.18 4752.275 7652.905
IL-10 3269.1 589.05 2680.05
Table 5.2. Net levels of Ag-specific cytokine production from splenocytes of mice 
depleted of CD25^ cells prior to infection with L3
A group of mice were given PC61 prior to s.c. infection with 50 L3 of B. pahangi, At day 
12 p.i. splenocytes from these groups of mice were cultured with medium only (RPMI+) 
or with 10 pg/ml B. pahangi adult Ag. Ag-stimulated and spontaneous cytokine 
responses were measured at 72 hours. To calculate the net amount of Ag-specific 
cytokine production, levels of spontaneous cytokines were subtracted from levels of Ag- 
stimulated cytokines. Results are expressed as pg/ml.
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5.3. Discussion
Experiments carried out in Chapter 4 indicated that a population of CD4^ cells produced 
IL-10 in response to L3 infection, and when IL-IOR was blocked in vivo, increased 
levels of Ag-specific proliferation resulted. With recent studies reporting that T cells 
cloned from O. volvulus infected individuals bear the characteristics of Trl cells 
(produce elevated levels of IL-10, TGF-p and express CTLA-4) (Doetze et a l, 2000; 
Satoguina et al., 2002), it was of interest to further characterize the cellular source of 
IL-10 in the B. pahangi mouse model. Therefore the experiments outlined in this 
Chapter were carried out to investigate if L3 infection resulted in the expansion of Treg 
cells and also to define the role of Tregs in L3 infection.
Initial experiments confirmed that CD4^ T cells are the main producers of IL-10, and 
also demonstrated that this population express elevated levels of TGF-|3 ex vivo. 
Characteristically, these two cytokines are associated with the presence of a regulatory 
population of T cells. Trl cells have been shown to produce high levels of IL-10 and 
TGF-p (Weiner, 2001), and Tli3 cells produce high levels of TGF-p with varying 
amounts of IL-10 (Roncarolo et a l, 2001b). The role of cytokines in the suppressive 
mechanisms of CD4^CD25^ cells is controversial. Although these cells do produce IL- 
10, it is thought that cell-cell contact is their mode of suppression, with surface bound 
TGF-p being implicated (Nalcamura et a l, 2001; Nakamura et a l,  2004). However, 
although my results show that the CD4^ population express both cytokines, they do not 
determine whether an individual cell co-expresses IL-10 and TGF-p. To confirm if an 
individual cell was producing both cytokines, intra-cellular cytokine staining, ELISPOT 
or single cell RT-PCR would be required.
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Further characterization of the CD4^ population was carried out by examining the cell 
surface expression of markers commonly associated with a regulatory phenotype. There 
are many markers which have been reported to be associated with Treg cells (GITR, 
0X40, LAP) (Read and Powrie, 2001; Nakamura et al. 2004 ). However, the markers I 
chose to use in the course of my experiments were CD4, CD25 and CTLA-4. CTLA-4 
was selected, as this molecule had been identified previously to be expressed on the 
Treg cells identified in the O. volvulus studies (Satoguina et a l,  2002). In addition, a 
significant role for CTLA-4 was recently identified in mediating the diminished parasite 
Ag-specific hyporesponsiveness observed in W. bancrofti infected individuals. In that 
study, the greatest intensity of CTLA-4 expression occurred on CD4'*'CD25'^ cells (Steel 
and Nutman, 2003). In splenocyte culture from L3 infected mice there was a significant 
expansion of CD4^ cells which co-expressed CD25 and CTLA-4, compared to cells 
from MF infected or control animals. This was, therefore, a strong indication that the L3 
of B. pahangi elicited a population of Treg-like cells in the mouse model. It was also 
observed that the percentage of activated cells (CD25‘^ ) was much higher in L3 infected 
animals compared to MF infected animals, as was the proportion of cells expressing 
CTLA-4. This is not surprising, as cells which have been activated express elevated 
levels of CTLA-4 after stimulation. However when CD4 cells co-express both 
molecules, it suggests that these cells may be regulatory in function. These results are 
intriguing, in that these cells are not expanded in MF infected mice, whereas the most 
significant down-regulation in proliferation seen in human studies is in MF+ patients. 
Also, CD25 is a marker of activation, yet in MF infected mice, the expression of this 
marker was not up-regulated. However, previous studies have shown that CD4^ cells are 
clearly activated in MF infected mice, as demonstrated by their ability to produce Ag- 
specific IFN-y (Jenson et a l, 2002) and also to express high levels of an alternative
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marker of activation, CD44 (O'Connor and Devaney, 2002).These results suggest that 
the L3 and MF stages of the parasite use different mechanisms to down-regulate 
immune responses, at least in the mouse. However the situation is bound to be more 
complex in infected humans, who are exposed to multiple life cycle stages 
simultaneously.
To further characterize these cells, parallel experiments were carried out in IL-4-/- mice. 
Previous studies showed that IL-4 was not required for the development of a population 
of Treg cells which down-regulated the effects of Thl-mediated colitis in the mouse. 
This effect was dependent on TGF-p, but these cells did not require IL-4 (Powrie et al., 
1996). Therefore RT-PCR was carried out on purified CD4^ and 3220"*' cells from WT 
and IL-4-/- mice infected with L3 to detect levels of IL-10 and TGF-p mRNA 
expression. These experiments showed that there was no significant difference in 
mRNA levels for either cytokine in the CD4^ population, supporting the hypothesis that 
these cytokines are being produced by T cells other than Th2 cells. However, Th2 cells 
can expand via an IL-4 independent pathway (Fluang et a l, 1997; Bird et a l, 1998; 
Kropf et a l, 1999) therefore, further experiments would be required to formally prove 
that IL-10 and TGF-P are expressed by Treg cells. For example, it would be possible to 
distinguish between Th2 and Treg cells by using RT-PCR to detect Foxp3, the 
transcription factor associated with Treg cells (O'Garra and Vieira, 2003; Sakaguchi, 
2003) or ST2L which is a marker for Th2 cells (Kropf et a l,  1999). However, further 
experiments carried out in IL-4-/- mice demonstrated that there was similar expansion 
of CD4'^CD25'^CTLA-4^ cells in splenocyte cultures from these animals compared to 
infected WT mice, lending fuither support to the hypothesis that these cells are a 
regulatory population, that may express IL-10 and TGF-p.
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In order to investigate the function of these cells in L3 infected mice, depletion 
experiments were carried out using an Ah (PC61), which eliminates CD25'*' cells. It was 
important to administer this Ab prior to infection, as administration post-infection 
would lead to the depletion of activated cells which express CD25 (the a  chain of the 
high affinity IL-2R) upon activation, whereas administration before infection targets 
Treg cells (Sakaguchi et a l, 1995). It is notable that ~ 25% of CD4’*' cells express CD25 
post-infection with L3 but only -  7% of this sub-population co-express CTLA-4. 
Therefore, cells co-expressing all three markers are a minor population within the 
splenocyte cultures from these animals. However results from these experiments 
demonstrated that this small population was vital in regulating immune responses to 
infection with L3. FACS analysis of splenocyte cultures from animals given PC61, 
revealed a significant reduction in the expansion CD4^CD25^CTLA4"^ cells in vitro. In 
all experiments there was approximately 50% reduction in the numbers of Treg cells 
following administration of PC61. This may relate to the fact that the MAb was not 
affinity purified prior to administration. In future experiments, the Ab could be purified 
using Protein G columns, which would allow a higher concentration of pure Ab to be 
administered and may further reduce expansion of Treg cells. Another interesting point 
from these experiments was that the percentage of CD4^CD25^ cells did not decrease in 
splenocyte cultures from mice given PC61 (data not shown), indicating that activated 
cells were not being deleted. This provides additional confirmation that the depleted 
population are regulatory cells, as opposed to activated cells.
Proliferation and cytokine assays were carried out on splenocytes from PC61 treated 
animals to investigate whether these cells had a regulatory function. Depletion of Tregs 
had a profound effect on immune Ag-specific responses but also affected spontaneous
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responses (medium only). For example, Ag-specific proliferation was significantly
' Ienhanced in PC61 treated mice. Along with the ability to down-regulate Thl responses,
■4
Treg cells can also suppress Th2 responses (although to a lesser extent) (Cosmi et a l, "%
2003), therefore, increased levels of proliferation observed in PC61 treated mice may 
reflect modulation of Th2 responses by Treg cells as proposed by Maziels and 
Yazdanbakhsh (2003). In addition, elevated levels of spontaneous proliferation were ,n
observed demonstrating an extreme dysregulation in the absence of Treg cells. Similar 
results were observed with Ag-specific cytokine responses, where levels of IL-4 and IL-
10 were significantly higher in cultures of splenocytes from mice given PC61. Increased , i■Ï
levels of IL-5 were observed in each experiment but this did not reach statistical 
significance, while no effect was observed on levels of IFN-y. In addition, the potent 
immunomodulatory effect of these cells was demonstrated by spontaneous cytokine 
production in these cultures. In intact mice, spontaneous cytokine production is never 
observed. Flowever in mice given PC61, there were elevated levels of each cytokine 
(IL-2, IFN-y, IL-4, IL-5, IL-10). Again this illustrates that removal of these regulatory 
cells appears to have resulted in major dysregulation of responses. Interestingly, in the 
absence of these cells, IL-10 was elevated, suggesting that Treg cells may regulate IL- 
10 production by other cell types, such as Th2 cells. These results suggest a complex 
network of regulation in which Thl responses ai*e limited by Th2 cells elicited by 
helminth infection, with Tregs then preventing an overwhelming Th2 response, which 
can also be damaging to the host.
Other parasitic models which have utilized the PC61 Ab to eliminate Treg cells have 
shown that the balance between T effector and Treg mechanisms is important for 
parasite clearance (Long et al., 2003; Hisaeda et a l, 2004). In addition, in the L. major
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system, elimination of CD4^CD25^ cells resulted in a sterile cure with loss of 
concomitant immunity. This is a very different model system to that described in this 
thesis, as the Belkaid studies deal with a chronic infection where up to 50% of 004^^ 
cells in the dermis are CD25"  ^cells. In addition, IL-10 produced by these CD4^CD25 ^  
cells has been shown to have an important role in parasite persistence. Transfer of 
CD4^CD25^ and CD4^CD25' cells from IL-10-/- mice into RAG-/- mice resulted in 
complete clearance of parasites. In contrast, when cells from WT mice were implanted, 
this resulted in non-healing lesions at the dermal site and maintenance of parasitaemia. 
These data indicate that IL-10 may modulate APC function, directly inhibiting IFN-y or 
rendering macrophages refractory to activation. Therefore, in this system, IL-10 has a 
role in the establisliment of persistent infection, which in the long term results in 
concomitant immunity, with benefits to both host and parasite (Belkaid et a l, 2002).
These studies and those presented in this Chapter address the question as to whether 
immune suppression elicited by Tregs protects the parasite or the host. This is a difficult 
question to answer as maintenance of parasitaemia is required for resistance in the L  
major and Plasmodium studies and also for the transmission of the parasite. From these 
studies it appears that the presence of Tregs is involved in maintenance of low-level 
infection. In the context of lymphatic filaiiasis, there are many outstanding questions. 
Do L3 elicit Treg cells in humans? Do these cells regulate immune responses that might 
otherwise kill adults and MF? How does protective immunity develop in this situation? 
Clearly, to answer these questions, further investigation into the role of Treg cells in 
filarial infection is required.
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Investigations into the role of Treg cells in infectious disease are only just beginning 
(see 5.1) as previously most studies were carried out examining their properties in 
autoimmune disease and tumour immunity. Now these cells have been shown to be 
involved in parasitic, bacterial and fungal infection. However despite recent advances 
there are still many unanswered questions relating to Treg cells. For example, three 
different subsets of Treg have been defined, CD4"^CD25^, Trl and Tli3, but there are 
many similarities between these groups and further study is required to define their 
origins. In terms of helminth infection, the work of van der ICleij and colleagues (2002) 
is very important as they identified IL-10 producing Treg cells (which were clearly in a 
separate lineage from Th2 cells), the APC driving this population and the molecule 
responsible for this immune response. Whether a similar cell type is involved in 
initiation of responses that give rise to a Treg population in the L3 infected BALB/c 
mouse remains to be seen. Further characterization of these cells and the L3-specific 
molecules which induce their development are required.
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Chapter 6. B cells modulate immune responses in mice infected with L3
6.1. Introduction
The development of appropriate and effective immune responses requires T cells to 
come into contact with antigen-bearing cells of many sorts, such as DC, macrophages 
and B cells. Various sub-groups of APC are essential in initiating and directing T cell 
responses (as reviewed in the Introduction). APC provide ligands for signalling via the %
TCR by processing and presenting Ag in the form of peptides associated with MHC 
class I or II molecules, or lipid molecules bound to CDl proteins. These cells also 
deliver a costimulatory signal to the T cell via B7-1 and B7-2 ligation with CD28 on the 
surface of the T cell. In addition, DC can influence the pathway of differentiation by the 
secretion of cytokines (Banchereau and Steinman, 1998). However, CD4"  ^ cells must 
also physically associate with Ag-bearing, Ag-receptor activated B cells (Cyster, 1999;
Jenkins et a l, 2001). B cells aie a major component of the adaptive mammalian 
immune system as they have the unique ability to secrete immunoglobulins of various 
isotypes. Alone, this property ensures that B cells are essential to immunity, but 
activated B cells can also produce a variety of chemokines and cytokines and act as 
APC. For example, the role of B cells in Ag-presentation has been described in the 
NOD mouse model of autoimmune type 1 diabetes. B cells were shown to contribute to 
the disease as they have the ability to preferentially trigger pathogenic CD4^ cells 
(Silveira et a l, 2002), thus initiating insulitis and sialitis (Noorchashm et a l, 1997). B 
cells can act as potent APC, in the main part due to the ability of the Ig receptor to 
mediate rapid and specific Ag-uptake (Chesnut and Grey, 1981). Early experiments in B 
cell-deficient mice supported the hypothesis that B cells play a significant role in Ag- 
presentation required for T cell activation (Hayglass et a l, 1986; Kurt-Jones et a l.
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1988). Ron et al (1987) described a major role, for B cells in T cell priming in LN of 
mice. Irradiated mice injected i.v. with purified T cells manifested poor T cell priming 
in the LN after s.c. injection with Ag. It was reasoned that as B cells are highly radio­
sensitive, the lack of B cells resulted in decreased levels of T cell priming. To confirm 
this, i.v. injection of B cells into irradiated recipients of T cells led to high priming of T 
cells in the LN after s.c. injection of Ag (Ron and Sprent, 1987).
Initital studies into the expression of B7 on the surface of B cells described up- 
regulation of this molecule (B7-1 was the only molecule Imown at this time) on the 
surface of activated B cells and its ligation with the CD28 receptor on the surface of 
naïve T cells. The co stimulatory effect of this interaction was also demonstrated as 
stimulation of T cells with B7^ transfected cells resulted in increased proliferation and 
production of IL-2 (Linsley et al., 1991). Further studies identified an additional ligand 
for CD28 which was constitutively expressed on the surface of DC and expressed on 
activated B cells. This molecule was named B7-2 and was shown to co-stimulate naïve 
T cells upon exposure to alloantigen. Interestingly, B7-1 was shown to be expressed on 
the surface of only a subset of B cells after 48- hours, whereas B7-2 was shown to be 
expressed on the surface of the majority of LPS-activated B cells within 6-12 hours 
post-stimulation (Lenschow et a l, 1993). In a subsequent study it was shown that naïve 
B cells do not express B7-1 and B7-2, but that engagement of the B cell receptor (BCR) 
resulted in the rapid up-regulation of B7-2 on the B cell surface. These data help explain 
why Ag-pulsed B cells are such potent APC (Lenschow et a l, 1994).
I chose to investigate the properties of B cells in relation to infection with L3 due to a 
number of key factors. Firstly, it has been shown previously that B cells preferentially 
induce a Th2 type response in OVA-specific clones from lymph node cells, compared to
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adherent cells which induce Thl type responses (Gajewski et a l, 1991). Therefore, 
there was a possibility that B cells were acting as APC post-infection with L3 in the 
mouse model, as splenocytes from infected animals produce high levels of Tli2 
cytokines. Secondly, previous data from this model system has shown that infection of 
BALB/c mice with the L3 of B. pahangi resulted in inhibited Thl responses. However, 
when APC from control mice were added to cultures in place of resident APC, this 
inhibition was reversed. Although the phenotype of the suppressive APC was not 
identified, it was notable that irradiation of the resident APC resulted in reversal of Thl 
inhibition. As mentioned previously, B cells are very sensitive to radiation, suggesting 
that B cells may be the suppressive APC in this model system (Osborne and Devaney, 
1999). In addition, recent work carried out by Wilson and colleagues, demonstrated that 
ES-62, a major ES product of filarial nematodes, has a potent immuno-modulatory 
effect on B cells, rendering them hyporesponsive to Ag-stimulation. In addition, a 
separate lineage of B cells, B1 cells, has been shown to produce IL-10 in response to 
exposure to ES-62 (Wilson et a l, 2003a; Wilson et a l, 2003b) and taken together, these 
results suggest that the secreted products of helminth parasites can modulate B cell 
responses.
Therefore, the work presented in this chapter aimed to further clarify the role of B cells 
in L3 infection, in terms of cytokine production, capacity to proliferate in response to 
Ag, and Ag presentation.
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6.2. Results
6.2.1. The role of B cells in L3 infection
(i) B cell depletion and pMT experiments
To define the role of B cells in L3 infection, experiments were carried out with groups 
of five BALB/c mice injected sub-cutaneously. with 50 L3 of B. pahangi or an equal 
volume of HBSS. At 12 dp.i., spleens were removed and B cells were depleted from 
single cell suspensions using magnetic beads and a FITC anti-mouse B220 MAb (RA3- 
6B2) (see Materials and Methods 2.5.1). The efficiency of the depletion was analysed 
by FACS and was greater than, or equal to 95% in all experiments. Proliferation and 
cytokine assays were carried out on the remaining depleted populations. In addition, 
similar experiments were carried out with groups of five L3 infected B-cell deficient 
(pMT) mutant mice on the C57BL/6 background. At 12 d.p.i. spleens were removed 
from these animals and the appropriate controls and in vitro analysis was carried out.
(ii) Ag-specific proliferative responses
Proliferative responses of splenocytes from L3 infected mice, pre- and post-depletion of 
B cells were measured after 72 hours of in vitro re-stimulation with 10 pg/ml B. 
pahangi adult Ag. As shown in the representative experiment in Figure 6.1, depletion of 
the B cell population resulted in a decrease in levels of Ag-specific proliferation (62% 
decrease in the experiment shown). In tlnee separate experiments, the mean percentage 
reduction was 49%± 15.17 compared with whole splenocytes culture (p=0.0809). As in 
vitro depletion of B cells had a major effect on Ag-specific proliferation, the role of B 
cells in L3 infection was further examined using pMT mice. As illustrated in Figure 6.2,
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levels of Ag-specific proliferation were significantly lower (85% reduction) in 
splenocytes from L3 infected pMT mice, than in wild type mice (p =0.013). Despite the 
fact that the pMT mice are on the C57BL/6 background the results were similai' to those 
obtained by depletion of B cells from BALB/c mice. These data suggest that either B 
cells may be proliferating in response to re-stimulation with Ag, or that B cells may act 
as APC for CD4^ T cell proliferation.
(iii) CFSE labelling of splenocytes from L3 infected mice
In order to define the precise role of B cells in L3 infected BALB/c mice, CFSE staining 
was carried out prior to in vitro stimulation of cells with 10 pg/ml B. pahangi adult Ag. 
At 96 hours cells were harvested and labelled with anti-CD4 MAb, anti-B220 MAb or 
CD8 MAb. The samples were then analyzed by flow cytometry. Figures 6.3 and 6.4 
show data from a representative experiment (medium only controls not shown) in which 
the proliferation of CD4^, B220^ and CD8^ cells were tracked using CFSE. The FACS 
plots in Figure 6.3 are from individual mice, whereas Figures 6.4A and B depict the 
mean results from five mice. It can be seen from these Figures that the major cell type 
proliferating in response to Ag is in fact the B cell population with proliferating B220^ 
cells accounting for 17% of the total lymphocyte population. Proliferating CD4^ cells 
accounted for ~ 5% and proliferating CD8^ cells only ~ 2.2% of the total lymphocyte 
population (Figure 6.4A). When the results are expressed as a percentage of dividing 
cells, it is clear that B cells account for the majority of the dividing cells in L3 infected 
mice (Figure 6.4B). Therefore it can be concluded that B cells have the ability to 
proliferate in response to L3 infection in an Ag-specific manner. These data confirm 
findings outlined in 3.2.4, where it was shown that B cells proliferate in response to Ag, 
in both WT and IL-4-/- mice.
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(iv) Ag-specific cytokine responses after in vitro depletion of B cells
In four separate experiments, the depletion of B cells from splenocytes of L3 infected 
mice resulted in decreased levels of Ag-specific cytokines. The results of a 
representative experiment are shown in Figure 6.5. As shown previously, levels of IL- 
10 were reduced by 40%, results which are similar to those from mRNA expression, 
where B cells were shown to account for ~ 40% of IL-10 message. However of all 
cytokines measured, levels of IL-5 were most reduced (75% in the experiment shown), 
while little difference was recorded in IL-4 levels (22% reduction in the experiment 
shown). Levels of IFN-y were increased in two out of four experiments (75% increase in 
the experiment shown), while in the remaining two experiments, there was no increase 
following B cell depletion. No IL-2 was detected in either group. The mean percentage 
decrease/increase in cytokines post-depletion of B cells in several experiments is shown 
in Table 6.1 and illustrates a consistent decrease in Th2 cytokines following B cells 
depletion.
(v) Ag-specific cytokine responses of L3 infected pMT mice
Cytokine responses of splenocytes from L3 infected and control pMT mice were 
examined at 72 hours. As shown in Figure 6.6, levels of IL-10 were reduced by 60% in 
the KO mice compared to levels in their wild type counterparts. Flowever, IL-4 and IL-5 
remained unchanged between groups. No IL-2 or IFN-y was detected in either group. 
The reduction in levels of IL-10 in pMT mice was similar to that described previously 
following depletion of B cells from BALB/c mice. However in contrast to the depletion 
experiments, there was no difference in levels of IL-5 or IL-4. It is notable that levels of 
these cytokines were considerably lower in both pMT mice and their WT counterparts
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compared to BALB/c mice. This may be due to the fact that pMT mice aie on the 
C57BL/6 background while the depletion experiments were carried out in BALB/c mice 
(the parasite induces a stronger Th2 response in the BALB/c mice than in C57BL/6 
mice).
6.2.2. Investigating a role for B7 cell surface molecules expressed on B cells
As B cells generate a Th2 like response with model Ag such as OVA, it is possible that 
these cells act as APC in mice infected with B. pahangi. An important way in which 
APC modulate T cell responses is by the expression of their costimulatory ligands B7-1 
and B7-2. Therefore the following experiments examined the role of these molecules in 
L3 infection. B7-1 and B7-2 are known to play an essential role in the proliferative 
capacity of T cells via interaction with the co stimulatory molecule CD28, so it was of 
interest to investigate the possibility of increased expression of these molecules on 
splenic cells which had been primed by the L3 compared to that of control animals. MF 
infected animals were also included in some of these experiments as these mice display 
a different, more Thl-like profile.
(i) B7-1 and B7-2 expression on the surface of B220^ cells
Splenocytes from L3 infected, MF infected and control BALB/c mice were restimulated 
in vitro with 10 pg/ml B. pahangi adult Ag for 72 hours. Cells were then harvested and 
two-colour FACS analysis was carried out to determine the percentage of B220’^ cells 
which expressed B7-1 or B7-2. Figure 6.7 shows FACS plots from individual mice, 
representative of a group of five. In control animals -7.8%  of total lymphocytes co­
express B220 and B7-1 while ~ 3.6% co-express B220 and B7-2. Following infection 
with L3 the expression of both B7-1 and B7-2 on B cells is up-regulated with -14.8% of
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all lymphocytes expressing B7-1 and B220 and 21.7% expressing B7-2 and B220. 
Infection with MF results in a similar up-regulation of B7-1 on the surface of B220^ 
cells (-15.9%) whereas approximately 10.2% of total lymphocytes from these animals 
co-express B220 and B7-2. These results indicate that infection with L3 and MF 
induces the up-regulation of both B7-1 and B7-2 on the surface of B cells. Flowever the 
L3 has the ability to up-regulate B7-2 with approximately double the efficiency of MF. 
These data also show that the vast majority of cells which express B7-1 or B7-2 are in 
fact B cells, with -90%  of B7-2"  ^ cells co-expressing B220 and 70% of B7-l^ cells co­
expressing B220 (Figure 6.8). However, further analysis of these data indicated that not 
all B cells express B7-1 or B7-2 (see Figure 6.7).
(ii) Effect of IL-10 on the expression of B7-1 and B7-2 on the surface of B220^ 
cells
Previous experiments described in this thesis have shown that neutralizing IL-10 in 
vitro has a significant effect on cytokine production in splenocytes culture from L3 
infected mice. In addition when IL-IOR was blocked in vivo levels of Ag-specific 
proliferation were increased significantly in splenocytes from infected mice. One 
mechanism by which IL-10 can affect T cell responses is via its effect on APC, where it 
is reported to down-regulate expression of B7-1 and B7-2. To assess the effect of IL-10 
on B7-1 and B7-2 in L3 infected mice, experiments were carried out using IL-10-/- 
mice and in vitro neutralization of IL-10.
(iii) Effect of in vitro neutralization of IL-10 on B7-1 and B7-2 expression
Splenocytes from L3 infected mice were re-stimulated in vitro for 72 hours with 10 
pg/ml B. pahangi adult Ag, Ag plus 1 pg/ml neutralizing IL-10 MAb or Ag plus 1 pg/ml
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isotype matched control. Cells were then harvested and two colour FACS analysis was 
performed as described previously. The results of these experiments are shown in 
Figure 6.9 demonstrate that neutralizing IL-10 results in a small, but significant increase 
in the percentage of B cells that express B7-1 and B7-2. Notably and confirming 
previous results, in all these experiments more B cells from L3 infected mice express 
B7-2 than B7-1. The percentage of lymphocytes which co-express B7-1 or B7-2 and 
B220 was increased in cultures where IL-10 was neutralized compared to Ag only or Ag 
plus isotype control cultures. Figure 6.10 shows mean results of five mice per group as a 
percentage of total lymphocytes which co-express B7-1 or B7-2 and B220.
(iv) B7-1 and B7-2 expression in IL-10-/- mice
During the course of this study, there was an opportunity to infect IL-10-/- mice on the 
C57BL/6 background at the University of Manchester. Splenocytes from L3 infected 
IL-10-/- mice and their wild type counterparts were re-stimulated in vitro with 10 pg/ml 
B. pahangi adult Ag for 72 hours. Cells were then harvested and two-colour FACS 
analysis performed as described above. Figure 6.11 shows FACS plots from an 
individual WT and IL-10-/- mouse. It can be seen that the expression of both B7-1 and 
B7-2 on B cells is elevated in IL-10-/- mice. In addition, B7-2 and in part B7-1 are also 
expressed on a significantly higher percentage of non-B cells in IL-10-/- mice. Figure 
6.12 shows the mean percentage of total lymphocytes which co-express B220 and B7-1 
or B7-2 and demonstrates a number of differences between the groups. L3 infected IL- 
10-/- mice express significantly higher levels of both B7-1 and B7-2 compared to L3 
infected WT mice, consistent with the role of IL-10 in regulating expression of these 
CO stimulatory molecules. Included in Figure 6.12 is data from eontrol animals, which 
shows that levels of B7-1 are significantly up-regulated in L3 infected KO animals
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compai'ed to control uninfected IL-10-/- mice, whereas this result did not reach 
significance in WT animals. However, when examining expression of B7-2 on B cells 
from both KO and wild type mice, levels were significantly increased between L3 
infected and control animals from both groups of mice.
(v) Effect of neutralizing B7-1 and B7-2 on Ag-specific proliferation
The following experiments were carried out to address the significance of B7-1 and B7- 
2 in the regulation of proliferation. As infection with L3 results in a significant up- 
regulation of these molecules on the surface of B cells, it was proposed that blocking 
the B7-1/2 interaction with CD28 might influence T cell proliferation.
Proliferative responses of splenocytes from L3 infected mice were measured over a time 
course from 48 to 96 hours of in vitro re-stimulation with 10 pg/ml B. pahangi adult Ag 
in culture containing 1 pg/ml neutralizing B7-1, B7-2 or both MAb or the appropriate 
isotype control. Figure 6.13 shows data from 48 and 72 hour cultures. At 48 hours, 
levels of Ag-specific proliferation were significantly reduced when either B7-1, B7-2 or 
both molecules were neutralized. However, at 72 horns levels of Ag-specific 
proliferation were only reduced significantly when B7-2 was neutralized. Neutralization 
of both molecules together resulted in reduced levels of proliferation but this failed to 
reach statistical significance. By 96 hours, no differences were observed (data not 
shown).
(vi) Effect of neutralizing B7-1 and B7-2 on Ag-specific cytokine production
Ag-specific cytokine responses of splenocytes from L3 infected mice were measured 
after 72 hours of in vitro re-stimulation with 10 pg/ml B. pahangi adult Ag, Ag plus
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1 pg/ml anti-B7-l MAb or Ag plus 1 pg/ml anti-B7-2 MAb or Ag plus both Abs. As 
shown in the representative experiment in Figure 6.14, levels of Ag-specific IL-5 were 
significantly reduced when B7-2 or both molecules were neutralized together. 
Neutralization of B7-1 also reduced levels of IL-5, but this did not reach statistical 
significance. Levels of both IL-4 and IL-10 were significantly reduced when B7-1 and 
B7-2 were neutralized simultaneously but no significant difference was observed when 
either B7-1 or B7-2 was neutralized alone. Interestingly, despite the significant decrease 
in Tli2 cytokines observed in these experiments, there was no consequent increase in 
Ag-specific IL-2 or IFN-y.
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Figure 6.1. Depletion of B cells from splenocytes of L3 infected mice 
results in reduced levels of Ag-specific proliferation
Mice were infected sub-cutaneously with 50 L3 of B. pahangi or an equal volume of 
HBSS only (C). At 12 d.p.i. splenocytes from L3 infected mice were pooled and B cells 
were depleted using MACS anti-FITC beads and magnetic columns. The negative 
fraction was then re-stimulated in vitro with 10 pg/ml B. pahangi adult Ag. Ag-specific 
proliferative responses from whole splenocytes from five animals (L3 mean), from 
pooled cells prior to depletion (L3pool+Bcells) and from splenocytes depleted of B cells 
(L3pool-Bcells) were measured at 72 hours. Results are expressed as cpm.
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Figure 6.2. Splénocytes from L3 infected pMT mice display significantly lower Ag- 
speciflc proliferation compared to their wild-type counterparts
|iMT mice on the C57BL/6 background (KO) and wild-type mice (WT) were infected 
sub-cutaneously with 50 L3 of B. pahangi or an equal volume of HBSS only. At 12 
d.p.i. splenocytes from individual mice were re-stimulated in vitro with lOpg/ml B. 
pahangi adult Ag. Ag-specific proliferative responses from whole splenocytes were 
measured at 72 hours. Results show means and standard deviations of five mice per 
group and are expressed as cpm.
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Figure 6.3. CFSE labelling of cells from L3 infected mice in Ag-stimulated 
culture shows that B cells proliferate in response to Ag
Splenocytes from BALB/c mice given 50 L3 of B. pahangi (A  - C) or an equal 
volume of HBSS (D - F), were labelled with CFSE and cultured with lOpg/ml B. 
pahangi adult Ag. Cells were harvested at 96 hours, surface stained with anti-CD4 
MAb (A and D) or anti-B220 MAb (B and E) or anti-CD8 (C and F) and analyzed 
by flow cytometry. Each panel shows the CFSE staining profile of CD4^, B220'*' or 
CD8^ splenocytes in an individual mouse. The numbers at the top left hand corner of 
each panel indicate the percentage of CD4^, B220^ or CD8^ cells displaying reduced 
fluorescence intensity in FL-1, indicating they have divided in Ag-stimulated 
culture. These figures are representative of the responses of five animals per group.
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Figure 6.4. B cells proliferate in response to L3 infection
Splenocytes from mice given 50 L3 of B. pahangi or an equal volume of HBSS (C), 
were labelled with CFSE and cultured with 10 pg/ml B. pahangi adult Ag for 96 hours. 
Cells were harvested, stained with anti-CD4 MAb, anti-CD8 MAb or anti B220 MAb 
and analysed by flow cytometry. Graph A depicts the mean results of five animals per 
group, expressed as division of individual cell types as a percentage of total 
lymphocytes. Graph B depicts the mean results of five animals per group expressed as 
division of individual cell types as a percentage of dividing cells.
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Figure 6.5. Depletion of B cells population from spleens of L3 infected mice results 
in decreased levels of Ag-specific IL-10 and IL-5
Mice were infected sub-cutaneously with 50 L3 of B. pahangi or an equal volume of 
HBSS only (C). At 12 d.p.i. splenocytes from L3 infected mice were pooled and B cells 
were depleted from culture using MACS anti-FITC beads and magnetic columns. The 
negative fraction was then re-stimulated in vitro with 10 pg/ml B. pahangi adult Ag. 
Ag-specific cytokine responses from whole splenocytes (L3) and splenocytes depleted 
of B cells (L3-B) were measured at 72 hours. Results are expressed as pg/ml.
205
IL-4 IL-5 IL-10 IFN-y
% change in 
cytokine levels 
post-depletion 
of B cells
32+11.3
DECREASE
(n-4)
80.5 ±27.5 
DECREiASE 
(n=4)
53.5 ± 14.85 
DECREASE 
(n=4)
59.5 ±40.4 
INCREASE 
(n=2)
Table 6.1. Changes in cytokine levels post-depletion of B cells
Mice were infected sub-cutaneously with 50 L3 of B. pahangi or an equal volume of 
HBSS only (C). At 12 d.p.i. splenocytes from L3 infected mice were pooled and B cells 
were depleted from culture using MACS anti-FITC beads and magnetic columns. The 
negative fraction was then re-stimulated in vitro with 10 pg/ml B. pahangi adult Ag. 
Ag-specific cytokine responses from whole splenocytes (L3) and splenocytes depleted 
of B cells (L3-B) were measui'ed at 72 hours. Results are expressed a mean percentage 
decrease or increase in cytokine levels post-depletion of B cells in four separate 
experiments, except for IFN-y which is the mean of two experiments.
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Figure 6.6. Splenocytes from L3 infected pMT mice produce less IL-10 
compared to those from L3 infected WT mice
Five pMT mice (KO) (C57BL/6 backgi'ound) and five WT mice (C57BL/6 
background) were infected sub-cutaneously with 50 of L3 B. pahangi or an equal 
volume of HBSS only. At 12 d.p.i., splenocytes from individual mice from each 
group were restimultated in vitro with lOpg/ml B. pahangi adult Ag. Ag-specific 
cytokine responses from whole splenocytes were measured at 72 hours. Results show 
means and standard deviations of five mice per group and are expressed as pg/ml.
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Figure 6.7. Two colour FACS labelling shows more B220^ cells express B7-1 and 
B7-2 in L3 and MF infected mice compared to control mice
Mice were infected s.c. with 50 L3 of B. pahangi, or 1 X 10  ^MF or an equal volume 
of HBSS only. At day 12 p.i. splenocytes from L3 infected (A and B), MF infected (C 
and D) and HBSS control mice (E and F) were cultured with 10 pg/ml B. pahangi 
adult Ag for 72 hours. Cells were harvested and stained with anti-mouse B220 and 
either anti-mouse B7-1 MAb anti-mouse or B7-2 MAb (B220 -  APC, B7-1/B7-2 - 
FITC). Cells were analysed by flow cytometry. Each panel shows the staining profile 
of an individual mouse from each group. The numbers at the top right hand corner of 
each panel indicate the percentage of splenocytes which are B220'" and either B7-1'' 
or Wl-2^. These figures are representative of the responses of five animals per group.
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Figure 6.8. The majority of cells expressing B7-1 or B7-2 co-express B220
Mice were infected s.c. with 50 L3 of B. pahangi, or 1 X 10  ^ MF or an equal 
volume of HBSS only. At day 12 p.i. splenocytes from L3 infected (A and B),
MF infected (C and D) and HBSS control mice (E and F) were cultured with 10
pg/ml B. pahangi adult Ag for 72 hours. Cells were harvested and stained with 
anti-mouse B220 and either anti-mouse B7-1 MAb anti-mouse or B7-2 MAb 
(B220 -  APC, B7-1/B7-2 - FITC). Cells were analysed by flow cytometry. 
Graphs depict levels of B7-1 or B7-2 expressing cells from L3 and MF infected 
and control animals which co-express B220.
B7-l^ cells which co-express B220 L3 VS MF p  = 0.0601 
B7-2^ cells which co-express B220 L3 VS MF p  = 0.0373
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Figure 6.9. The percentage of B cells which express B7-1 and B7-2 is elevated 
when IL-10 is neutralized
Mice were infected s.c. with 50 L3 of B. pahangi. At 12 d.p.i., splenocytes (1 x 
10^/ml) were re-stimulated in vitro with 10 pg/ml B. pahangi adult Ag (A and D) in 
the presence of 1 pg/ml neutralizing IL-10 Ab (B and E) or 1 pg/ml isotype matched 
control (C and F) for 72 hours . Cells were harvested and stained with anti-mouse 
B220 and either anti-mouse B7-1 MAb (A-C) or anti-mouse B7-2 MAb (D-F) 
(B220-APC, B7-1/B7-2 - FITC). Cells were analysed by flow cytometry. Each panel 
shows the staining profile of an individual mouse from each group. The numbers at 
the top right hand corner of each panel indicate the percentage of splenocytes which 
are B220'' and either B7-l^ or B7-2'". These figures are representative of the 
responses of five animals per group.
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Figure 6.10. Neutralizing IL-10 results in increased levels of B7-1 and B7-2 
expression on splenocytes
Mice were infected s.c. with 50 L3 of B. pahangi. At 12 d.p.i,, splenocytes (1 x 
10^/ml) were re-stimulated in vitro with 1 Opg/ml B. pahangi adult Ag in the presence 
of 1 pg/ml neutralizing IL-10 Ab (aIL-10) or 1 pg/ml isotype matched control for 72 
hours. Cells were harvested and stained with anti-mouse B220 and either anti-mouse 
B7-1 Mab (A) or anti-mouse B7-2 Mab (B) (B220 -  APC, B7-1/B7-2 - FITC). Cells 
were analysed by flow cytometry. Graphs depict the mean percentages of 
splenocytes which are B7-1/2 expressing B220'’ cells from 5 mice per group.
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Figure 6.11. The percentage of B cells which express B7-1 and B7-2 is higher in 
IL-10-/- mice
Wild-type (WT) and IL-10-/- mice were infected s.c. with 50 L3 of B. pahangi. At 12 
d.p.i. splenocytes from WT (A and C) and IL-10-/- mice (B and D) were cultured 
with 10 pg/ml B. pahangi adult Ag for 72 hours. Cells were harvested and stained 
with anti-mouse B220 and either anti-mouse B7-1 MAh or anti-mouse B7-2 MAb 
(B220 -  APC, B7-1/B7-2 - FITC). Cells were analysed by flow cytometry. Each 
panel shows the staining profile of an individual mouse from each group. The 
numbers at the top right hand corner of each panel indicate the percentage of 
splenocytes which are B220^  ^ and either B7-1'* or B7-2'''. These figures are 
representative of the responses of five animals per group.
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Figure 6.12. B7-1 and B7-2 are up-regulated on B cells from IL-10-/- mice
Wild-type (WT) and IL-10-/- (KO) mice were infected s.c. with 50 L3 o f B. pahangi. 
At day 12 p.i. splenocytes from WT and IL-10-/- mice were cultured with 10 pg/ml
B. pahangi adult Ag for 72 hours. Cells were harvested and stained with anti-mouse 
B220 and either anti-mouse B7-1 MAh (A) or anti-mouse B7-2 MAh (B) (B220 -  
APC, B7-1/B7-2 - FITC). Cells were analysed by flow cytometry. Graphs depict the 
mean percentages of splenocytes which are B7-1/2 expressing B220^ cells from 5 
mice per group.
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Figure 6.13. Neutralizing B7-1 and B7-2 in cultures of splenocytes from L3 
infected mice results in significantly reduced levels of proliferation at 48 and 72 
hours
Mice were infected sub-cutaneously with 50 L3 .6. pahangi or an equal volume of 
HBSS only. At 12 d.p.i., splenocytes were re-stimulated in vitro with lOpg/ml B. 
pahangi adult Ag. Ag-specific proliferative responses were measured at 48 (A) and 
72 (B) hours in the presence or absence of 1 pg/ml neutralizing B7-1 (AB71) or/and 
B7-2 (AB72). Results are expressed as cpm and all values represent the mean and 
standard deviation of five mice per group.
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Figure 6.14. Neutralizing B7-1 and B7-2 in cultures of splenocytes from L3 
infected mice results in significantly reduced levels of specific cytokines
Mice were infected sub-cutaneously with 50 L3 .6. pahangi or an equal volume of 
HBSS only. At 12 d.p.i., splenocytes (1 x 10^/ml) were re-stimulated in vitro with 
lOpg/ml B. pahangi adult Ag. Ag-specific cytokine responses were measured at 72 
hours in the presence or absence of 1 pg/ml neutralizing B7-1 (AB71) or/and B7-2 
(AB72). Results are expressed as pg/ml and all values represent the mean and 
standard deviation of five mice per group.
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6.3. Discussion
The results presented in this chapter indicate that B cells play an important role in the 
development of immune responses in mice infected with L3 of B. pahangi via the 
ability to proliferate, to act as APC and to produce cytokines. Infection with Brugia L3 
results in the up-regulation of Th2 cytokines and good proliferative responses at day 12- 
post infection. The contribution of B cells to this response was investigated by either 
depleting B cells from culture or by carrying out experiments in B cell deficient mice 
(pMT mice on the C57BL/6 background). The results of depletion experiments 
indicated that B cells were important in the development of good proliferative responses 
in the spleen of infected animals, as there was a 62% reduction in proliferation post­
depletion. In vivo experiments in pMT mice gave similar results, in that the proliferative 
capacity of splenocytes from L3 infected pMT mice was significantly lower than that of 
WT mice. However, these experiments do not identify the precise role of B cells, as 
removal of one population of cells may have dramatic effects on the ability of another 
population to expand. For example, B cells may proliferate in response to the L3 but 
may also act as APC for T cells, as described in other model systems (Noorchashm et 
a l, 1997; Silveira et a l, 2002). Therefore, cells from L3 infected and control animals 
were labelled with CFSE and cultured for 96 hours to track proliferation of dividing 
cells. Data from these experiments revealed that B cells were in fact the major 
splenocyte population dividing in response to Ag, confirming previous experiments in 
IL-4-/- mice (Chapter 3). Therefore, one explanation for the decrease in proliferation 
following depletion or in pMT mice is the lack of B cell expansion.
Similar to this situation, studies on the role of B cells in S. mansoni infected mice have 
shown that splenic B220" ,^ CD4', CDS' (B cells) proliferate in response to a sugar found
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on soluble egg antigen (SEA) named lacto-N-fucopentaose (LNFPIII) which contains 
the trisaccharide Lewis^ Ag. In addition, LNFPIII induced splenic B cells to produce IL- 
10 (Veiupillai and Harn, 1994). Whether the L3 of B. pahangi contain similar molecules 
that induce B cells to proliferate and produce cytokines is not known. Fmther 
experiments in murine S. mansoni infection examined the role of B-1 cells 
(CD5'"B220'’) from the peritoneum of infected animals. These cells are autoreactive, 
have been shown to produce large amounts of IL-10 and are typically found in the 
peritoneal and plural cavities but not in the spleen (O'Garra et a l, 1992). Exposure to 
SEA or LNFPIII resulted in elevated numbers of B-1 cells in susceptible hosts (CBA/J, 
C3H/HeJ and BALB/c). These studies also identified a role for IL-12, IL-10 and IFN- 
Y in regulating the expansion of B-1 cells (Veiupillai et a l, 1996). Although the focus of 
these studies was peritoneal B-1 cells, it was also observed that coincident with the 
decline in B-1 expansion observed 5 to 6 weeks post-infection, splenic CD23 '"B220'  ^
cells increased from 11% to 30% of total splenocytes. These results indicate that the 
expansion of B-1 cells at 2 to 3 weeks post infection may initiate the down-regulation of 
Thl responses and that the continued release of IL-10 by splenic B cells during the 
acute phase of infection may continue to polarize the immune response towards a Th2 
phenotype (Veiupillai et a l, 1997). Therefore, in that model system B cells are 
expanding and also producing Th2 enhancing cytokines.
These results are similar' to data presented in this Chapter, in that B cells proliferate in 
response to infection with the L3 of B. pahangi and also contribute to the production of 
cytokines such as IL-4, IL-5 and IL-10. In the absence of the splenic B cell population, 
levels of IL-5 and IL-10 were dramatically reduced, while a more modest effect on IL-4 
levels was observed. One interpretation of these results is that B cells are affecting the
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ability of T cells to produce Tli2 cytokines, an observation supported by the production 
of IFN-y in the absence of these suppressive Th2 cytokines. These results indicate the 
importance of B cells in maintaining a Th2 type environment in WT mice. An 
alternative explanation is that B cells themselves are a source of Th2 cytokines, as 
demonstrated for IL-10 in Chapter 4. Additional studies will be required to address this 
point using either TaqMan RT-PCR or ELISPOT. In this study, an interesting 
correlation was observed between the strength of the IL-10 response and the production 
of IFN-y post-depletion of B cells. For example-, in the experiment shown in Figure 6.5 
levels of IL-10 were reduced to approximately 6400 pg/mi post-depletion of B cells. In 
the other experiment where IFN-y was detected, levels of IL-10 were reduced to 4000 
pg/ml following B cell depletion. However, in the experiments where IFN-y was not 
detected following the removal of B cells, IL-10 levels were much higher, 
(approximately 20,000 pg/ml post depletion). Thus, it is possible that the intensity of the 
IL-10 response determines whether IFN-y is produced or not. The differences in IL-10 
levels between experiments may relate to the viability of L3 used or the differences in 
the batch of Ag used to re-stimulate the splenocytes.
Interestingly, in L3 infected pMT mice there were no significant differences in cytokine 
production compared to WT animals. Presumably in vivo in pMT mice, other cell types 
compensate for the lack of B cells by acting as APC for cells. It is notable that 
levels of IL-10 and IL-5 were lower in L3 infected pMT mice than in WT mice, 
although these differences did not reach statistical significance. In addition, no IFN- 
y was detected in the KO animals as was observed in some B cell depletion 
experiments. However, these results are complicated by the fact that the pMT mice 
available were on the C57BL/6 background while all other experiments used BALB/c
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mice. Ideally, further experiments would be carried out using KO mice on the BALB/c 
background. Although the removal of B cells results in a decrease in Ag-specific Th2 
responses, L3 are still capable of inducing a-Tli2 response in infected pMT mice, 
reinforcing the concept that this life cycle stage is important in driving the T helper bias.
The results of this present study are in contrast to the situation observed with T. muris 
infection of pMT mice (Blackwell and Else, 2001). These animals were permissive to 
infection, producing significantly less IL-4 and IL-5 compared to resistant WT mice. In 
addition T. muris infected pMT mice produced increased levels of IFN-y compared to 
WT mice indicating that these mice mount a Thl response in the absence of B cells, 
thus conferring susceptibility. The importance" of B cells in this model system was 
further eonfirmed when it was shown that reconstitution with B cells from WT mice 
restores resistance to T. muris, with elevated levels of IL-4 and IL-5.
B cells can modulate the host response to parasitic infection, particularly via their 
capacity to produce IL-10. Additionally, B cells may also enhance the production of IL- 
10 and Th2 cytokines from other cell types while down-regulating potentially harmful 
Thl responses. The role of B cells has been investigated in other parasitic infections 
using Xid mice, which are deficient in B-1 cells. Lack of B-1 cells and B-cell derived 
IL-10 in mice carrying the Xid immunodeficiency was associated with reduced Th2- 
induced granuloma formation in S. mansoni infection (Velupillai ei a l, 1997) and 
lowered susceptibility to L  major (Floerauf et a i,  1994). The Xid mouse has also been 
used in studies on L. sigmodontis. Worm development in susceptible BALB/c mice is 
controlled by CD4^ cells and worm loads correlate negatively with Th2 cytokine 
production. BALB/c.Xid mice were shown to be more susceptible than WT mice to L3
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of L. sigmodontis with a lower Th2 response, which was attributed to the decrease in IL- 
10 from B cells (Al-Qaoud et a l, 1998). These studies further support the hypothesis 
that B cells are a source of IL-10 in many parasite systems.
One way in which IL-10 modulates the immune response is via the regulation of B7-1 
and B7-2 on the surface of APC. The up-regulation of these ligands on the surface of B 
cells post-infection with L3 implies that B cells act as APC in this model. As the ligand 
for CD28 and CTLA-4, the level of expression of B7-1 and B7-2 on APC is an 
important determinant of T cell activation. FACS analysis of splenic B cells illustrated 
that infection with L3 resulted in a significant up-regulation in levels of both B7-2 and 
B7-1 compared to control animals. In addition there was a significant increase in the 
percentage of B220^ cells that express B7-2 in L3 infected mice compared to that of MF 
infected mice. Up-regulation of B7-2 is consistent with the observation that L3 elicit a 
strong proliferative response and induce Th2 like cytokines in the mouse model. 
However in MF infection reduced capacity to up-regulate B7-2 may partially account 
for reduced levels of proliferation observed in splenocytes from MF infected animals. 
However, expression of B7-1 on the surface of B220^ cells from MF infected mice was 
equal to that of L3 infected mice. Co-stimulation via B7-1 has been shown to be 
associated with up-regulation of Thl responses (Freeman et a l,  1995; Kuchroo et a l, 
1995), therefore this may be a contributing factor to the production of IFN-y in cultures 
from MF infected mice. Co-stimulation via B7-2 in L3 infected mice may be a strong 
enough stimulus to promote a Th2 over a Thl response.
The role of IL-10 in modulating expression of B7-1 and B7-1 on the surface of B cells 
from L3 infected mice was first examined using a neutralizing IL-10 MAb in vitro. It
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was found that neutralizing IL-10 resulted in significant up-regulation of both B7-1 and 
B7-2. These results were further substantiated in a single experiment in which IL-10-/- 
mice on the C57BL/6 background were infected with L3 of B. pahangi. B cells from IL- 
10-/- animals exhibited elevated levels of both B7-1 and B7-2 compared to those of 
their WT counterparts. These data confirm previous findings that IL-10 regulates the 
ability of cells to proliferate via its effect on APC. Therefore it is possible that B cells 
act in a negative feedback mechanism to restrict Th2 expansion in mice infected with 
L3 of Brugia. B cells produce IL-10, which in turn modifies the expression of surface 
costimulatory molecules, thus attenuating their own efficiency in presenting Ag to T 
cells. This may be a further important mechanism of regulating Th2 responses in 
Brugia infection.
To further clarify the role of B7-1 and B7-2 in L3 infection, these molecules were 
neutralized in vilro and cytokine and proliferation assays were carried out. When B7-1 
and B7-2 were neutralized together there was a significant reduction in proliferation of 
splenocytes from L3 infected mice at 48 and 72 hours. The effects of neutralizing B7-1 
and B7-2 individually also gave interesting results. When B7-1 was neutralized alone, 
proliferation was only significantly reduced at 48 hours and levels recovered after this 
time point. However, when B7-2 was neutralized levels of proliferation were 
significantly inhibited at 48 and 72 hours. It has been reported previously that B7-1 and 
B7-2 deliver different costimulatory signals. Stimulation of naïve T eells with B7-2 
results in a more Th2 like response with the production of IL-4, by comparison to 
stimulation with B7-1 (Freeman et a l, 1995). With this in mind it is probable that 
neutralizing B7-2 will have a greater effect on levels of proliferation in response to the 
L3 as this life cycle stage induces Tli2 cells. However the results of these experiments
2 2 1
suggest that B7-1 does play an important role in the co-stimulation of T cells, at least at 
48 hours of culture, as a reduction in proliferation was observed at this time point. 
Cytokine responses in these cultures were also examined and levels of IL-5, IL-4 and 
IL-10 were significantly reduced when B7-1 and B7-2 were neutralized simultaneously. 
Only IL-5 was reduced significantly when B7-2 was neutralized alone, whilst 
neutralizing B7-1 had no significant effect on any of the cytokines measured (although 
levels of IL-5 were reduced, this did not reach statistical significance). As there was no 
concurrent increase in the levels of Thl cytokines, it is likely that the reduction in 
cytokine levels reflects lower levels of proliferation in these cultures.
The results presented in this chapter highlight the importance of B cells in filarial 
infection, in terms of the expression of costimulatory molecule (i.e. acting as APC), 
producing anti-inflammatory cytokines and proliferating in response to infection. While 
results of the depletion experiments indicate that B cells provide help for Th2 cells, 
pMT mice also generate a Th2 response. These results indicate that B cells are not 
essential for Th2 generation and provide further evidence for the strong Th2 priming 
nature of the L3.
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C hapter 7. General Discussion
Lymphatic filarial worms have an extraordinary ability to modulate host immune 
responses. These long-lived helminth parasites down-regulate pro-inflammatory 
iimnune responses (Maizels et a l, 2000), in a maimer which protects the parasite from 
being eliminated, but in turn, minimizes severe pathology in the host. PBMC from 
infected individuals display a skewing of the immune response, secreting IL-4 and IL- 
10 in favour of inflammatory Thl cytokines. IL-4 is the prototype Th2 cytokine and IL- 
10, although produced by many cells types, has recently been shown to be produced by 
Treg cells (Groux et a l, 1997; Poussât et a l,  2003; Battaglia and Roncarolo, 2004). In 
fact, in some studies, neutralizing IL-10 or TGF-P in cultures of PBMC from infected 
individuals resulted in elevated levels of proliferation (King et a l,  1993). Therefore, 
what was once thought to be a skewing of the immune response towards a Th2 
phenotype, is also likely to involve the expansion of regulatory cells; together these 
mechanisms will result In the down-regulation Thl responses and suppression of Ag- 
speciflc proliferation in infected individuals. However Treg cells suppress both Thl and 
Th2 responses and it is equally likely that Treg cells in lymphatic filariasis also function 
to suppress over-expansion of Th2 cells, which can also be pathogenic. In endemic 
areas some degree of proliferative suppression occurs in each clinical group, even EN 
and those who have cleared their parasites (Yazdanbakhsh et a l,  1993a). This suggests 
that the L3 may be the cause of this suppression, as all groups are constantly exposed to 
incoming infective larvae. In addition, proliferative suppression has been linked to 
intensity of L3 transmission, lending further support to the theory that the L3 is a highly 
immunoregulatory life cycle stage (King, 2001).
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Results described in this thesis confirm that the L3 of B. pahangi is a potent modulator 
of immune responses in the mouse model. Previous experiments have shown that IL-4 
mRNA transcripts can be detected in draining lymph nodes of mice at 24 hour post­
infection with L3 (Osborne and Devaney, 1998). In the current study, it was 
demonstrated that IL-4 was essential for down-regulating Thl responses, as elevated 
levels of IL-2 and IFN-y were detected in splenocytes from L3 infected IL-4-/- mice. In 
addition, levels of Ag-specific proliferation were significantly reduced, with B cell and 
CD4^ expansion inhibited in the absence of IL-4. These results demonstrate that in WT 
mice, L3-driven IL-4 has a major effect on Thl cells. Extrapolation of these results to 
humans would suggest that infection with L3 may lead to the development of IL-4 
producing cells prior to the establishment of patent adults. Interestingly, in areas of high 
transmission of W. bancrofti, plasma IL-4 increases but PBMC derived IL-4 does not, 
indicating that IL-4 may be produced by cells other than T cells. In fact, it was shown 
that basophils preferentially respond to L3 extracts with IL-4 secretion (King et a l, 
2001). As these cells are present in the dermis, events in the skin immediately following 
infection may be an important determinant of subsequent responses. The importance of 
early events in the skin was well documented in a study by Hogg et al, who 
demonstrated that elevated levels of IL-12 were detected in skin-draining lymph nodes 
following immunization with irradiated cercariae of S. mansoni. In that study, IL-10 
was implicated in the development of immunity, as challenge infection with irradiated 
parasites resulted in lower levels of IL-10. IL-10 was also shown to have an important 
role in controlling inflammation at the infection site as IL-10-/- mice displayed a 
thickening of the dermis with elevated cellular infiltration to the site. Thus, production 
of early IL-10 at the site of infection controls Thl events which lead to immunity (Hogg 
et a l, 2003). In this study, immune responses were compared in the draining lymph
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node and spleen of mice infected by mosquito transmission or syringe inoculation of 
L3. No major effect was observed, although it was notable that lymphocytes from mice 
that had been infected via mosquito transmission were generally less responsive to Ag 
restimulation. However, whether mosquito transmission of L3 is immunologically 
“silent” or whether mosquito saliva contains immunomodulatory factors, has yet to be 
determined. In light of work carried out in the schistosome model, future studies should 
attempt to investigate cytokines and cell types which are present at the site of infection.
Although IL-4-/- mice showed a dramatic change in the immune response to the L3, 
there was no difference in worm recovery compared to WT mice . However, there was a 
significant difference in the levels of MF produced by adult female worms in IL-4-/- 
mice. Therefore, IL-4, or IL-4 driven responses, appears to affect the fecundity of the 
adult worm. It is interesting to consider whether IL-4 may have a similar effect in 
humans. Although there are no studies that have indicated a direct link between MF 
levels and IL-4, a seasonal study of infected individuals showed that MF density 
decreased in April to July and increased in July to November. IFN-y levels appeared to 
be associated with low parasite density, but a small increase in IL-4 levels was noted 
between July and November in MF+ subjects. These results are difficult to interpret as 
the numbers of individuals studied was very small and there are known differences in 
mosquito biting rates (and presumably transmission of L3) in wet and dry areas 
(Sartono et a l, 1999).
Along with IL-4, IL-10 has been implicated in the control of Thl responses (Moore et 
al., 2001). As infection of mice with L3 of Brugia leads to elevated levels of IL-10 with 
diminished Thl responses, experiments were carried out to determine the role of this
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inliibitory cytokine. Results from these experiments indicated an important role for IL- y
10 in down-regulating Thl responses and in addition, when IL-IOR was blocked in vivo, j
levels of proliferation were significantly enhanced. This increase in proliferation was
,S
found to be CD4 specific, as levels of B cell proliferation were unaffected. These 
results are similar to those observed using PBMC from infected humans where 
spontaneous and Ag-driven levels of IL-10 correlate negatively with levels of T cell
sproliferation (Mahanty et a l,  1996b). Additionally, neutralizing IL-10 resulted in a |
4significant elevation in levels of lymphocyte proliferation to filarial Ag in MF infected
5humans (King et a l, 1993). In the infected human, MF Ag has been implicated in the
"I
production of IL-10, but the data presented in this thesis suggest that the L3 is also an 
important stage for the induction of an IL-10 response. Although infected humans (who 
harbour all life cycle stages) have been shown to express high levels of both 
spontaneous and Ag-specific IL-10, it is very difficult to study the human disease in 
terms of stage-specific responses and this is where the laboratory animal is extremely 
useful. While long-lived adult parasites or MF probably have a role in maintaining the 
production of IL-10, which ultimately suppresses damaging Thl responses and T cell 
proliferation, the initial life cycle stage which induces IL-10 may be the L3.
In the past, immune responses in lymphatic filariasis used the Thl/Tli2 dichotomy to 
explain the down-regulation of IFN-y and proliferation associated with active infection. 
However, further studies indicated that lymphatic filariasis did not fit neatly into the 
Thl/Tli2 cross-regulation observed in inbred mouse models of parasite infection (Allen 
and Maizels, 1997). For example, while IFN- y is clearly suppressed, so is IL-5, 
suggesting that both Thl and Tli2 responses are modulated over the course of infection 
(Sartono et a l, 1997). Thus, additional mechanisms of suppression have been the focus
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of recent studies. IL-10 has long been known to be produced by a variety of cell types 
(Fiorentino et a l, 1989), However the concept of Treg cells has been the focus of many 
recent studies. The suppressive activity of at least two of the Treg subsets (Th3 and Trl 
cells) is associated with IL-10 and TGF-p, while the role of cytokines is controversial in 
the mode of action of the CD4'^CD25^subset. These cells are thought to function via a 
cell-cell contact dependant mechanism, which may involve surface bound TGF-(3 or 
CTLA-4. The notion that Treg cells may be elicited in filarial infection is not surprising 
as the generation of a suppressive cell type could explain immune responses in infected 
individuals. For example, the induction of IL-10 and TGF-p, proliferative 
hyporesponsiveness, down-regulation of IFN-y and IL-5 responses and constant 
exposure of T cells to parasite Ag all support the hypothesis that filarial worms may 
induce Treg cells. The first formal proof of a Treg population in filarial infection came 
with the cloning of T cells from PBMC of O. volvulus infected individuals. These T 
cell clones had a unique cytokine profile consistent with Trl cells (no IL-2 but high IL- 
10 and/or TGF-y6 production) (Doetze el a l, 2000). In addition, CD4’*'CD25’^ CTLA-4^ 
cells have been shown to be important in maintaining the Thl/Th2 balance in W, 
bancrofti individuals (Steel and Nutman, 2003). As these are chronic infections of 
humans it might be expected that the long-lived adult worms would induce such a 
population. Therefore, it was somewhat surprising during the course of these 
experiments in L3 infected mice, to identify a population of CD4"  ^ cells which co­
express CD25^ and CTLA-4^, suggesting that regulatory T cells are being generated in 
response to the L3. These cells were not observed in MF infected animals or control 
uninfected animals suggesting that, at least in the mouse, this is an L3-specific effect. In 
additional experiments, adult worms were implanted into the peritoneal cavity of mice, 
but this did not result in the development of these cells in the spleen (data not shown).
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This observation may be due to the fact that peritoneal implantation does not result in 
vigorous immune responses in the spleen. However, CD4^CD25^CTLA4^ cells were 
elicited in L3 infected IL-4-/- mice and these mice also had the ability to express IL-10 
and TGF-p, demonstrating that these cytokines are being produced via an IL-4 
independent pathway. Although the development of Treg cells may be associated with 
chronic infection and long-term exposure to Ag, these experiments demonstrate just 
how potent the effects of infection with the L3 can be. The profound 
immunomodulatory effects of the L3 are also evident in infected humans as 
demonstrated in studies in PNG by King et al (2001), who compared immune responses 
of individuals from villages with different levels of L3 transmission. Immune responses 
were suppressed in individuals from the high transmission village, even when MF and 
CFA levels were equivalent, indicating an L3-speciflc effect. Levels of proliferation of 
PBMC from individuals from the high transmission village were 11-fold less than that 
of those from the low transmission village. A degree of “spill over” was also observed, 
as PBMC from individuals in the area of high transmission also had a reduced capacity 
to proliferate in response to non-parasite Ag and PHA.
Experiments described in this thesis attempted to demonstrate the regulatory function of 
the CD4'CD25^ CTLA-4"'' cells by depletion with an anti-CD25 MAb (PC61). PC61 
treatment resulted in a 50% reduction in the expansion of CD4^CD25"''CTLA-4^ T cells 
from L3 infected mice and Ag-specific and spontaneous cytokine and proliferative 
responses were increased in these cultures. Further studies are required to phenotype the 
cells that expand in the absence of Tregs cells, but these are likely to be T cells 
(Sakaguchi et a l,  1995). Interestingly, when the Treg population was reduced, elevated 
levels of IL-10 were observed. However the depletion of these cells appeared to
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override any of the effects of IL-10 described previously, i.e. down-regulating Thl 
responses and proliferation. These data therefore implicate a Treg population in the 
control of immune responses to the L3 and gives rise to an interesting question. Are 
these T cells naturally occurring and non-specific or is there a population of Treg cells 
which can develop into Ag-specific T cells after exposui'e to L3? Other studies on the 
role of Treg cells in bacterial (McGuirk and Mills, 2002) and protozoan infection 
(Belkaid et a l, 2002) have also addressed this point, with Belkaid at al defining a 
population of L. major Ag-specific CD4'''CD25^ Treg cells at the site of infection 
(Belkaid et a l, 2002). In addition, parasites may have the ability to mediate the 
conversion of naïve T cells to Treg-like cells by mechanisms, such as that described by 
van der Kleij et al In that study DC were shown to induce IL-10 producing Treg cells 
when matured in the presence of a lipid fraction from S. mansoni eggs (van der Kleij et 
a l, 2002). Further analysis is clearly required of parasite moleeules, which drive this 
response, along with more precise characterization of Treg cells.
Other experiments in this thesis aimed to examine to role of B cells in filarial infection, 
an area which has been neglected until recently. Both macrophages and DC have been 
implicated in driving the characteristic Th2 response elieited by helminth infection. For 
example work by the Allen lab has described the development of alternatively activated 
macrophages in the peritoneum of C57BL/6 mice infected with L3 or adult worms of B. 
malayl These cells were shown to be IL-10 independent and IL-4 dependent, but have 
not yet been identified in the spleen or in the BALB/c mouse (MacDonald et a l, 1998; 
Alien and Loke, 2001). Alternatively activated macrophages suppress the proliferation 
of T cell clones and non-lymphoid cells by a cell-contact dependent mechanism (Loke 
et a l, 2000b). DC have also been shown to be important in the generation of a Th2
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response, as demonstrated by studies using the PC bearing ES62 secreted by A. vitae 
(Goodridge et a l,  2001). However, as B cells have been shown to be a source IL-10 
preferentially diverting naïve T cells towards the Th2 pathway (Gajewski el a l,  1991), 
experiments were carried out to examine the role of these cells In L3 infection. B cells 
were shown to be the major proliferating population in splenocyte cultures from L3 
infected mice and were shown to be an important source of IL-10. Depletion of B cells 
also resulted in diminished levels of IL-4 and IL-5, and interestingly in two out of four 
experiments, levels of IFN-y were increased, suggesting that B cells preferentially 
inhibit Thl responses by affecting Th2 expansion, perhaps through the production of 
IL-10 or via effects on T cells during Ag presentation. To investigate the latter, the 
expression of costimulatory molecules B7-1 and B7-2 were measured on the B cell 
surface. Firstly it was shown that levels of B7-2 were significantly up-regulated on the 
surface of B cells from L3 infected animals compared to MF infected or control mice. 
This observation is in keeping with other studies which have demonstrated that B7-2 is 
important in the generation of a Th2 response. Another interesting finding in these 
experiments was that in L3 infected IL-10-/- mice, or when IL-10 was neutralized in 
cultures from L3 infected WT mice, a significant increase in B7-1 and B7-2 was 
observed. These results suggest that IL-10 has no preference for either molecule and 
demonstrates a mechanism by which IL-10 might be involved in modulating of 
proliferative responses in this model system. The production of IL-10 by B cells and 
consequent down-regulation in B7-1/2 expression, is proposed to represent a negative 
feedback mechanism to control CD4^ responses in the mouse.
One important factor which is missing from these studies is an understanding of the 
component/s of the L3 which cause the characteristic skewing of the immune response.
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Molecules associated with immunomodulation have been identified in B. malayi from 
the EST project (Maizels et a l, 2001). For example a cystatin which interferes with the 
MFIC class II pathway, blocking Ag-presentation has been characterized (Manoury et 
a l, 2001). A similar molecule is secreted by O. volvulus (onchocystatin) (Schonemeyer 
et a l, 2001). B. malayi MF have also been shown to synthesize and release 
Prostaglandin E%, and this molecule may have effects on macrophages and DC (Liu et 
a l, 1992). Therefore it would be of considerable interest to investigate whether 
molecules secreted by the L3 of B. pahangi, are involved in eliciting a population of 
Treg-like cells, or inducing the production of high levels of IL-4, TGF-|3 and IL-10.
The results presented in this thesis have identified novel mechanisms by which the L3 
modulate immmie responses, particularly with respect to B cell expansion and the 
development of a Treg-like population. These data confirm that the L3 use a 
multiplicity of mechanisms to influence the host immune response. However it is 
important to remember that the L3 can also induce protective immunity in both mice 
and man, suggesting that under the appropriate conditions the immune response can 
override the modulatory effects of the L3. With the identification of novel molecules 
which stimulate protective immunity (Gregory et a l, 2000), the challenge for the future 
will be to dissect the mechanistic basis by which the host-parasite interaction results in 
a balance between regulatory and effector functions.
2 3 1
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